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ABSTRACT 
 
The term frontotemporal lobar degeneration (FTLD) describes a heterogeneous group of 
neurodegenerative disorders associated with frontal and temporal lobe atrophy. Within this 
spectrum, two progressive aphasia syndromes, progressive nonfluent aphasia (PNFA) and 
semantic dementia (SD), are well described. FTLD is commonly a genetic disorder and 
mutations in two genes, microtubule-associated protein tau (MAPT) and progranulin (GRN) 
account for a large proportion of familial cases.  
 
A retrospective imaging study using cortical thickness measures shows involvement of the 
anteroinferior temporal lobes in SD and the left inferior frontal lobe/insula in PNFA. Studies 
of disease severity and of longitudinal imaging reveal spread through the left hemisphere 
and into the right hemisphere in both groups.  
 
A genetics and heritability study shows that PNFA can be familial, although much less than 
the behavioural variant of FTLD, and that this is often due to mutations in GRN. Differing 
patterns of atrophy are shown between different genetic mutations and also between 
different pathologies with the same clinical syndrome.  
 
Evidence from the neurological, neuropsychological, neuroanatomical, genetic and 
pathological features of the nonfluent aphasias suggests that there are at least three 
nonfluent aphasia syndromes: a disorder with motor speech impairment with or without 
agrammatism, a disorder with agrammatism but no apraxia of speech (found in patients with 
progranulin mutations) and a disorder without agrammatism or apraxia of speech but with 
word-finding pauses (consistent with descriptions of logopenic/phonological aphasia and 
pathologically associated with Alzheimer’s disease).  
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Studies of specific deficits (single word processing, prosody, neologistic jargon, apraxia and 
behavioural symptoms) in the progressive aphasias provide further insight into the disease.  
 
This thesis therefore provides neurological, neuropsychological and imaging data with 
related genetic and pathological information that can provide greater insights into the 
natural history and classification, and therefore pathophysiological basis of the 
neurodegenerative disorders that cause primary progressive language impairment. 
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most point of Sylvian fissure to superior-lateral most point of medial temporal lobe, D) Slice before the accessory 
gyrus inclusion, E) Slice after the accessory gyrus inclusion. 
2.1.2 Poorly segmented scan during initial phase of Freesurfer cortical thickness pipeline 
 
3. Neuroanatomy of language impairment in FTLD  
3.1.1 Longitudinal series of coronal and axial T1 MR images from pathologically-confirmed patients with SD (TDP-43-
positive pathology type 1, Sampathu classification) and PNFA (tau-positive Pick’s disease). Three scans, registered 
into the same space and each separated by approximately one year, are shown in order to highlight the progression 
in atrophy, as described in the summary section. The images are shown in radiological convention i.e. left 
hemisphere on the right of the picture.  
3.3.1  Pattern of significantly thinner cortex in A) SD and B) PNFA compared to controls (coloured bar represents 
FDR corrected p-values) 
3.3.2 Pattern of significantly thinner cortex in A) pathologically-confirmed SD and B) pathologically-confirmed PNFA 
(represented on an averaged brain, top, and an inflated cortical map, bottom) compared to controls (coloured bar 
represents FDR corrected p-values)  
3.3.3 Percentage cortical thickness difference from controls in SD in groups 1, 2, 3 and the total group (only lateral 
views are shown, coloured bar represents percentage thickness difference). 
3.3.4 Percentage cortical thickness difference from controls in PNFA in groups 1, 2, 3 and the total group (only 
lateral views are shown, coloured bar represents percentage thickness difference).  
3.4.1 Rate of atrophy of the right temporal lobe as a function of the rate of atrophy of the left temporal lobe in each 
of the 21 patients with semantic dementia  
 
4. Genetics and pathology of language impairment in FTLD 
4.3.1 Age at onset, age at death and duration of disease is shown in the GRN mutation carriers (GRN +ve), MAPT 
mutation carriers (MAPT +ve) and GRN-negative FTLD-U (U+ GRN-ve). The dotted vertical line indicates the mean 
age at clinical onset for each group. Red lines = bvFTD, dark blue lines = PNFA, light blue lines = SD, yellow lines = 
CBS, grey = ‘dementia’ unspecified. 
4.3.2 Annualized rates of whole brain atrophy (as measured using the boundary shift integral) in the MAPT mutation 
(diamonds) and GRN mutation (triangles) groups as well as the controls (circles). 
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4.3.3 Left/right hemisphere volume ratio in the three groups (A) and in patients with longitudinal imaging as a 
function of disease duration (B)!
4.3.4 VBM analysis on grey matter (GM) regions in GRN- and MAPT-associated FTLD relative to healthy controls. 
The colour bar (lower right) indicates the t score. Left (L) and right (R) markers are shown for ease of reference 
however this analysis was performed on flipped images (see above).  
4.3.5 VBM analysis on white matter (WM) regions in GRN- and MAPT associated FTLD relative to healthy controls. 
The colour bar (lower right) indicates the t score. Left (L) and right (R) markers are shown for ease of reference 
however this analysis was performed on flipped images (see above).  
4.3.6 VBM analysis comparing grey matter (GM) and white matter (WM) atrophy between GRN- and MAPT-associated 
FTLD groups. The top panels show regions where tissue intensity was reduced in the GRN group relative to the 
MAPT group (GRN<MAPT) and bottom panels show regions where tissue intensity was reduced in the MAPT group 
relative to the GRN group (MAPT<GRN). The colour bar (lower right) indicates the t score. Left (L) and right (R) 
markers are shown for ease of reference however this analysis was performed on flipped images (see text).  
4.4.1 Left/right hemisphere volume ratio as a function of disease duration: TDP type 1 (black diamonds), Pick’s 
disease (grey triangles), MAPT mutations (red squares). The dotted lines represent the upper and lower limit of the 
control ratio. 
4.4.2 Cortical thickness maps showing patterns of thinning compared to controls, corrected for multiple 
comparisons at FDR<0.01. Top row: TDP type 1, Pick’s disease and MAPT mutation groups versus controls; 2nd and 
3rd rows, a conjunction analysis looking at the overlap in patterns of thinning between the groups compared to 
controls. 
 
5. Heterogeneity of the nonfluent progressive aphasia variants 
5.2.1 Examples of spontaneous speech from nonfluent aphasic patients (total time in seconds for which the patients 
spoke in each example is given in parentheses, speech production errors are italicized) 
5.3.1 Cortical thickness maps showing patterns of cortical thinning in disease groups compared to healthy controls. 
For each disease panel, left hemisphere sections are shown above and right hemisphere sections below. Maps are 
thresholded at p<0.001 after FDR correction over the whole brain volume.  The coloured bar represents FDR 
corrected p-values.  
5.3.2 Cortical thickness maps showing patterns of cortical thinning in between disease-group differences. For each 
disease panel, left hemisphere sections are shown on the left and right hemisphere sections on the right. Maps are 
thresholded at p<0.05 after FDR correction over the whole brain volume. The coloured bar represents FDR 
corrected p-values. 
5.3.3 VBM analysis on grey matter regions in PPA groups relative to healthy controls. For each axial section, the left 
hemisphere is shown on the left; sagittal sections are through the left hemisphere. Maps are thresholded at p<0.05 
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after FDR correction over the whole brain volume.  Grey matter differences are colour coded (red-yellow) in terms 
of t-score as indicated on the colour bar (right). 
5.3.4 VBM analysis on grey matter regions in disease group comparisons.  For each axial section, the left 
hemisphere is shown on the left. Maps are thresholded at p<0.001 uncorrected.  Grey matter differences are colour 
coded (red-yellow) in terms of t-score as indicated on the colour bar (lower right). 
5.3.5 VBM analysis on white matter regions in PPA subgroups relative to healthy controls.  For each axial section, 
the left hemisphere is shown on the left; sagittal sections are through the left hemisphere. For control comparisons, 
maps are thresholded at p<0.05 after FDR correction over the whole brain volume; for disease group comparisons, 
maps are thresholded at p<0.001 uncorrected.  White matter differences are colour coded (red-yellow) in terms of t-
score as indicated on the colour bar (right).The LPA subgroup showed no significant areas of white matter loss 
relative to other disease groups at the prescribed threshold. 
5.4.1 Coronal T2 magnetic resonance sections of GAA’s brain (left hemisphere shown on the right) three years after 
symptom onset, showing predominantly left fronto-temporo-parietal atrophy 
5.4.2 Series of five registered T1-weighted MRI images from 8.5 years pre-symptom onset to 1.5 years after 
symptoms in case PAF: a) Symptom onset -8.5 years; b) Symptom onset -1.5 years; c) Symptom onset -6 months; d) 
Symptom onset + 6 months; e) Symptom onset + 1.5 years 
5.4.3 Sagittal and coronal MRI images in case PAF with voxel-compression-mapping overlay over time period:  a, 
Symptom onset -6 months to +6 months ; b, Symptom onset +6 months to +1.5 years 
5.4.4 Whole brain (a) and hemisphere (b) volumes from baseline to 13 years after baseline 
5.5.1 Asymmetry ratio (left:right hemisphere volumes) as a function of disease duration in years  
5.5.2 Patterns of cortical thinning in the AD-PPA groups versus healthy controls, categorized by severity of anomia: 
group1 (less severe: A), group 2 (most severe: B), For each hemisphere, the top panels are lateral views, the bottom 
panels medial views. Percentage thinning maps are shown; the coloured bar represents percentage values. 
5.6.1 Cortical thickness maps showing patterns of cortical thinning in disease groups (yellow/red) compared to 
controls (blue): A) PNFA without PSP and B) PSP-PNFA. No significant areas of thinning were seen in a comparison 
of PSP-RS and controls. Left hemisphere is shown above, right hemisphere below; for each hemisphere, the top 
panels are lateral views, the bottom panels medial views. Coloured bar represents FDR corrected p-values.   
5.6.2 Cortical thickness maps showing patterns of cortical thinning in disease comparisons: A) PNFA without PSP 
(yellow/red) versus PSP-PNFA (blue) and B) PSP-PNFA (blue) versus PSP-RS. Left hemisphere is shown above, right 
hemisphere below with lateral views shown. Left sided pictures represent significance maps with coloured bar 
representing uncorrected p-values; right-sided maps represent percentage thinning maps with coloured bar 
representing a percentage value. 
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6. Further neuropsychological and behavioural studies 
6.1.1 VBM analysis correlating grey matter with scores on the naming, comprehension and reading tasks in the PPA 
cohort. Statistical parametric maps (SPMs) have been thresholded at p<0.05 (FDR corrected) and rendered on a 
study-specific average group T1-weighted MRI template image in DARTEL space. The colour bar (right) indicates the 
t score. The right hemisphere is shown on the right side of the image in the coronal sections. 
6.2.1 Diagram showing the design of task 1, testing the acoustic processing of prosodic components: A) pair 
discrimination  subjects heard either a pair of syllables of same pitch, duration and intensity or two pairs of 
differing pitch, intensity (represented by thicker rectangle) or duration; and B) contour discrimination  subjects 
heard two 4-syllable sequences (1 and 2, in either order) for either pitch, intensity or duration and were asked to say 
whether same or different.  
6.3.1 Coronal T1-weighted MR images (with left hemisphere shown on the right of the images) through the frontal, 
mid-temporal, posterior temporo-parietal  and posterior parietal regions and a sagittal MR image through the left 
temporo-parietal region with a voxel-compression-mapping overlay to show the progression of regional atrophy 
(degree of volume loss and expansion coded in the colour scale: red represents 20% or greater expansion of voxels 
and blue represents 20% or greater contraction of voxels.): A) Case 1: coronal images 5 years after symptom onset; 
sagittal image shows change over time period 3.5 to 5 years from symptom onset B) Case 2: coronal images 4.5 
years after symptom onset; sagittal image shows change over time period 3.5 to 4.5 years from symptom onset  
6.4.1 Diadochokinetic rate score (A), orofacial apraxia score (B) and limb apraxia score (C) as a function of disease 
duration in each of the patients. Mild, moderate and severe score cut-offs (based on ABA-2 norms) are denoted by 
dotted lines. 
6.4.2 VBM analysis correlating grey matter loss with diadochokinetic rate (apraxia of speech) score (A), orofacial 
apraxia score (B) and limb apraxia score (C). Statistical parametric maps (SPMs) have been thresholded at p<0.001 
(uncorrected) and rendered on coronal (left), axial (middle) and sagittal (right) sections of a study-specific average 
group T1-weighted MRI template image in DARTEL space. In coronal and axial sections, the left hemisphere (L) is 
shown on the left side of the image as indicated. All sagittal sections are through the left hemisphere. 
6.5.1 VBM analyses on grey matter regions in contrasts based on presence versus absence of abnormal behaviours 
as shown. Statistical parametric maps (SPMs) have been thresholded at p<0.001 (uncorrected) and rendered on a 
study-specific average group T1-weighted MRI template image in DARTEL space. In coronal and axial sections, the 
right hemisphere (R) is shown on the right side of the image. Left (L) and right (R) markers are shown for the sagittal 
sections. 
 
7. General conclusions: the progressive aphasias 
7.1.1 Clinico-pathological and clinico-genetic associations in primary progressive aphasia. PPA as a syndrome has 
heterogeneous genetic and pathological associations. However, the importance of subtyping PPA is shown by the 
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third row of boxes which show in a schematic manner the pathological associations with SD, PNFA, LPA and with 
the familial GRN-associated form of PPA, where one pathological subtype tends to dominate. Each of the 
pathological subtypes are indicated by a separate coloured box: FTLD-TDP types 1 to 3 or type unclear if subtyping 
had not been performed, FTLD-tau (corticobasal degeneration, CBD; progressive supranuclear palsy, PSP; and 
Pick’s disease), and Alzheimer pathology.  
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ABBREVIATIONS 
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MRI  Magnetic resonance imaging 
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1. Introduction 
Acquired impairment of language in humans is most commonly seen as a result of stroke but 
over the last thirty years it has been recognized that neurodegenerative disorders can also 
cause an aphasia (Warrington, 1975; Mesulam, 1982; reviewed in Grossman et al, 2004; 
Hodges et al, 2007). The aim of this thesis is to study the group of patients who present with 
progressive language impairment from a number of different aspects: the clinical and 
neuropsychological features, the neuroanatomy, and the genetic and pathological causes of the 
disorder. This introductory chapter starts with a discussion of the clinical syndromes in which 
aphasia can be a presenting syndrome of neurodegenerative disease, namely frontotemporal 
lobar degeneration (FTLD) and primary progressive aphasia (PPA). In particular, the two most 
well-defined aphasia subtypes, semantic dementia (SD) and progressive nonfluent aphasia 
(PNFA) are introduced and defined. A simple model of language production is presented to 
understand the linguistic deficits that occur in FTLD and PPA, before comparing these disorders 
with the features that occur in the more common acute stroke aphasias. 
 
Progressive language impairment as a primary feature of neurodegenerative disease was 
initially described by Pick in the late 19th Century (Pick, 1892) and such cases continued to be 
described intermittently in the early 20th Century. However, recent decades have seen a 
resurgence of research in this field. In a series of studies, Mesulam described a group of 
patients with “primary progressive aphasia” (PPA) who had a variety of different impairments of 
language (Mesulam, 1982; Mesulam, 2001; Mesulam, 2003). Independently, in the mid 1970’s 
Warrington described patients with progressive impairment of semantic memory (Warrington, 
1975), which was later to be called semantic dementia (Snowden et al, 1989). Although 
language impairment dominated the presentation in these groups it was observed that many of 
these patients later developed behavioural features similar to the disorder frontotemporal 
dementia (Snowden et al, 1992) and hence in the “Neary criteria” of 1998 (Neary et al, 1998) 
the term ‘frontotemporal lobar degeneration’ (FTLD) was introduced to cover three disorders: 
the behavioural syndrome of frontotemporal dementia (FTD or behavioural variant FTD, 
bvFTD) and two syndromes presenting with language impairment, namely progressive 
 19 
nonfluent aphasia (PNFA), a disorder of speech production with agrammatism, and semantic 
dementia (SD), a disorder of semantic knowledge which commonly presents with fluent 
aphasia and loss of vocabulary. The overlap of the progressive aphasias with FTLD was noted 
to be not just in terms of the clinical syndrome but also in terms of the underlying pathology 
(Neary et al, 1998; McKhann et al, 2001; Mackenzie et al, 2007).  
 
PPA is a relatively rare disorder but there are no large epidemiological studies and so it is 
unclear exactly how common it is as a syndrome or the relative preponderance of the PNFA 
and SD subtypes within the overall PPA or FTLD spectrum. PPA may be familial, particularly 
when the underlying syndrome is PNFA and this is discussed in detail in Chapter 4. The non-
genetic risk factors for PPA are unclear although one study has shown an increased frequency 
of learning disability in patients with PPA and their first-degree relatives (Rogalski et al, 2008). 
 
Speech and language pathways: where they can go wrong 
The linguistic deficits seen in PPA as in other aphasia disorders can be understood by 
identifying where the normal speech and language pathway (Levelt et al, 1999) can go wrong. 
In a simple model of language production, the key stages include:  
1. Generation of verbal thought 
2. Semantic knowledge: the knowledge of concepts including the meaning of words 
3. Word retrieval 
4. Phonology: the selection and ordering of individual sounds into syllables and words 
5. Grammar: the ordering of words at the level of phrases and sentences, including the use of 
‘function words’ (articles, prepositions and conjunctions) 
6. Motor programming: phonetics, articulation and prosody 
Each of these stages can go wrong to cause a different language deficit and often multiple 
levels of deficit occur in the same syndrome. 
 
1. Generation of verbal thought 
Many patients with neurodegenerative disease participate less in conversations as a non-
specific result of reduced facility with language but in some cases a reduction in propositional 
 20 
speech can be the primary impairment where the patient seems literally to have ‘nothing to 
say’. This problem has been called dynamic aphasia (Luria et al, 1967; Costello et al, 1989; 
Robinson et al, 1998; Warren et al, 2003; Robinson et al, 2006) and such patients are thought 
to have a selective deficit at the level of the generation of verbal thought: although the amount 
of speech is reduced, the sense and structure of the message (provided it can be generated in 
the first place) usually remain intact. Sentence generation is dependent on context: a patient 
may be able to describe a simple picture but may not be able to talk about an everyday topic or 
may provide a sparse (but error-free) description of a complex scene. Compared to this 
decreased spontaneous output, speech can be produced relatively normally in specific 
contexts, such as naming tasks, repetition or reading. A similar decrease in speech output 
occurs in many patients with frontal and subcortical deficits who exhibit a generalized inertia 
and slowing of thought. However in pure dynamic aphasia there is retained ability to generate 
novel non-verbal material such as song, suggesting that dynamic aphasia is a true language 
disorder and not simply a consequence of abulia (Warren et al, 2003). This syndrome is 
probably relatively rare and is generally not thought of as one of the key PPA syndromes. 
 
2. Semantic knowledge  
Some patients lose the ability to access the meaning of words i.e. their verbal semantic 
knowledge. This is usually evident as a deficient vocabulary with the patient using approximate 
or imprecise expressions (circumlocutions) that substitute for a single word (e.g. ‘the thing’, ‘the 
whatchamacallit’), and speech (though fluent) may seem vague and lacking in substance. Errors 
of meaning or ‘semantic paraphasias’ may be evident as context-inappropriate words (for 
example, ‘dog’ may be used when ‘pig’ is meant). Superordinate or descriptive terms (such as 
‘animal’) are used rather than more specific ones (such as ‘squirrel’ or ‘lobster’) and often 
accompany the use of circumlocutory phrases in an attempt to compensate for the deficiency 
of verbal knowledge.  (It should be noted that ‘semantic paraphasias’ do not occur just in 
patients with semantic impairment but occur in any patient with word-finding difficulty.) There 
may also be increased reliance on stereotyped expressions, stock phrases and clichés. Such 
fluent but ultimately empty speech is characteristic of conditions in which there is damage to 
the verbal knowledge store, the paradigm for which is SD (Warrington 1975, Snowden et al, 
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1989; Hodges et al, 1992). In this situation the patient is usually anomic and has impaired 
comprehension of single word meaning.  
 
3. Word retrieval 
Some patients have difficulty retrieving words from the lexicon despite evidence that 
comprehension of the meaning of words (i.e. verbal semantic knowledge) is well preserved. In 
this situation there may be prolonged word-finding pauses affecting both spontaneous discourse 
and naming. This occurs in typical amnestic Alzheimer’s disease (AD) and may occur relatively 
early in the disease (Bayles et al, 1987; Emery, 2000).  
 
4. Phonology 
Impaired phonological structure manifests as speech sound errors, or ‘phonemic (‘literal’) 
paraphasias’ at the level of individual words and syllables, most commonly substitutions 
(‘crabon’ for ‘crayon’), transpositions (‘aminal’ for ‘animal’), omissions (‘elphant’ for ‘elephant’) 
or additions (‘hippopototamus’ for ‘hippopotamus’) (Duffy, 2005). Such errors often first appear 
and remain more evident with polysyllabic words. This is seen in the PNFA syndrome and may 
be a very early symptom (Neary et al, 1998). 
 
5. Grammar 
Impaired grammatical structure (agrammatism) typically manifests as disjointed or ‘telegraphic’ 
speech composed of single words and short phrases, omitting function and connecting words 
(e.g. ‘bird sat branch’). Incorrect ordering of words may occur, grammatical elements such as 
plurals or tenses may be misused or binary grammatical alternatives (such as ‘yes-no’, ‘him-
her’) may be confused (Frattali et al, 2003). As with phonological deficits, this is also seen in 
the PNFA syndrome and is generally considered one of the primary features of this disorder 
(Neary et al, 1998). 
 
6. Motor programming of speech: phonetics, articulation and prosody 
Impairment at any of the levels detailed in 1-5 above is generally considered an aphasia i.e. an 
impairment in language. However, impairments later in the speech pathway i.e. in motor 
 22 
programming usually affect the volume, rate, rhythm and intonation rather than the content of 
speech. The dysarthrias are disorders of articulation and usually caused by disease outside of 
the cortex i.e. extrapyramidal disease and with cerebellar and subcortical (pseudobulbar or 
bulbar) pathologies. However, cortical disease can also cause impairment of articulation: 
apraxia of speech (AOS) is a term that has been used to describe a motor speech disorder 
which (by analogy with other ‘apraxias’) can be defined operationally as impairment of the 
motor gestures of speech that is not attributable to a primary motor deficit (Darley, 1969; Croot, 
2002; Ogar et al, 2005). Although the cognitive basis of AOS remains controversial, it is likely 
to arise at the level of cortical programming of phonetics, the step in speech production where 
the phonological structure is converted into an ‘articulatory score’ that directs the relevant 
muscles of the vocal tract to produce the word or phrase. AOS is probably therefore 
synonymous with phonetic breakdown or disintegration. The characteristic features of AOS are 
slow speech rate with hesitancy (difficulty initiating utterances), effortfulness (with articulatory 
groping, i.e. multiple attempts at trying to get to the right word and self-correction, worse with 
longer words), phonetic errors (errors in the shaping and timing of individual syllables) and 
dysprosody (abnormal rhythm, stress and intonation, partly attributable to poor phonetic 
sequencing) (Dabul, 2000; Croot, 2002; Duffy, 2005; Ogar et al, 2005; Duffy, 2006). Patients 
may describe the problem as a stutter or stammer. AOS is seen in the PNFA syndrome and 
although it was included as a supportive diagnostic feature in the Neary criteria (Neary et al, 
1998) other studies have considered it a primary feature of the syndrome (Gorno-Tempini et al, 
2004a; Josephs et al, 2006).  
 
Other components of the motor programme that are functionally separate from phonetic 
encoding can also be disrupted by neurodegenerative disease: a key example is prosody, the 
intonational pattern of pitch, stress and timing that constitutes the ‘melody’ of speech (Ross, 
1981). Many patients with speech-production difficulties lose the normal rhythms of 
conversational speech and the ability to regulate fine pitch and accent shifts. If severe, 
dysprosody may disrupt the intelligibility of the utterance as a whole and could be 
misinterpreted as a primary verbal problem. Commonly, dysprosody is secondary to poor 
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articulation (e.g. in PNFA) but rare cases of primary progressive dysprosodia have been 
described (Confavreux et al, 1992; Ghacibeh et al, 2003). 
 
Summary of clinical features in PNFA and SD (Table 1.1) 
The characteristic features of PNFA are the presence of agrammatism and hesitant, effortful 
speech secondary to apraxia of speech. Spontaneous speech is therefore nonfluent with the 
presence of sound errors (phonetic and phonemic) (Weintraub et al, 1990; Tyrrell et al, 1991; 
Turner et al, 1996; Westbury et al, 1997; Neary et al, 1998; Gorno-Tempini et al, 2004a; Ogar 
et al, 2007). Most patients will eventually become mute. Other features include anomia that is 
initially mild with a suggestion that verb naming may be affected more than nouns (the 
opposite pattern to that seen in SD: Hillis et al, 2002; Hillis et al, 2004a). The underlying 
cognitive deficit causing anomia has not been completely clear in PNFA and although there is 
some evidence that a primary word retrieval deficit is implicated this may not be the only or 
primary domain (Rogalski et al, 2008). Semantic knowledge and single word comprehension 
are essentially normal early in the disease but usually become affected a number of years into 
the illness (Blair et al, 2007). The cause of impaired single word comprehension in PNFA as the 
disease develops is also unclear although there have been reports of patients with very early 
processing deficits in the comprehension pathway of an auditory agnosia (Uttner et al, 2006). 
As well as the expressive agrammatism seen in PNFA, patients also have receptive 
agrammatism and a sentence comprehension deficit (Cooke et al, 2003; Grossman et al, 
2005a; Peelle et al, 2007). Patients perform poorly on complex sentences but relatively 
normally with simple sentence structures. Patients with PNFA have an early difficulty with 
repetition of polysyllabic words and sentences. This progresses such that later in the disease 
even monosyllabic word repetition becomes difficult. The impaired polysyllabic word 
repetition compared to intact single word comprehension has been suggested to be a simple 
bedside measure for distinguishing the nonfluent aphasias from SD e.g. asking the patient to 
repeat hippopotamus and then point to which is the picture of the hippopotamus (Hodges et al, 
2008). Patients with PNFA often have a phonological dyslexia and writing may be agrammatic 
with phonological errors although this tends to be affected later than speech.  
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Non-linguistic cognitive domains can also be affected in PNFA e.g. calculation and limb praxis 
(Joshi et al, 2003). Episodic memory is relatively intact in patients with PNFA as are 
visuospatial and visuoperceptual skills. Although language impairment is the dominant feature 
early on in the disease patients may develop behavioural features similar to the behavioural 
variant of FTLD as the disease progresses. Early on this may be a co-existing depression 
(Medina et al, 2007) but later there may be apathy, anxiety or irritability (Marczinski et al, 
2004; Rosen et al, 2006; Banks et al, 2008). Neurological examination may reveal a 
parkinsonian syndrome or more rarely motor neurone disease. 
 
The characteristic features of SD are anomia and impaired single word comprehension 
secondary to a deficit in verbal semantic knowledge. Spontanous speech is relatively fluent but 
empty in content and circumlocutory with semantic errors. There is loss of the use and 
understanding of words that were formerly in the patient’s vocabulary. The underlying deficit is 
in semantic knowledge and as the disease progresses deficits in non-verbal domains develop, 
the most common being an associative visual agnosia (Bozeat et al, 2000; Adlam et al, 2006). 
Patients also have a surface dyslexia i.e. a difficulty in reading ‘irregular’ words (which they 
regularize e.g. reading pint as rhyming with mint) and this is also due to loss of verbal semantic 
knowledge. Behavioural symptoms are more common in SD than PNFA with patients often 
developing disinhibited behaviour or changes in appetite behaviour as the disease progresses 
(Snowden et al, 2001; Rosen et al, 2006). Neurological examination is usually normal in 
patients with SD. 
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Table 1.1 
Summary of clinical features of SD and PNFA 
!
 PNFA SD 
Spontaneous speech 
Slow with hesitancy, effortfulness 
secondary to motor speech disorder 
and/or agrammatism 
 
Phonetic/apraxic errors 
Phonemic errors 
Normal rate but fluent, empty and 
circumlocutory 
 
Semantic errors 
Semantic knowledge/ 
single word 
comprehension 
Initially intact but in late disease 
becomes affected 
Impaired secondary to verbal 
semantic impairment 
Word retrieval/naming 
Initially can be normal but anomic as 
disease progresses 
Anomia 
Grammar/sentence 
comprehension 
Impaired for complex sentences 
Normal initially but becomes 
impaired as single word 
comprehension deteriorates 
Single word repetition 
Impaired with phonetic/apraxic 
errors 
Normal 
Sentence repetition Can be impaired 
Often normal initially but can make 
transposition errors 
Motor speech 
impairment/apraxia of 
speech 
Present None 
Reading Phonological dyslexia Surface dyslexia 
Other cognitive 
domains involved 
Can later develop dominant parietal 
impairment (dyscalculia, limb 
apraxia) particularly if associated 
with corticobasal syndrome 
Non-verbal semantic impairment, 
can develop object 
agnosia/prosopagnosia 
Behavioural symptoms Depression, apathy Disinhibition, appetite change 
Neurological 
examination 
Can be associated with a 
parkinsonian syndrome or rarely 
motor neurone disease 
Usually none 
!!
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Other phenotypes of language impairment in neurodegenerative diseas 
Although PNFA and SD are the most common of the progressive language disorders, other 
disorders have been described. The rare disorders of progressive “dynamic” aphasia (probably 
secondary to a deficit at the level of generation of verbal thought: Warren et al, 2003) and 
progressive dysprosodia (a primary prosodic deficit: Confavreux et al, 1993; Ghacibeh et al, 
2003) have been described above. A disorder which has been described as being relatively 
common by one research group is logopenic aphasia (more recently also called the 
logopenic/phonological variant of PPA, LPA), held to be secondary to a deficit in short term or 
working memory (Gorno-Tempini et al, 2004a; Gorno-Tempini et al, 2008; Wilson et al, 
2009b). Less common phenotypes described include progressive anomia or non-fluent anomic 
aphasia where anomia is the initial symptom (Snowden et al, 2003; Snowden et al, 2007b; 
Pickering-Brown et al, 2008) or progressive mixed aphasia where features of both PNFA and 
SD occur early in the same disorder (Grossman et al, 2004; Alladi et al, 2007). Chapter 4 of 
this thesis investigates the heterogeneity of progressive language disorders in more detail. 
 
Current investigation and levels of classification of progressive language impairment  
The syndromes of progressive language impairment are currently described at a clinical level 
i.e. by the cognitive deficits seen during bedside cognitive testing and in particular 
neuropsychological assessment. This is mirrored in the current descriptive criteria for the 
disorders: the 1998 Neary criteria for FTLD (Neary et al, 1998) describe the features of PNFA 
and SD; the 2001 McKhann criteria for FTD (McKhann et al, 2001) merely describe a 
“language presentation of frontotemporal dementia” without specifying any subtypes; and the 
“Mesulam criteria” (Mesulam, 2001; Mesulam 2003) describe the features of “primary 
progressive aphasia”, also without specifying any subtypes (and in this case separating the 
progressive language disorders completely away from the behavioural disorder of 
frontotemporal dementia). Although neuroimaging, particularly structural magnetic resonance 
imaging (MRI) or functional imaging (posititron emission tomography, PET, or single photon 
emission computed tomography, SPECT), have been used in the diagnostic process they 
currently only form a relatively minor part of criteria e.g. as non-specific supportive features in 
the Neary criteria. However, the feature of focal temporal lobe atrophy in SD has often led to it 
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being described at a neuroanatomical level as the “temporal variant” of FTLD by some 
research groups (e.g. Seeley et al, 2005). The neuroimaging features of the specific subtypes are 
described in more detail in Chapters 3 and 5. Beyond the clinical/neuropsychological and 
anatomical descriptions of the progressive aphasias it has been difficult to provide a 
comprehensive pathological or genetic level of classification for these disorders. Whilst most of 
the disorders that present with language impairment seem to have one of the proteinopathies 
considered to be a “FTLD pathology” i.e. a problem in either of the proteins tau or TDP-43, a 
minority of the patients have the same pathology as Alzheimer’s disease (i.e. amyloid plaques 
and tau neurofibrillary tangles). This has led some groups to describe patients as having a 
“language presentation” of Alzheimer’s disease, which is logically a different level of 
classification to describing a progressive language disorder as having PNFA, SD or one of the 
other clinical phenotypes. The underlying genetics and pathology of these disorders is 
described in Chapter 4. 
 
Management of progressive language impairment 
There are currently no symptomatic or curative pharmaceutical therapies for PNFA or SD. 
Some small trials have taken place without any clearly positive results (bromocriptine: Reed et 
al, 2004; galantamine: Kertesz et al, 2008) as well as a number of unsubstantiated single case 
reports of the use of a variety of drugs (Tobinick, 2008; Decker et al, 2008). Although there is 
no clear evidence base, many patients find speech and language therapy helpful to provide 
communication strategies: the use of Augmentative and Alternative Communication methods 
are little studied but low-technology input such as communication notebooks are generally 
favoured over more high-technology devices such as hand-held computers (Rogers et al, 2000; 
Beukelman et al, 2007). Genetic counselling is important in those with a family history and/or 
a known mutation. 
 
A comparison of progressive language impairment with acute language impairment 
Although there is considerable overlap between the vascular aphasic syndromes and the 
progressive aphasias, certain features are more typically seen in one setting rather than the 
other.  
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Anomia occurs in all aphasias: in aphasic stroke it commonly remains as an isolated deficit as 
recovery occurs (Kertesz et al, 1977) whereas pure anomia is rare (or rarely persists as an 
isolated feature) in degenerative disease, reflecting the progressive nature of the disease 
process. 
 
Deficits of single word comprehension are characteristic of SD and are also common in acute 
lesions involving the anterior temporal lobe (notably herpes simplex encephalitis) (Warrington 
et al, 1984; Noppeney et al, 2007) and the posterior superior temporal lobe (Hillis, 2007). 
Category effects are more common in the acute setting (Lambon Ralph et al, 2003; Noppeney 
et al, 2007), perhaps because they require complete destruction of a discrete functional region, 
rather than the more diffuse and partial damage that attends degenerative pathologies.  Fluent 
aphasia arising from acute damage involving the posterior superior temporal lobe (so-called 
‘Wernicke’s area’) (Wernicke, 1874) tends to be associated with less severe impairment of 
single word comprehension and more prominent phonological errors and neologisms (‘jargon 
aphasia’) than are observed in the fluent aphasias of degenerative disease.  
 
Phonemic errors are seen both in acute (‘Broca’s aphasia’) and chronic progressive (PNFA) 
settings, and are classically associated with nonfluent aphasia. Phonological breakdown often 
co-exists with agrammatism, so that patients with PNFA or with Broca’s aphasia typically have 
telegraphic or ‘agrammatic’ speech and concurrent deficits at the level of sentence 
comprehension (Grossman et al, 2005a). Furthermore, just as PNFA is commonly associated 
with progressive AOS, so patients with a Broca’s aphasia often have an accompanying AOS 
(Dronkers, 1996; Hillis, 2007).  
 
Classically, ‘transcortical’ and ‘conduction’ aphasias are considered to arise from acute 
damage respectively involving the cortical ‘centres’ for speech comprehension and production 
or the anatomical pathways connecting these centres (Lichtheim, 1885). ‘Transcortical’ sensory 
and motor aphasias are associated with relative sparing of speech repetition despite defective 
comprehension and production, respectively (Goldstein, 1912). Conversely, the hallmark of 
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‘conduction aphasia’ (Lichtheim, 1885; Bartha et al, 2003) is a relatively selective deficit of 
speech repetition at the level of phrases, with relatively well preserved spontaneous speech, 
suggesting a disruption of the transfer of information between input and output speech 
pathways. These different patterns are generally observed as acute vascular syndromes, but 
transcortical motor aphasia has features similar to dynamic aphasia while transcortical sensory 
aphasia closely resembles the fluent aphasia of the SD syndrome, and conduction aphasia has 
been reported rarely as a presenting feature of neurodegenerative disease (Hachisuka et al, 
1999). By analogy with the explanation proposed for the greater preponderance of semantic 
category effects in the acute setting, it is likely that the transcortical and conduction syndromes 
require relatively discrete damage that removes a nodal region or disconnects it from other 
regions in a functional network. These conditions are most likely to be met in acute vascular 
damage, rather than degenerative disease, in which there is greater potential for incomplete 
damage involving a number of cortical regions and their functional connections 
 
These observations raise the more fundamental issue of the basis for the observed 
dissimilarities between acute vascular and degenerative aphasic syndromes. To the extent that 
the acute and progressive aphasic syndromes both illustrate the effects of interruption of 
distributed functional networks, the acute and progressive aphasias are predicted to share 
certain phenomenological similarities. The many divergences between the progressive and 
acute syndromes of language breakdown illustrate the effects of chronic, evolving damage 
distributed amongst functionally connected brain areas, versus the acute failure of a single 
network component. The vascular anatomy of the human language cortices means that certain 
syndromes are intrinsically more likely (for example, jargon aphasia due to focal posterior 
superior temporal lobe damage) or less likely (for example, semantic disintegration due to 
anterior temporal lobe damage) to occur in the acute setting. Moreover, the degenerative 
aphasias result from subtotal damage simultaneously involving a number of cortical regions 
and their connections, and therefore in principle might have no precise acute analogue. In 
contrast to acute infarction, degenerative pathologies have the potential for continuing ‘noisy’ 
information processing within and between affected brain regions. Furthermore, it is likely that 
the microstructure of language networks is differentially affected by chronic diseases with 
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abnormal protein deposition in surviving cellular components, and by acute necrosis affecting 
all components in a region more or less uniformly. 
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Chapter 1 Summary 
Progressive language impairment occurs as part of neurodegenerative disorders. The nosology 
of (and therefore terminology used in) these disorders is complicated. They have been included 
in the group of diseases known as frontotemporal lobar degeneration (FTLD) because of the 
known overlap clinically, genetically and pathologically with the more common disorder 
frontotemporal dementia which presents with behavioural symptoms (and is therefore 
sometimes known as behavioural variant frontotemporal dementia, bvFTD). However, other 
research groups have sought to separate them from bvFTD and create descriptive criteria solely 
for progressive language disorders, naming this primary progressive aphasia (PPA). It seems 
clear that whichever overarching spectrum of disorders they are included within (FTLD or PPA) 
there are multiple subtypes of progressive language impairment: the two most common are 
PNFA and SD but it is unclear how many other clinical/neuropsychological phenotypes there 
are. It is also clear that there is no one-to-one correlation between the 
clinical/neuropsychological phenotypes of progressive language disorders and the acute 
aphasias, which are more common and therefore generally better known to the neurologist and 
neuroscientist. It is important to reiterate, as discussed above, that progressive language 
disorders can be described at multiple levels of classification and that currently the 
clinical/neuropsychological phenotypic description is the most prominent. However, as there is 
no one-to-one clinico-genetic or clinico-pathological correlation, when it comes to entering 
patients into clinical drug trials using drugs targeting a particular protein or gene it will be 
important to be able to classify the disorders according to their underlying genetics and 
neuropathology. Neuroanatomical descriptions using particular neuroimaging techniques may 
provide an interface between clinical/neuropsychological phenotypes and genetic/pathological 
phenotypes.  
 
This thesis sets out to answer some of these questions. The general hypotheses of the thesis are 
that: 
1) There are multiple clinical subtypes of language impairment in frontotemporal lobar 
degeneration/primary progressive aphasia. 
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2) There are multiple pathological and genetic causes of the progressive aphasias and 
increasing knowledge of clinical subtypes will allow better clinico-pathological and 
clinico-genetic correlation. 
3) Clinical subtypes are defined by their pattern of neuropsychological deficits, which map on 
to neuroanatomical patterns of cell loss. Changes in clinical and neuropsychological 
phenotype over time are paralleled by concurrent changes in the pattern and extent of 
atrophy over time. 
 
Chapter 2 sets out the techniques and methods used in the thesis both from an imaging and 
neuropsychological perspective. 
 
Chapter 3 aims to answer the questions: what patterns of cortical cell loss are seen in the well-
defined clinical subtypes of PNFA and SD and what is the change in atrophy over time? The 
chapter uses a retrospective cohort of patients with PNFA and SD to define the 
neuroanatomical patterns of cell loss in these disorders using the relatively new technique of 
cortical thickness measurement. The same cohort is then explored with longitudinal volumetric 
measurements of rates of atrophy to look at patterns of change over time. 
 
Chapter 4 aims to answer the questions: what is the genetic and pathological basis of 
progressive aphasias and can investigation of the patterns of atrophy in defined genetic and 
pathological subtypes improve clinico-genetic and clinico-pathological correlation? This 
chapter uses a retrospective cohort of patients within the whole FTLD spectrum, including 
patients with the behavioural variant FTD for comparison, who have had DNA samples or 
pathological specimens collected. The heritability of each subtype is examined and then 
patterns of atrophy are investigated in specific genetic and pathological subtypes. 
 
Chapter 5 aims to answer the questions: how many clinical subtypes of progressive aphasia are 
there and how do these map on to neurological features and on to specific genetic and 
pathological causes. This chapter investigates a prospectively studied cohort of patients with a 
progressive aphasia from a clinical, neuropsychological and neuroanatomical perspective in 
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order to define specific subtypes. Case studies of two patients with genetically-defined disease 
and a case series of patients with a specific neurological syndrome are also presented. 
 
Chapter 6 aims to answer the questions: what do specific behavioural and neuropsychological 
deficits in the progressive aphasias tell us about the disease and how are they related to the 
underlying neuroanatomical pattern of cell loss? Patients with progressive aphasia were studied 
prospectively to look at areas previously little studied in this group, namely single word 
processing, prosodic processing, the production of neologistic jargon, the presence of orofacial 
and limb apraxia and abnormal behaviour. 
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2. Techniques and methods 
 
2.1 Imaging techniques 
 
Brain image acquisition 
All MR brain images were acquired on a 1.5T GE Signa scanner (General Electric, Milwaukee, 
WI) using an inversion recovery-prepared fast Spoiled Gradient Recall acquisition (echo time = 
5ms, repetition time = 12ms, inversion time = 650ms). T1-weighted volumetric images were 
obtained with a 24-cm field of view and 256 x 256 matrix to provide 124 contiguous 1.5-mm-
thick slices in the coronal plane.  
 
Cross-sectional volumetric measurement 
Whole brain  
A rapid, semi-automated technique of brain segmentation was performed for each scan using 
the MIDAS software package (Freeborough et al, 1997a). This involves interactive selection of 
thresholds, followed by a series of erosions and dilations, and yields a brain region which is 
separated from surrounding cerebrospinal fluid, skull and dura. This provides a whole brain 
volume measurement in millilitres. 
 
Cerebral hemispheres 
Left and right cerebral hemisphere volumes were calculated as follows. Scans and associated 
brain regions (generated in the whole brain segmentation step described above) were initially 
transformed into standard space by registration to the Montreal Neurological Institute (MNI) 
template (Mazziota et al, 1995) within the MIDAS software package. Left and right hemisphere 
MNI templates were created by dividing the MNI whole brain template along a line coincident 
with the interhemispheric fissure also within the MIDAS software package. Left and right 
hemispheric regions were thus defined in each scan by an intersection of each individual's 
whole brain region and the hemisphere MNI templates. This provided a measure of left and 
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right hemisphere volume and therefore also a measure of cerebral asymmetry by dividing one 
hemisphere volume by the other i.e. a left/right (or right/left) volume ratio.  
 
Ventricles 
Ventricular volumes were calculated using a semi-automated segmentation technique within 
the MIDAS software package. The volumes included the lateral ventricles and temporal horn of 
the lateral ventricles but not the third or fourth ventricle and were outlined on all sequential 
brain slices encompassing these regions.  
 
Temporal lobes 
A technique for temporal lobe segmentation has previously been described (Chan et al, 
2001b). The method used here is a variation on this with some changes made to improve 
accuracy. Trials on twenty scans during the pilot phase of the study revealed an intraclass 
correlation coefficient of 0.99 and an average segmentation time per temporal lobe of 30 
minutes. 
 
Initially each scan was reflected across the mid-sagittal plane, producing two scans, each a 
mirror image of the other. This enabled the temporal lobe to be consistently measured on the 
right hand side of the presented image, whether the temporal lobe was left or right. All the 
boundaries of the temporal lobe were traced around with two orthogonal views available. A 
consistent threshold of 60% of mean brain intensity was applied to exclude lower intensity 
voxels, which correspond predominantly to CSF. The caudal boundary was defined as the 
coronal slice where the thalamus and fornix first become distinct structures and is generally 
where the longest length of the fornix is observable (Figures 2.1.1A and 2.1.1B). An arbitrary 
cut off point was used for the temporal lobe stem, determined by a straight line connecting the 
most inferior and medial point of the Sylvian fissure to the superior lateral-most point of the 
medial temporal lobe, adjacent to the stem (Figures 2.1.1C). However, if this demarcating line 
clearly eliminated any subcortical structures then an alternative cut off was used. In these 
cases, a straight line was drawn from the same inferiormedial portion of the Sylvian fissure, 
now connecting to the most superior surface of the subcortical structure (i.e. hippocampus or 
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amygdala) after which the demarcating line followed the curve of this structure back to the 
superior lateral-most point of the medial temporal lobe. The accessory gyrus was included as 
soon as the CSF was just visible between the medial side and the temporal stem on the coronal 
view (Figures 2.1.1D and 2.1.1E).  
 
Figure 2.1.1 
Temporal lobe segmentation protocol: A) First slice i.e. caudal boundary at longest length of fornix, B) 
Second slice where the thalamus begins to obstruct the fornix, C) Standard cutoff of temporal stem 
from inferior-medial most point of Sylvian fissure to superior-lateral most point of medial temporal 
lobe, D) Slice before the accessory gyrus inclusion, E) Slice after the accessory gyrus inclusion. 
 
A)                              B)     
   
C)      D)                                                               E) 
         
 
Midbrain 
Midbrain volumes were calculated using the MIDAS software package and a previously 
described segmentation method (Paviour et al, 2006): two orthogonal views were used to 
define a superior cutoff (upper border of the midbrain tegmentum in the mid-sagittal slice), an 
inferior border at the superior border of the pons in the mid sagittal slice, and anterior and 
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posterior borders defined by the brain tissue/cerebrospinal fluid boundary (interpeduncular 
cistern anteriorly and including the quadrigeminal plate). 
 
Cortical thickness 
The measurement of cortical thickness in volumetric MRI scans is a relatively new technique 
(Dale et al, 1999; Fischl et al, 2000; Kim et al, 2005; Hutton et al, 2008). In neurodegenerative 
disease it has yet to be used extensively in investigating patterns of cortical cell loss and 
although the patterns seen using this technique are likely to substantially overlap with other 
techniques such as voxel-based morphometry (see below) it may be that it will provide 
complementary information (e.g. about areas that are difficult to assess using methods such as 
voxel-based morphometry) or be a more sensitive or specific measure of change.  
 
In this thesis cortical thickness estimation was performed using the Freesurfer image analysis 
suite (Dale et al, 1999; Fischl et al, 2000), version 4.0.3 on a 64-bit Linux CentOS 4 Cluster 
managed by a Sun Grid Engine. This is a freely available set of software tools that can be 
downloaded from the internet (http://surfer.nmr.mgh.harvard.edu/) and is an automated process 
generating a measurement of cortical thickness. Initially registration of the scans to the 
Talairach atlas is performed followed by an intensity normalization step and then removal of 
non-brain tissue in each scan using a skull-stripping process. At this point, instead of the 
standard Freesurfer brain mask being used, this was replaced with the brain region made using 
the MIDAS software package as described above in whole brain volumetric methods 
(Freeborough et al, 1997a). An automated white matter segmentation is then performed 
followed by a surface tessellation and deformation process that creates an accurate grey/white 
boundary (white matter surface) and grey/CSF boundary (pial surface). The results of these 
surface reconstructions were visually inspected. During the initial trial phase of running 
Freesurfer it was noted that segmentations were poor if there was substantial atrophy, 
particularly around the lateral ventricles when they were large (Figure 2.1.2).  
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Figure 2.1.2 
Poorly segmented scan during initial phase of Freesurfer cortical thickness pipeline 
 
 
 
This problem was solved by incorporating the ventricle segmentations (that are generated in 
Freesurfer in its volume processing stream) into the white matter mask. Further visual 
inspection also revealed occasional misclassification of white matter, particularly in the 
temporal lobes. This was solved by a manual editing process available within Freesurfer where 
‘control points’ can be added to define areas of white matter followed by re-running of the 
initial processing stream. 
 
Cortical thickness can be estimated by computing the average shortest distance between the 
white matter surface and the pial surface. For group comparison, all subjects’ cortical 
reconstructions (or rather an inflated model of them) are registered to a common spherical 
surface-based atlas. The data are smoothed using a surface-based Gaussian kernel of 20mm full 
width half-maximum. Parcellation of the cortex into different units based on gyral and sulcal 
structure is also performed (Desikan et al, 2006). 
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A vertex-by-vertex analysis using a general linear model was then performed to examine 
differences in cortical thickness between groups. The particular model used in each of the 
studies described in the thesis is shown in the chapter. 
 
Voxel-based morphometry (VBM) 
Voxel-based morphometry (VBM) is a computational neuroimaging technique that allows 
analysis of structural MRI scans to investigate differences in morphology (tissue density) 
between groups (e.g. where in the brain is there less grey matter density in a disease group 
compared to controls?) or the relationship of morphology to a behavioural or 
neuropsychological score (e.g. where in the brain does grey matter density correlate with 
naming score?). In comparison to region of interest methods VBM is essentially unbiased as all 
areas of the brain are considered. 
 
The process of VBM consists of a number of steps: 
1) Normalization or registration – this is a process where all scans are put into the same space 
so that they can be compared. 
2) Segmentation – this classifies brains into grey matter, white matter and CSF. 
3) Modulation – this process corrects for any changes in volume that occur because of the 
normalization step e.g. small brains may be stretched to match large brains removing any 
effect of disease. Intensities within the segmented images are multiplied by the Jacobian 
values (which essentially are a measure of volume change due to normalization) which 
means that intensities now represent relative volume. 
4) Smoothing – this allows data to be more normally distributed which is required for 
statistical analysis and reduces the effects of misregistration. 
5) Statistical parametric mapping (SPM) – this is the statistical method by which data are 
examined. Essentially a statistical test (t-test) is performed at each voxel to determine 
whether there is a statistical difference at that voxel. 
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In this study VBM was performed using SPM5 software (http://www.fil.ion.ucl.ac.uk/spm) and 
the DARTEL toolbox (Ashburner, 2007, Ashburner et al, 2009) with default settings for all 
parameters. As per the steps described above:  
1)/2) Using SPM 5 and the DARTEL toolbox a unified segmentation and spatial normalization 
procedure is performed. Brain images undergo an initial segmentation process that estimates 
transformation parameters for warping grey matter (GM), white matter (WM) and cerebrospinal 
fluid tissue probability maps (TPMs) onto the images. The native space GM and WM segments 
are then rigidly spatially normalized, using just the rotations and translations from the inverse 
of the TPM transformation. These "imported" images are then iteratively warped to an evolving 
estimate of their group-wise GM and WM average template using the DARTEL toolbox. The 
GM and WM segmentations are then normalized using the final DARTEL transformations. 
3) Segmentations are then modulated to account for volume changes.  
4) The images are then smoothed using a 6mm full-width at half-maximum (FWHM) Gaussian 
kernel.  
5) An SPM analysis was then performed using a general linear model. The particular model 
used in each of the studies described in the thesis is shown in the chapter. 
 
Longitudinal volumetric imaging 
Rates of atrophy for different brain structures can be calculated by dividing the difference in 
volume between the repeat and baseline scans by the baseline volume and then adjusting for 
the time interval between the scans. This requires scans to be registered together (i.e. the scans 
are aligned so that they are in the same spatial framework). Registration can be linear (i.e. each 
voxel throughout the image has the same parameters applied) or nonlinear (where the 
parameters vary throughout the image allowing more accurate registration). In this study, scans 
were generally initially transformed into standard space by registration to the MNI template 
(Mazziotta et al, 1995) and then an affine (12 degrees of freedom) registration was performed 
in order to align the repeat scan onto the baseline image (Woods et al, 1998). 
 
In some cases other methods were used: 
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Boundary shift integral (BSI) 
This is a semi-automated linear registration method which calculates change at the border of 
the brain (brain/CSF boundary) at every point across a registered pair of scans, summing these 
to give a value of total volume loss between the two scans (Freeborough et al, 1997b). BSI-
derived whole-brain volume changes (BBSI) were expressed as annualized volume change as a 
percentage of the baseline brain volume.  
 
SIENA 
SIENA (Smith et al, 2002) is part of FSL (Smith et al, 2004) and similar to BSI it allows two-
timepoint percentage brain volume change to be estimated.  The process is similar to BSI: 
following skull stripping the two scans are aligned (using the skull images to constrain the 
registration scaling) and segmentation is performed to find the brain/non-brain edge. 
Perpendicular edge displacement between the two scans is estimated and the mean of these 
values converted into an estimate of percentage volume loss between the two scans. 
 
Voxel-compression mapping 
Linear registration does not allow localization of change between scans. However, non-linear 
registration techniques can do this by modelling the whole brain. One method is to model the 
brain as a viscous compressible fluid (Freeborough et al, 1998; Scahill et al, 2002) allowing 
each voxel to contract or expand to match the other image. The process should lead to a 
registered repeat image (the second scan) which is an exact match for the baseline image (first 
scan). The stretch file (Jacobian) gives a value for each voxel which is the extent of contraction 
or expansion undergone for the second scan to match to the first scan. This stretch file can be 
seen as a coloured overlay image onto the baseline image (first scan) in order to visualize 
where the differences are between the scans. 
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2.2 Neuropsychological methods and techniques 
 
Standard neuropsychological methods and techniques 
In the retrospective analyses performed in this study (particularly in chapters 3 and 4) multiple 
neuropsychological tests are used to examine for the presence of deficits in different cognitive 
domains: 
• Verbal and performance IQ 
• Recognition memory (verbal and visual) 
• Confrontational naming 
• Single word comprehension 
• Spelling 
• Calculation 
• Visuospatial and visuoperceptual skills 
• Executive function 
 
The tests used in each part of the study are documented in the particular chapter. 
 
Development of a neurolinguistic battery of tests for use in patients with progressive aphasia 
In chapter 5 a battery of neuropsychological tests is used to try to assess various aspects of 
language in the progressive aphasias and to provide tests that may distinguish between different 
clinical subtypes. 
 
1) Spontaneous speech 
A sample of spontaneous speech was obtained by asking subjects to talk, firstly, freely about 
their last holiday and, secondly, to describe the Cookie Theft Scene from the Boston Diagnostic 
Aphasia Examination (Goodglass et al, 1983). Each speech sample was recorded and 
subsequently transcribed. This allowed for analysis of fluency, the presence of word pauses, 
the content of the speech (noun and verb frequency) and the presence of agrammatism as well 
as speech errors and articulatory impairment. 
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2) Naming  
a. All patients were tested on the Graded Naming Test (McKenna et al, 1980), a standardized 
naming test with control norms. It is a relatively difficult naming test e.g. the first few items 
are kangaroo, scarecrow and buoy and the last item is retort. This is useful because it can 
detect subtle naming difficulties and/or changes in performance over time in someone 
whose premorbid naming capability is well above average. 
b. However, as many patients were likely to score near to the floor on the Graded Naming 
Test, a simple naming test was designed containing 20 items (with the first few items being 
chair, shoe and pen). All of the pictures were photographs taken from the internet (freely 
available to download) placed against a white background. 
 
3) Single word comprehension 
a. A noun synonyms test (Warrington et al, 1998) e.g. does “javelin” mean the same as 
“shield” or “spear”, was presented visually and aurally 
b. A verb synonyms test (Manning et al, 1995) e.g. does “to annihilate” mean “to abandon” 
or “to destroy”, was presented visually and aurally. 
c. A word-picture matching test (a shortened version of the British Picture Vocabulary Scale: 
Dunn et al, 1982) in which patients had to match a word to one of four pictures was 
presented with the word both written and spoken. 
 
4) Verbal short-term memory, sentence comprehension and grammar 
All patients were initially tested on their maximum digit span forwards (with two attempts at 
each level allowed). Sentence comprehension and verb tense comprehension were 
subsequently assessed in detail using the following tests:  
a. A modified version of the PALPA55 spoken sentence-picture matching (3 alternative 
forced choice) test (Kay et al, 1992) comprising 24 sentences testing comprehension of 
reversibility and active/passive constructions.  
b. A spoken sentence-picture matching (2 alternative forced choice) test of verb tense 
comprehension that was an adapted version of the Lesser Syntax test (Lesser, 1974; Parisi 
et al, 1970) comprising 20 pairs of pictures which differ in whether the agent is doing 
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something/has done something (present/past comparison, 10 items) or whether the agent is 
doing something/is about to do something (present/future comparison, 10 items).  
 
5) Speech repetition 
Three tests of repetition were performed in all subjects: "# Sixty single words, consisting of twenty one-syllable, twenty two-syllable and twenty 
three-syllable words. In each of the sets of twenty words, ten words were of high 
frequency and ten of low frequency. !!
1-syllable high frequency 
wrong 
strike 
song 
view 
will 
sort 
cause 
stood 
watch 
life 
 
2-syllable high frequency 
ready 
nature 
minute 
include 
country 
question 
practice 
because 
against 
never 
 
3-syllable high frequency 
continue 
anything 
exercise 
suddenly 
together 
tomorrow 
different 
material 
wonderful 
department
1-syllable low frequency 
prowl 
tout 
quirk 
poach 
etch 
slang 
gild 
hark 
mute 
twirl 
2-syllable low frequency 
sliver 
robust 
glimmer 
notion 
abstain 
trample 
quibble 
denude 
festoon 
collide 
3-syllable low frequency 
notify 
mutiny 
democracy 
revulsion 
erratic 
sinister 
feverish 
cohesion 
tyranny 
mutinous 
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b. Twenty nonwords consisting of ten three-letter consonant-vowel-consonant words and ten 
words of 1 to 3-syllables taken from the PALPA8 nonword repetition task (Kay et al, 1992). 
!
mip 
lub 
dak 
pel 
rop 
nuv 
bim 
pab 
fep 
vot !
splack 
cleast 
prench 
grank 
gaffic 
larden 
polid 
ality 
enitor 
inima 
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!
c. twenty sentences (McCarthy et al, 1984), consisting of A) ten sentence clichés e.g. “As 
blind as a bat”, “A flash in the pan”, and B) ten novel sentences e.g. “She met me at the 
airport”, “He mended the plug”. Sentence length varied between 3 and 7 words without a 
significant difference in length between the clichés (4.4 words per sentence) and novel 
sentences (4.8 words per sentence).  
!
6) Reading and spelling  
Patients were tested on three reading tests:  
a. The Schonell Reading Test (Schonell et al, 1952), a mixture of different types of words 
(score out of 100) 
b. An irregular word reading test (score out of 30) was designed to look for the presence of 
surface dyslexia i.e. regularization of irregular words on reading.  
!
Examples: 
touch 
plumb  
aisle 
subtle 
 
c. The Graded Difficulty Nonword Reading Test (Snowling et al, 1996; score out of 20).  
 
Examples: 
hast 
kisp  
mosp  
drant 
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Patients were also tested on the Graded Difficulty Spelling Test (Baxter et al, 1994), a series of 
30 graded difficulty words, starting with two, world, said and ending with cemetery, 
kaleidoscope, and iridescent. 
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3. Neuroanatomy of language impairment in FTLD 
There are a number of studies that have previously looked at various aspects of neuroimaging 
in PNFA and SD (reviewed in 3.1) but the studies in this chapter were designed to look at novel 
ways of examining the patterns of cell loss in PNFA and SD, using a large cohort of patients 
that includes a subgroup with pathologically-confirmed FTLD (3.2). Initially, the relatively new 
method of looking at the thickness of the cortex using automated software was used to examine 
the neuroimaging patterns in PNFA and SD, including how cortical thickness changes with 
disease severity (3.3). There have been few longitudinal studies of PNFA or SD and the last part 
of this Chapter describes a study using volumetric imaging measures to identify patterns of 
change over time (3.4). 
 
The specific hypotheses of Chapter 3 are: 
1. Patterns of cortical thinning in PNFA and SD will overlap substantially with the patterns 
seen in other imaging techniques. 
2. Patterns of cortical thinning in the whole clinical cohort will be similar to those seen in the 
smaller pathological cohort. 
3. Rates of whole brain atrophy will be similar in PNFA and SD and greater than controls. 
4. Rates of atrophy in regions of interest will differ between the two hemispheres in PNFA and 
SD. 
5. Patterns of change in the regions of interest over time will map onto known changes in the 
clinical syndrome. In particular increasing right temporal lobe involvement will be seen in 
SD consistent with increasing behavioural symptoms. 
 
 
 
 !!
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3.1 Overview of previous neuroimaging studies 
The most common type of imaging of PNFA and SD has been cross-sectional structural 
magnetic resonance imaging (MRI) or functional imaging (positron emission tomography, PET, 
or single photon emission computed tomography, SPECT) studies of patterns of atrophy or 
hypometabolism. The majority of these studies have used whole brain or voxel-wise imaging 
methods such as statistical parametric mapping (SPM) but some have also looked at particular 
regions of interest such as specific temporal lobe structures. 
 
Atrophy or hypometabolism in PNFA and SD is usually asymmetrical, being worse in the left 
hemisphere, with structural and functional imaging studies showing similar findings 
(Desgranges et al, 2007; Panegyres et al, 2008). However, there are also left-handed patients 
described with greater right hemisphere involvement (Drzezga et al, 2002; Mesulam et al, 
2005). Examples of longitudinal series of structural images in patients with pathologically-
confirmed SD (TDP-43 positive type 1, Sampathu classification) and PNFA (tau-positive Pick’s 
disease) are shown in Figure 3.1.1. 
 
Figure 3.1.1 
Longitudinal series of coronal and axial T1 MR images from pathologically-confirmed patients with SD 
(TDP-43-positive pathology type 1, Sampathu classification) and PNFA (tau-positive Pick’s disease). 
Three scans, registered into the same space and each separated by approximately one year, are shown 
in order to highlight the progression in atrophy, as described in the summary section. The images are 
shown in radiological convention i.e. left hemisphere on the right of the picture.  !
!
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SD is the most comprehensively studied in terms of cross-sectional patterns of atrophy 
(Mummery et al, 1999; Mummery et al, 2000; Chan et al, 2001b; Galton et al, 2001: Rosen et 
al, 2002a; Boxer et al, 2003; Grossman et al, 2004; Halpern et al, 2004; Studholme et al, 2004; 
Davies et al, 2004; Gorno-Tempini et al, 2004a; Gold et al, 2005; Short et al, 2005; Schroeter 
et al, 2007; Lindberg et al, 2009; Pereira et al, 2009). Initial VBM studies of clinically 
diagnosed SD identified an asymmetrical pattern of atrophy affecting mainly the anterior, 
inferior and lateral temporal lobes, more so in the left hemisphere (Mummery et al, 1999; 
Mummery et al, 2000). The findings of these studies were extended by detailed region of 
interest (ROI) studies of temporal lobe structures which showed that the temporal pole, fusiform 
gyrus, entorhinal cortex, inferior temporal gyrus as well as the amygdala and hippocampus 
were the most affected areas with relative sparing of the superior temporal gyrus; there was also 
the presence of an antero-posterior gradient with relatively less atrophy posteriorly (Chan et al, 
2001b; Galton et al, 2001). Further VBM studies showed that there may be involvement of 
areas outside the temporal lobes in SD, particularly orbitofrontal, insular and anterior cingulate 
cortices (Rosen et al, 2002a). This asymmetrical temporal, frontal and anterior cingulate pattern 
distinguishes SD from Alzheimer’s disease (AD), which has more symmetrical hippocampal 
atrophy involvement without an antero-posterior gradient (Chan et al, 2001b) and greater 
posterior cingulate and parietal lobe atrophy (Boxer et al, 2003). ROI and VBM studies have 
been shown to produce similar results (using either manual segmentation e.g. Chan et al, 
2001b; Good et al, 2002, or a visual rating scale e.g. van de Pol et al, 2006; Davies et al, 
2009). A small VBM study of pathologically-confirmed patients found that patterns of atrophy 
were similar in SD cases associated with both ubiquitin-positive and tau-positive FTLD 
pathology but in the rare cases with Alzheimer’s pathology there was mainly left hippocampal 
atrophy (Pereira et al, 2009). Similar patterns of asymmetrical temporal lobe hypometabolism 
have been found in PET and SPECT imaging (Soriani-Lefevre et al, 2003; Diehl et al, 2004; 
Clark et al, 2005; Drzezga et al, 2008).  There have been a couple of studies of white matter 
disease in SD (Chao et al, 2007; Borroni et al, 2007) with one diffusion tensor imaging (DTI) 
study showing particular involvement of the inferior longitudinal fasciculus with additional 
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involvement of inferior fronto-occipital fasciculus, callosal and superior longitudinal fasciculus 
tracts (Borroni et al, 2007). 
 
The majority of SD cases described in the literature have asymmetrical left greater than right 
temporal lobe atrophy but there are a number of reports of the opposite pattern with right 
greater than left temporal lobe atrophy (Rosen et al, 2002b; Thompson et al, 2003; Gorno-
Tempini et al, 2004c; Seeley et al, 2005; Chan et al, 2009). This right temporal variant appears 
to be less common than the left temporal variant although this may simply represent an 
ascertainment bias. Patients often have initial behavioural symptoms rather than a progressive 
aphasia (Seeley et al, 2005) with the development of semantic impairment only later in the 
illness (leading some authors to argue that this right temporal variant should be logically 
separated from the primary progressive aphasias e.g. Mesulam et al, 2009). The pattern of 
atrophy in these right temporal variant appears to be the mirror image of the left temporal 
variant (Brambati et al, 2009b), although the underlying pathology remains unclear.  
 
Longitudinal studies in SD are less common (Chan et al, 2001a; Whitwell et al, 2004; Diehl-
Schmid et al, 2006; Bright et al, 2008; Czarnecki et al, 2008; Brambati et al, 2009b; Knopman 
et al, 2009; Krueger et al, 2009). In those with the left temporal variant there seems to be 
increased right temporal lobe involvement as the disease progresses as well as spread of 
atrophy within the left hemisphere, particularly more posterior temporal areas and the 
orbitofrontal, anterior insular, inferior frontal and anterior cingulate lobes (Diehl-Schmid et al, 
2006; Bright et al, 2008; Brambati et al, 2009b). In the right temporal variant, limited evidence 
suggests that a similar but mirror-image pattern of atrophy spread is seen (Brambati et al, 
2009b).  
 
PNFA is less well-studied than SD and patterns of neuroanatomical involvement are not quite 
so clear (Nestor et al, 2003; Gorno-Tempini et al, 2004a; Grossman et al, 2004; Zahn et al, 
2005; Josephs et al, 2006; Ogar et al, 2007; Schroeter et al, 2007; Nestor et al, 2007; Lindberg 
et al, 2009). This is partly because of the heterogeneity of PNFA and also the differences in 
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definition between research groups. Similar to SD, atrophy or hypometabolism is usually 
asymmetrical and more marked in the left hemisphere. The most significantly affected areas are 
in the left inferior frontal lobe (particularly the frontal opercular region) and anterior insula 
(Nestor et al, 2003; Gorno-Tempini et al, 2004a; Ogar et al, 2007). However, left middle and 
superior frontal, superior temporal and caudate involvement are also frequently reported in 
studies with less frequent involvement of anterior parietal lobes (Gorno-Tempini et al, 2004a; 
Ogar et al, 2007). ROI studies are limited in PNFA (van de Pol et al, 2006; Looi et al, 2008; 
Chow et al, 2008; Looi et al, 2009) but have shown involvement of striatal structures, 
particularly the caudate. There are few pathologically-confirmed studies of PNFA and these 
have often studied mixed pathological groups but despite this have shown fairly consistent 
findings compared to the clinical studies e.g. anterior insula and inferior frontal involvement in 
mixed groups of tau-positive patients (Josephs et al, 2006). 
 
There are limited longitudinal studies of PNFA (Gorno-Tempini et al, 2004b), although it seems 
that with disease progression there is spread from the left inferior frontal and insular cortex to 
involve superior temporal, middle and superior frontal and anterior parietal lobes (Gorno-
Tempini et al, 2004b). More posterior atrophy, particularly of the left anterior parietal lobe, 
may herald the presence of an accompanying corticobasal syndrome (CBS) (Gorno-Tempini et 
al, 2004b).  
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3.2 Methods 
!
Patient cohort 
The patients included in the studies in this chapter were those with a clinical diagnosis of 
PNFA or SD according to consensus criteria who had attended the National Hospital for 
Neurology and Neurosurgery Specialist Cognitive Disorders Clinic, Queen Square, London and 
who had had at least one volumetric 1.5T MRI brain scan. Patients were identified by 
performing a retrospective review of the Specialist Cognitive Disorders Clinic patient database. 
For SD the criteria used were modified Neary criteria as per Adlam et al, 2006 (Neary et al, 
1998; Adlam et al, 2006) whilst for PNFA diagnosis was based on Neary criteria (Neary et al, 
1998) with patients having a speech production impairment characterized by agrammatism 
and apraxia of speech. These criteria allow patients with SD and PNFA to be separated on 
clinical or neuropsychological grounds, independent of imaging findings. 
 
For the cross-sectional study (3.3) there were 44 SD patients and 32 PNFA patients. A control 
group of 29 cognitively-normal subjects matched for gender and age was also studied for 
comparison. There were no significant differences between any of the groups in terms of 
gender, age or duration at scan (Table 3.2.1). 
!
!
!
!
!
!
!
!
!
!
!
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Table 3.2.1  
Demographic data for the SD, PNFA and control groups in the cross-sectional study i.e. who had had at 
least one volumetric MRI scan. Age and duration at scan are mean values in years with standard 
deviation in parentheses. !
Group Number % male 
Age at scan  
(years) 
Duration at scan  
(years) 
SD 44 59 64.1 (7.5) 4.3 (1.8) 
PNFA 32 66 65.8 (7.7) 4.4 (2.0) 
Controls 29 60 65.2 (8.7) N/A !
Eleven SD patients were known to be pathologically-confirmed at the time of study: 64% male, 
mean age at scan 65.9 (5.9) years old, mean duration 4.7 (2.5) years, with type 1 FTLD-TDP 
pathology in all cases (Cairns et al, 2007). Four PNFA patients were pathologically-confirmed: 
75% male, mean age at scan 62.7 (7.0) years old, mean duration 4.4 (0.6) years, with tau-
positive pathology in all cases (two patients had corticobasal degeneration and two had Pick’s 
disease).  
 
For the longitudinal study, all patients with two or more scans were included: there were 21 
patients with SD (8 with pathological-confirmation, all with type 1 FTLD-TDP) and 24 patients 
with PNFA (2 with pathological-confirmation, one with Pick’s disease and one with 
corticobasal degeneration). A control group of 20 cognitively-normal subjects was also 
included for comparison. There were no significant differences in age, gender, or interscan 
interval between any of the groups.   
!
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Table 3.2.2  
Demographic data for the SD, PNFA and control groups in the longitudinal study i.e. who had had at 
least two volumetric MRI scans. Age and duration at scan as well as interscan interval for the first two 
scans are mean values in years with standard deviation in parentheses. !
Group Number % male 
Age at scan 
(years) 
Duration at scan 
(years) 
Interscan interval 
(years) 
SD 21 57 64.2 (7.2) 3.9 (1.5) 1.5 (0.9) 
PNFA 24 63 66.6 (6.6) 5.2 (2.1) 1.3 (0.6) 
Controls 20 60 63.8 (9.1) N/A 1.7 (0.9) 
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3.3 Patterns of cortical thinning in PNFA and SD 
The measurement of cortical thickness can provide complementary information to other 
imaging techniques about the neuroanatomy of neurodegenerative disorders as it allows the 
regional distribution and quantification of grey matter cortical loss to be specifically assessed in 
contrast to gyral or lobar volumetric studies which combine grey and white matter within 
regional volumes. There are currently few studies that have examined cortical thinning in 
neurodegenerative disease (Gold et al, 2005; Lerch et al, 2005; Dickerson et al, 2007; Rosas et 
al, 2008) and so the objective of this study was to look at the cross-sectional patterns of cortical 
thickness in PNFA and SD.  
 
METHODS 
Cortical reconstruction and thickness estimation was performed as described in Chapter 2. A 
vertex-by-vertex analysis using a general linear model was performed to examine differences in 
cortical thickness between the patient groups and the control group.  Cortical thickness, C, was 
modelled as a function of group, controlling for age, sex and the scanner used by including 
them as nuisance covariates.  C=!1 SD + !2 PNFA + !3 controls + !4 age + !5 sex + !6 scanner + 
µ + " (where µ is a constant, and " is error) with the contrasts of interest being the two-tailed t-
tests between the estimates of the group parameters, i.e. !1 and !3, !2 and !3. Maps showing the 
significant differences between the disease groups and controls were generated, correcting for 
multiple comparisons by thresholding the images of t-statistics to control the False Discovery 
Rate (FDR) at a 0.05 significance level.  
 
In order to examine changes in cortical thickness as the disease progressed performance on 
naming tests was used as a measure of disease severity. Other markers of disease severity such 
as estimated disease duration may be unreliable and subject to recall bias, while global indices 
of cognitive function such as the MMSE (Folstein et al, 1975) are insensitive and may not be 
relevant to the specific deficits produced by the language-based dementias. In contrast, 
impaired naming ability is observed in both language variants of FTLD and central to the 
clinical syndrome in each case, and performance can be easily quantified: naming 
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performance is therefore a suitable index of clinical severity that can be applied across 
individuals and groups. The standard naming test performed in patients who attend the 
Specialist Cognitive Disorders Clinic is the Graded Naming Test (GNT) (McKenna et al, 1980) 
but this is a difficult naming test and when patients become very anomic and unable to score 
on this test (e.g. in patients with moderate to severe SD) the easier Oldfield Naming Test 
(Oldfield et al, 1965) is usually performed. In order to compare scores between these two tests 
a group of 55 patients with a neurodegenerative disease and 55 cognitively-normal controls 
have previously performed both tests and a conversion table generated allowing an equivalent 
score to be calculated. 28 patients with SD and 28 patients with PNFA performed one of the 
two naming tests within six months of the time of the scan and were therefore used for the 
analysis: mean equivalent Oldfield score in the SD group was 6.2 (standard deviation 4.8) and 
in the PNFA group was 21.4 (6.7). In both groups the patients were divided into three groups 
based on their naming scores. In PNFA group 1 (the least anomic) were those who could score 
within the normal range i.e. above the 5th percentile (greater than 13 on the GNT or an 
equivalent score of greater than 24 on the Oldfield Naming Test) and group 3 (the most 
anomic) were those unable to score on the Graded Naming Test or worse (equivalent to less 
than 14 on the Oldfield Naming Test) with group 2 those scoring in between these values 
(Table 3.3.1). Patients with SD scored lower as a group than PNFA with all scoring below the 
1st percentile and were therefore split into three approximately equal-numbered groups 
allowing for some patients scoring equally (Table 3.3.1). Effect size maps were generated based 
on the difference in mean thickness in each of these severity subgroups and in the whole SD 
and PNFA groups, comparing each to the controls and expressing the disease-control 
difference as a percentage of the mean control group thickness. As well as the surface maps, 
the Freesurfer processing stream also generates thickness measures from 33 cortical regions of 
interest as described in Desikan et al, 2006. Mean cortical thickness was calculated from these 
regions to create a mean lobar thickness and there are shown for each lobe in the different 
severity groups in Table 3.3.1.  
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RESULTS 
 
Whole group analysis (Figure 3.3.1) 
Compared with the healthy control group, in the SD group there was thinning of the cortex in 
an asymmetric pattern, most prominently affecting the temporal lobes on the left more than the 
right (Figure 3.3.1A). The areas of greatest thinning were anterior and inferior in the temporal 
lobes: on the left, the most affected areas were the temporal pole (reduced by 51% relative to 
control mean thickness), entorhinal cortex (46%), parahippocampal (30%), fusiform (27%) and 
inferior temporal (26%) gyri. On the right a similar but less extensive pattern of thinning was 
seen, particularly affecting the entorhinal cortex (reduced by 25% relative to control mean 
thickness), temporal pole (19%) and parahippocampal (14%) areas. Areas outside the temporal 
cortices were also affected although to a lesser extent; in particular thinning was seen in the left 
orbitofrontal, insular, inferior frontal and (particularly anterior) cingulate cortices (Figure 
3.3.1A). 
 
In the PNFA group the most significant areas of thinning were in the superior areas of the left 
temporal lobe (banks of the superior temporal sulcus (reduced by 14% relative to control mean 
thickness), superior temporal lobe (10%) and transverse temporal gyrus (9%)) as well as both 
left inferior frontal (pars opercularis, 9% and triangularis, 9%) and superior frontal lobes (9%) 
(Figure 3.3.1B). Cortical thinning was also seen in the left insula (although there is no region of 
interest cortical label for this area in Freesurfer and therefore no measure of the extent of 
thinning). There were no significant areas of thinning in the right hemisphere. !
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Figure 3.3.1  
Pattern of significantly thinner cortex in A) SD and B) PNFA compared with controls (coloured bar 
represents FDR corrected p-values) 
!
!
!
!
Pathologically-confirmed subgroup analysis (Figure 3.3.2) 
A similar pattern of cortical thinning was seen in the pathologically-confirmed SD group 
compared with the whole SD group (Figure 3.3.2A) with asymmetric left greater than right 
thinning of the temporal lobe cortices. 
 
The smaller pathologically-confirmed PNFA group showed only one area of significant thinning 
in the left insula (Figure 3.3.2B, top), which is seen more clearly on the inflated cortical map 
(Figure 3.3.2B, bottom).  
!
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Figure 3.3.2 
Pattern of significantly thinner cortex in A) pathologically-confirmed SD and B) pathologically-
confirmed PNFA (represented on an averaged brain, top, and an inflated cortical map, bottom) 
compared  with controls (coloured bar represents FDR corrected p-values)  
!
!
!
Modelling severity using performance on naming task (Figures 3.3.3 and 3.3.4) 
In SD there was greater thinning of the temporal lobe cortices as the disease became more 
severe (as assessed by the severity of anomia) (Table 3.3.1). In the least affected group the 
predominant thinning was in the anterior and inferior parts of the left temporal lobe with a 
similar but less affected area in the right temporal lobe (Figure 3.3.3). As the disease became 
more severe, there was involvement of more posterior and superior parts of the left temporal 
lobe, parts of the left frontal lobe (orbitofrontal and inferior gyri) and the insula and cingulate 
gyrus. A similar pattern of evolution with increasing disease severity was observed in the right 
temporal lobe cortex.  
 
In PNFA there was also greater thinning of the cortices as the disease became more severe 
(Table 3.3.1). In the least affected group the areas of thinning were in the left inferior frontal 
gyrus, insula and areas of the superior temporal lobe. As the disease became more severe, 
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these areas became thinner and there was additional involvement of the lateral left temporal 
lobe, anterior parietal lobe and middle and superior parts of the frontal lobe (Figure 3.3.4).  !
Figure 3.3.3 
Percentage cortical thickness difference from controls in SD in groups 1, 2, 3 and the total group (only 
lateral views are shown, coloured bar represents percentage thickness difference). !
!!
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Figure 3.3.4 
Percentage cortical thickness difference from controls in PNFA in groups 1, 2, 3 and the total group 
(only lateral views are shown, coloured bar represents percentage thickness difference).  !
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Table 3.3.1  
Comparison of disease groups by naming score (equivalent Oldfield score) and cortical thickness in 
each lobe (*p<0.05 disease group versus controls, N = number of patients) 
 
Mean (standard deviation) cortical thickness in each lobe (mm) 
Frontal  Temporal  Parietal  
Group N 
Range 
of 
naming 
scores 
Mean 
(standard 
deviation)  
naming  
score 
Left Right Left Right Left Right 
SD 1 9 >9 12.0 (2.0) 2.1 (0.2) 2.2 (0.1) 1.7 (0.2)* 2.1 (0.2)* 2.0 (0.1) 2.0 (0.2) 
SD 2 11 3-9 5.4 (2.0) 2.0 (0.1) 2.1 (0.2) 1.6 (0.1)* 2.0 (0.2)* 1.8 (0.1) 1.9 (0.2) 
SD 3 8 <3 0.8 (0.9) 1.8 (0.1)* 2.1 (0.2) 1.5 (0.1)* 2.0 (0.1)* 1.7 (0.1)* 1.9 (0.2) 
PNFA 1 11 >24 26.8 (1.0) 2.1 (0.2) 2.1 (0.2) 2.3 (0.3) 2.3 (0.4) 1.9 (0.2) 1.9 (0.2) 
PNFA 2 11 14-24 19.7 (4.1) 2.0 (0.1) 2.2 (0.2) 2.2 (0.3) 2.4 (0.3) 1.9 (0.1) 2.0 (0.2) 
PNFA 3 6 <14 10.5 (3.0) 2.0 (0.1)* 2.1 (0.1) 2.0 (0.3)* 2.3 (0.4) 1.8 (0.1)* 1.9 (0.2) 
Controls 29 N/A N/A 2.2 (0.2) 2.2 (0.1) 2.4 (0.3) 2.3 (0.3) 2.0 (0.2) 2.0 (0.2) !
DISCUSSION 
This study shows that there are distinct patterns of cortical thinning in SD and PNFA. The 
findings of predominantly asymmetric left greater than right temporal lobe atrophy in SD and 
predominantly left-sided superior temporal, inferior frontal lobe and insular atrophy in PNFA 
are consistent with previous reports using other image analysis techniques described in Chapter 
3.1. These findings further suggest that increasing disease severity is associated with distinct 
patterns of evolution of cortical thinning beyond these core regions: into the left frontal, insular 
and cingulate cortices in SD, and into left middle and superior frontal lobe and anterior left 
parietal lobe in PNFA. 
 
The initial and canonical feature of SD is progressive degradation of semantic knowledge 
resulting in anomia and impaired single word comprehension. Theories of semantic memory 
localization suggest the anterior left temporal lobe plays a critical role and this would be 
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consistent with the early involvement of this core area even in the least affected SD group. In 
PNFA the initial clinical feature is often apraxia of speech, which has been associated with left 
insula involvement (Dronkers, 1996; Ogar et al, 2007) and agrammatism, which has been 
associated with left inferior frontal lobe damage (Amici et al, 2007). Other regions of superior 
temporal cortex involved in the PNFA group here, in particular the superior temporal sulcus 
and transverse temporal gyrus, mediate the analysis, transcoding and short term storage of 
speech signals (Scott et al, 2003). Damage involving these areas might contribute to 
impairments of phonological encoding, working memory and grammar processing that are 
often prominent in this group suggesting testable hypotheses for future work. In the 
pathologically-confirmed subgroup of PNFA patients the most significant area of thinning was 
in the insular cortex consistent with previous findings that this area is critical for the 
development of speech production deficits in PNFA (Nestor et al, 2003).  
 
The findings concerning the effects of disease severity on cortical thinning in SD and PNFA are 
based on the analysis of stratified cross-sectional data indexed using a key neuropsychological 
function (naming performance), rather than longitudinal measurements in individual patients.  
However, allowing this caveat, the stratified cross-sectional findings are consistent with 
available data on patterns of disease evolution in SD and PNFA. In SD, disease progression is 
associated with the development of impairments of behaviour and social cognition (Rosen et 
al, 2006) and symptoms attributable to right temporal lobe dysfunction such as prosopagnosia 
(Seeley et al, 2005). These clinical features are consistent with the thinning of frontal 
(particularly left orbitofrontal), insula, right temporal and posterior temporal cortices observed 
in the more severely affected SD group here. In PNFA, disease progression is associated with 
increasing difficulties with speech repetition and often the emergence of non-language 
symptoms such as limb apraxia and dyscalculia, consistent with spread through the temporal 
lobes posteriorly to involve the left parietal lobe. There are few longitudinal imaging studies of 
either SD or PNFA (Whitwell et al, 2004; Bright et al, 2008; Brambati et al, 2009b). Although 
other studies have generally used estimated disease duration as a surrogate of severity, the 
patterns of disease spread described previously are qualitatively similar to those observed here: 
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namely, increasing involvement of right temporal and posterior temporal and left inferior 
frontal areas in SD, and more dorsal posterior left temporal and parietal areas in PNFA. 
However, the data concerning PNFA in particular should be interpreted with caution, given 
that pathological confirmation was available in only a minority of cases. The PNFA syndrome 
is likely to be pathologically heterogeneous, and involvement of parietal and other posterior 
cortical areas may be produced by specific pathological substrates rather than as a 
consequence of disease evolution per se. Resolution of this issue must await more complete 
histopathological data for the PNFA group. 
 
Measures of cortical thickness have been performed in various neurodegenerative diseases 
using a number of different techniques. From the neurobiological perspective, this technique 
can potentially provide important complementary information about cortical areas (such as the 
superior temporal sulcus region) that are likely to be crucial in the pathophysiology of the 
language-based dementias but difficult to assess using conventional imaging modalities on 
anatomical or geometrical grounds. The clinical utility of cortical thickness measurement has 
not been widely evaluated. Furthermore, the various techniques currently in use have not yet 
been adequately compared (Fischl et al, 2000; Kim et al, 2005; Hutton et al, 2008). Evaluation 
of the sensitivity and specificity of cortical thickness techniques, hypothesis-driven correlation 
with behavioural, pathological and other neuroimaging data, and longitudinal studies in 
degenerative disease are clear directions for future work.  
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3.4 Longitudinal volumetric imaging and sample sizes in PNFA and SD 
There are currently few longitudinal imaging studies of PNFA and SD and hence little is known 
about the patterns of change in cell loss over time (Whitwell et al, 2004; Bright et al, 2008; 
Brambati et al, 2009b). Information about such change will be important not only to 
understand these diseases more clearly but also because of the need to develop useful 
biomarkers of disease progression for clinical trials (Fox et al, 2005). This study was therefore 
designed with two aims: to characterise profiles of whole-brain and hemispheric atrophy 
longitudinally in PNFA and SD as well as temporal lobe atrophy in SD, and to determine 
whether such measures could constitute feasible imaging biomarkers for therapeutic trials in 
PNFA and SD.  
 
METHODS 
Image analysis was performed using the MIDAS software package (Freeborough et al, 1997a). 
Volumetric analysis was performed as described in Chapter 2. Segmentation was performed 
blinded to the subject's identity, whether in the disease or control group, whether 
measurements were being performed on the baseline or registered-repeat image, and the left–
right orientation of the scan. 
 
Statistics and sample size calculations 
The two disease groups and the healthy control group were compared statistically based on 
contrasts between the group means using a linear regression model in STATA 10 (Stata 
Corporation, College Station, TX). 95% bias-corrected bootstrap confidence intervals with 1000 
replicates were used. Standard methods were used to calculate sample sizes for detection of a 
moderate treatment effect (30% reduction in atrophy adjusting for control atrophy rate), 
including baseline and one follow-up assessment with 90% power and 5% two-tailed 
significance level (Fox et al, 2000).  
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RESULTS 
 
Whole brain, hemisphere and ventricle volumetric measurement in PNFA and SD 
Baseline brain and hemisphere volumes were smaller in the PNFA and SD groups compared to 
controls with ventricle volumes being larger in the disease groups. Left/right hemispheric 
asymmetry ratios in PNFA and SD were significantly lower than control ratios at baseline but 
not significantly different between the disease groups (Table 3.4.1). !
Table 3.4.1 
Baseline volumetric MRI data for the control, SD and PNFA groups 
 
 Controls SD PNFA 
Baseline brain volume (ml) 1180.6 (96.8) 1110.1 (106.6) 1054.5 (137.6) 
Baseline left hemisphere volume (ml) 581.4 (45.4) 528.7(46.5) 513.6 (60.2) 
Baseline right hemisphere volume (ml) 579.5 (47.8) 561.9 (56.1) 537.8 (64.0) 
Baseline left/right hemisphere ratio 1.00 (0.01) 0.94 (0.03) 0.96 (0.04) 
Baseline ventricular volume (ml) 27.7 (23.8) 43.1 (19.7) 43.7 (19.4) !
Rates of whole brain atrophy and ventricular enlargement were greater in each of the disease 
groups compared with controls with no significant differences between the disease groups 
(Tables 3.4.2). As in previous studies comparing BSI and SIENA, the SIENA rates were slightly 
higher than those found using BSI (Smith et al, 2007). Left hemisphere rates of atrophy were 
significantly greater than right hemisphere rates within disease groups however there were no 
significant differences in rates of left or right hemisphere atrophy between PNFA and SD 
(Tables 3.4.2). Hemispheric asymmetry (left/right hemisphere ratio) significantly increased in 
the SD groups over time with a non-significant trend toward increasing in the total PNFA group 
(Tables 3.4.2). However, three PNFA patients started with right greater than left asymmetry (two 
of whom were known to be left-handed) and if these patients were excluded from the analysis 
there was a significant increase in the left/right hemispheric asymmetry in the PNFA group.  
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Table 3.4.2  
Rates of whole brain atrophy, ventricular enlargement, hemispheric atrophy and change in left/right 
hemisphere ratio (1 Enlargement rate for ventricle BSI, * p<0.05, disease group worse than controls). 
 
Outcome measure Mean rate of atrophy1 (standard deviation) 
 Controls SD  PNFA  
Brain BSI (%/yr) 0.3 (0.4) 2.5 (1.5)* 2.5 (1.1)* 
Brain SIENA (%/yr) 0.5 (0.3) 3.2 (1.3)* 3.4 (1.7)* 
Left hemisphere rate (%/yr) 0.3 (0.9) 3.6 (3.0)* 4.2 (1.8)* 
Right hemisphere rate (%/yr) 0.0 (0.9) 2.8 (2.8)* 3.4 (1.9)* 
L/R hemisphere ratio change (%/yr) 0.3 (0.7) 0.8 (1.0)* 0.8 (1.1) 
Ventricle BSI (ml/yr) 0.7 (1.0) 6.9 (3.8)* 6.5 (3.4)* 
 
Sample size calculation 
Estimated sample sizes (Table 3.4.3) were smallest for left hemisphere rate and whole brain BSI 
in the PNFA group and for whole brain SIENA measurement in the SD group.  
 
Table 3.4.3  
Sample size required per treatment arm using different measurement methods, based on 90% power to 
detect a difference (1 Enlargement rate for ventricle BSI). 
 
 Sample size per treatment arm (30% reduction in atrophy rate1) 
 SD PNFA 
Brain BSI 109 59 
Brain SIENA 63 81 
Ventricle BSI 88 81 
Left hemisphere rate 193 50 
Right hemisphere rate 234 73 
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Temporal lobe volumetric measurement in SD 
The mean (standard deviation) baseline left temporal lobe volume was 31.9ml (6.9ml) in the 
SD group and 61.3ml (5.8ml) in the controls, whereas the mean baseline right temporal lobe 
volume was 49.2ml (9.5ml) in the SD group and 64.8ml (6.8ml) in the controls. The mean 
baseline left temporal lobe volume was significantly smaller than the right in the SD group. The 
mean annualized rates of both left and right temporal lobe atrophy were significantly greater in 
the SD group compared with controls (Table 3.4.4). However, the right temporal lobe atrophy 
rate for the SD group was significantly greater than the left temporal lobe atrophy rate (p=0.02). 
Furthermore, right and left temporal lobe atrophy rates were correlated, R2 = 0.31, p=0.008 
(Figure 3.4.1). The data from the subgroup of eight patients who had pathological confirmation 
of disease were also analyzed with no evidence for differences between the pathologically-
confirmed and the non-pathologically-confirmed SD groups. 
 
Table 3.4.4 
Annualized rates of temporal lobe atrophy in the control group, total SD group and pathologically-
confirmed SD group 
 
 Mean rate of atrophy (standard deviation) ml/year 
 Controls Total SD  Path-confirmed SD 
Left temporal lobe  0.4 (0.6) 2.8 (1.2) 2.5 (1.0) 
Right temporal lobe  0.4 (0.8) 3.9 (1.7) 4.0 (1.2) !
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Figure 3.4.1 
Rate of atrophy of the right temporal lobe as a function of the rate of atrophy of the left temporal lobe 
in each of the 21 patients with semantic dementia  
 
 !
Sample size calculations revealed a number per treatment arm of 60 for the left temporal lobe 
and 55 for the right temporal lobe i.e. substantially smaller than if whole brain or hemisphere 
volumes were used. 
 
DISCUSSION 
This study provides profiles of longitudinal global and regional brain atrophy in a cohort of 
patients with SD and PNFA. Both groups have asymmetrical (predominantly left-sided) cerebral 
atrophy at baseline with increasing asymmetry as the disease progresses. Overall rates of 
progression (based on whole brain or hemispheric atrophy rates) were similar between the 
groups. 
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The basis for increasing cerebral asymmetry with disease evolution in SD and PNFA is an 
unresolved issue with neurobiological implications. This longitudinal change in hemispheric 
ratio is not attributable simply to an arithmetical effect, which would follow if both 
hemispheres atrophied at a similar fixed rate: rather, the increase in hemispheric asymmetry 
was underpinned by a genuine disproportionate increase in left hemisphere atrophy. On face 
value this finding appears to run counter to the widely held view that focal dementias become 
‘global’ brain diseases over time, with more or less uniform involvement as an endpoint. To 
address this issue will require detailed regional analysis of the profile of longitudinal changes 
within as well as between hemispheres, as well as systematic sampling of atrophy rates 
throughout the course of the disease. One interpretation is that, at least during the phase of 
mid-stage disease, atrophy spread occurs via a mainly intrahemispheric network of connected 
brain regions, tending to ‘focus’ the effects of the pathological process within the more 
damaged (left) hemisphere. This interpretation would be consonant with other emerging 
evidence of network-specific damage in FTLD syndromes (Seeley et al, 2009) and suggests 
testable hypotheses about the mechanism of brain damage in FTLD more generally. 
 
The sample size calculations in this study have implications for the design of future trials of 
disease-modifying therapy in SD and PNFA (Knopman et al, 2008; Knopman et al, 2009). For 
SD, smaller sample sizes may be needed in clinical trials if MR measures of particular regions 
of interest (temporal lobes) are used rather than measures of whole brain, hemisphere or 
ventricular volume change. Measures of rate of atrophy for the left hemisphere in PNFA would 
yield practically useful sample sizes, however (by analogy with SD) the use of more specific 
regions of interest (e.g. inferior frontal lobe or insula) might improve sample size estimates. 
One further caveat is that this study used manual segmentation of the temporal lobes. Although 
this has good intra-rater reliability, it is relatively time-consuming and requires training of the 
segmentor. Development of more automated measurements would be useful and there are a 
number of possible approaches (e.g. template-based segmentation of temporal lobes) – these 
would need to be validated in SD scans but if reliable they may be easier and quicker to 
implement in a multicentre clinical trial. 
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Chapter 3 summary 
Chapter 3.3 described the patterns of cortical thinning in PNFA and SD – as hypothesized the 
cross-sectional results are broadly in keeping with previous studies using other techniques i.e. 
that the predominant areas of cell loss are in the anteroinferior temporal lobes in SD and the 
left inferior frontal lobe/insula in PNFA. The use of anomia as a measure of severity allowed 
investigation of the patterns of cell loss with increasing disease burden. Whilst this is not 
equivalent to a longitudinal study looking at changes with increasing disease duration, it is 
likely to provide broadly similar results. Longitudinal studies of PNFA and SD are lacking and 
both this part of Chapter 3.3 and also Chapter 3.4 provide more information about changes 
over time – in SD there is increasing spread of disease throughout the left hemisphere into 
more posterior temporal areas, as well as frontal and anterior cingulate lobes as well as spread 
into the right temporal lobe (which has, by the total millilitres lost a greater volume loss per 
year than the left temporal lobe). Although there is greater right temporal lobe involvement 
measures of hemisphere volume change show that there is in fact increasingly greater loss in 
the left hemisphere than the right hemisphere as a whole over time in SD. This is also the case 
for PNFA, which may have greatest atrophy in the inferior frontal lobe and insula but spreads 
throughout the left hemisphere to involve more of the frontal lobe as well as the temporal, 
particularly superior temporal lobe, and to a lesser extent anterior parietal lobe. Whilst whole 
brain measures are relatively simple and are currently used most commonly as secondary 
disease outcome measures in clinical trials of Alzheimer’s disease, it may be that a region of 
interest may provide smaller sample sizes in the progressive language disorders but more work 
is necessary to look at faster, more automated measures. !
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4. Genetics and pathology of language impairment in FTLD 
Although FTLD is commonly described in terms of its clinical syndrome i.e. behavioural 
variant frontotemporal dementia (bvFTD) and the language variants PNFA and SD, the 
underlying genetic and pathological basis of these disorders is heterogeneous without a clear 
one-to-one clinico-genetic or clinico-pathological correlation. It is often familial and there are 
five genes which are currently known to cause FTLD of which two are relatively common 
(microtubule-associated protein tau, MAPT, and progranulin, GRN) and three are rare causes 
(valosin-containing protein, VCP, chromatin modifying protein 2B, CHMP2B, and the gene 
encoding TDP-43 protein, TARDP) (Mackenzie et al, 2007; Benajiba et al, 2009). 
Pathologically, there are four main pathological subtypes characterized by which protein is 
found in cellular inclusions. Traditionally, FTLD pathology was split into those with tau-
positive pathology, which includes corticobasal degeneration (CBD), progressive supranuclear 
palsy (PSP) and Pick’s disease and those with tau-negative, ubiquitin-positive pathology, FTLD-
U. However, more recently FTLD-U has been shown to consist mostly of patients with 
inclusions containing the protein TDP-43 (FTLD-TDP, which can be subtyped even further into 
types 1 to 4) with a minority of patients having inclusions containing the protein FUS (FTLD-
FUS) and an even smaller number with a yet unknown disease-causing protein (called FTLD-
UPS after the ubiquitin-proteosome system which is known to be involved albeit not the 
disease causing proteins) (Cairns et al, 2007; Mackenzie et al, 2009; Neumann et al, 2009). In 
terms of genetic-pathological correlations, MAPT mutations are associated with FTLD-tau 
whilst GRN, VCP, TARDP and CHMP2B mutations are associated with FTLD-U: GRN, VCP 
and TARDP mutations with FTLD-TDP and CHMP2B with FTLD-UPS.  
 
After a review of previous studies (4.1), this chapter will initially look at the heritability of the 
different FTLD clinical syndromes (and in particular the language subtypes) and the extent to 
which the currently known mutations account for that heritability (4.2). The two common 
genetic mutations (GRN and MAPT) are then compared in terms of neuropsychological and 
particularly imaging features (4.3). In the last chapter (4.4) the clinico-pathological correlation 
of language impairment in FTLD is examined. 
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The specific hypotheses of Chapter 4 are: 
1. There will be variable heritability of the different clinical subtypes of FTLD and the 
language subtypes will be less familial than the behavioural variant of frontotemporal 
dementia. 
2. The different progressive aphasias will be associated with differing genetic and 
pathological causes. 
3. On a nonfluent aphasia versus semantic dementia dichotomy there will not be a one-to-
one clinico-pathological correlation. 
4. Different genetic and pathological forms of FTLD will have differing patterns of atrophy 
and differing associations with particular clinical syndromes. 
 
 !!!!!!!!!!!!!!!!!!
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4.1 Overview of previous genetics and pathology studies 
A number of studies have shown that FTLD is commonly familial (Stevens et al, 1998; Chow et 
al, 1999; Bird et al, 2003) with mutations in a number of different genes known to be causative 
of FTLD. Mutations were first discovered in the MAPT gene in 1998 (Hutton et al, 1998; 
Poorkaj et al, 1998; Spillantini et al, 1998) with mutations in VCP (Watts et al, 2004) and then 
CHMP2B (Skibinski et al, 2005) discovered in the mid 2000s. Mutations in these latter two 
genes are only rare causes of FTLD and it was not until 2006 that a more common genetic 
cause was found following discovery that mutations in the GRN gene on chromosome 17 
caused FTLD, finally explaining the conundrum of genetic linkage of families with FTLD-U to a 
region including MAPT (Baker et al, 2006; Cruts et al, 2006). Although mutations in MAPT and 
GRN are the most common of the FTLD disease-causing genes there is variability in the 
prevalence geographically across different reported series: MAPT mutation frequency varies 
between 3 and 14% (Houlden et al, 1999; Rosso et al, 2003; Stanford et al, 2004; Signorini et 
al, 2004) and GRN mutation frequency varies between 1 and 16% in different series (Cruts et 
al, 2006; Gass et al, 2006; Le Ber et al, 2007; Pickering-Brown et al, 2008; Borroni et al, 
2008b; Benussi et al, 2009) with some series reporting vastly different frequencies within the 
same country e.g. two studies of FTLD cohorts in Italy found frequencies of 1.6% and 15.2% 
(Borroni et al, 2008b; Benussi et al, 2009). Recent series have directly compared the frequency 
of MAPT and GRN mutations in FTLD populations (Cruts et al, 2006; Gass et al, 2006; Le Ber 
et al, 2007; Pickering-Brown et al, 2008: Table 4.1.1): some countries have families with a 
founder effect causing higher GRN mutation prevalence than MAPT e.g. in Belgium (Cruts et 
al, 2006). In the UK, the 10+16 MAPT mutation is common with a known founder effect 
(Pickering-Brown et al, 2004) which is likely to account for the higher frequency of MAPT 
mutations in some series (Pickering-Brown et al, 2008). 
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Table 4.1.1 
Previously reported series comparing frequencies of MAPT and GRN mutations in an FTLD spectrum 
population 
 
Series 
Geographical 
area 
Number 
in series 
% MAPT 
mutations 
% GRN 
mutations 
Cruts et al, 2006 Belgium 103 1.9 10.7 
Gass et al, 2006 USA 167 4.4 4.8 
Le Ber et al, 2007 France 210 2.9 4.8 
Pickering-Brown et al, 2008 UK 223 7.6 5.8 
 
Age at onset appears to be variable in both GRN and MAPT mutations: for GRN the youngest 
patient thus far reported had an age of onset of disease of 35 (Leverenz et al, 2007) with the 
oldest case being 83 years old at onset (Gass et al, 2006) with wide variability even within the 
same family. Some studies of GRN mutations have shown evidence of non-penetrance which 
may be age-related (Gass et al, 2006). MAPT mutations appear to be fully penetrant with an 
age at onset between 30 and 70 (van Swieten et al, 2007). 
 
While the clinical spectrum of both MAPT and GRN mutations is heterogeneous, certain 
features occur more frequently in association with a particular molecular substrate. Patients 
with MAPT mutations commonly present with bvFTD which may be accompanied by a 
corticobasal syndrome (CBS) or more rarely a progressive supranuclear palsy (PSP) syndrome 
(van Swieten et al, 2007). Cognitively, executive dysfunction is widely recognized but patients 
commonly develop semantic impairment later in the disease (Pickering-Brown et al, 2008) as 
well as prominent episodic memory difficulties (van Swieten et al, 2007). Patients with GRN 
mutations also present most commonly with bvFTD and there may be an associated CBS (van 
Swieten et al, 2008). However, unlike MAPT mutations patients in this group frequently present 
with one of the language variants of FTLD (van Swieten et al, 2008; Pickering-Brown et al, 
2008). 
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Clinico-pathological correlation in FTLD is similarly not one-to-one although there are a 
number of emerging patterns from more recent studies. The behavioural variant of FTLD 
appears to be associated with each of the different pathological subtypes with none being over-
represented. The language variants SD and PNFA however do appear to show some clearer 
associations with particular pathologies. SD seems to be most commonly caused by FTLD-TDP 
(with the original studies showing association with FTLD-U and more recent studies showing 
that this is the FTLD-TDP subtype: Rossor et al, 2000; Davies et al, 2005; Knibb et al, 2006; 
Snowden et al, 2007a; Pereira et al, 2009) although cases of FTLD-tau Pick’s disease and 
Alzheimer’s pathology have been more rarely reported. PNFA can be caused by both FTLD-tau 
and FTLD-TDP pathologies, although patients with a prominent motor speech impairment are 
associated particularly with the FTLD-tau pathologies, corticobasal degeneration, progressive 
supranuclear palsy and Pick’s disease (Josephs et al, 2006) rather than FTLD-TDP. However, a 
single case of progressive motor speech impairment and Alzheimer pathology is also reported 
(Gerstner et al, 2007).!!
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4.2 The genetics and heritability of FTLD 
The initial study in this Chapter set out to look at the heritability of FTLD in each of the 
different clinical syndromes and to investigate to what extent the known genes account for this 
heritability, and which clinical syndromes they are associated with. 
 
METHODS  
 
Sample collection 
Blood was collected for DNA extraction with written consent from patients attending the 
Specialist Cognitive Disorders Clinic at the National Hospital for Neurology and Neurosurgery, 
Queen Square, London and also from patients involved in studies of FTLD at the Dementia 
Research Centre, Institute of Neurology, Queen Square, London. Prior to the onset of this study 
a cohort of 100 DNA samples were available for study and a further 125 samples were 
collected during the period of this study i.e. in total 225 samples of patients who had a 
diagnosis within the FTLD spectrum (the canonical clinical syndromes of bvFTD, PNFA and SD 
as well as FTD-MND, CBS and PSP) according to consensus criteria (Neary et al, 1998; Boeve 
et al, 2003b; Litvan et al, 1996). 
 
Analysis of family history 
A measure of family history was devised by adapting a score used in Goldman et al, 2005 
where 1 is an autosomal dominant family history of FTLD, MND, CBS or PSP, defined as the 
presence of at least three affected people in two generations with one person being a first-
degree relative of the other two, 2 is familial aggregation of three of more family members with 
dementia but not meeting criteria for 1, 3 is one other affected family member with dementia 
and 4 is no or unknown family history. This was modified by changing a score of 3 into two 
separate scores: 3 only if there was a history of young-onset dementia within the family i.e. less 
than 65, and 3.5 if onset was above 65 All patients were given a “modified Goldman score” 
between 1 and 4 based on this scale. All patients had had a structured clinical interview which 
had included a detailed family tree. This had been discussed with the patient and family 
members (a minimum of one other person). The data for this study were ascertained from a 
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review of all of the clinical notes: data were available on 222 of the cases with only 3 patients 
scoring 4 because of an unknown family history (2 with bvFTD and 1 with FTD-MND). 
 
Genetic analysis 
All 225 patients were screened for mutations in MAPT and GRN detecting 39 pathogenic 
mutations. Of the remaining 186 mutation negative patients, sequencing was obtained for VCP 
exons 3, 5, 6 and 10 in 160 patients, TARDBP exons 4 and 6 in 179 patients, and CHMP2B in 
92 patients. Exon 15 of the FUS gene was also sequenced in 183 patients, mutations in which 
have been previously shown to be causative of motor neurone disease, although currently no 
mutations have been found in FTLD (Vance et al, 2009; Kwiatkowski et al, 2009).  
 
RESULTS 
 
Demographic and family history data (Table 4.2.1) 
Almost half of the 225 patients had bvFTD as their initial clinical syndrome (44.4%) with the 
next most common disorders being PNFA (20%) and SD (16.0%). Smaller numbers had CBS or 
a CBS/PNFA overlap syndrome, PSP or FTD-MND. Average age of onset for the different 
groups was between 54.8 years (bvFTD) and 61.6 years (PNFA) with a total mean of 57.3 
years. In total 58.2% of the patients were male with more male patients in each of the groups 
apart from the CBS and CBS/PNFA overlap groups. 10.2% of patients had an autosomal 
dominant inheritance (as defined by a modified Goldman score of 1) but the heritability of 
FTLD was substantially higher (41.8%) when a family history was defined by a modified 
Goldman score of 1, 2, 3 or 3.5). The bvFTD group had the largest proportion of cases with a 
family history (58.0% with modified Goldman score 1 to 3.5 and an average modified 
Goldman score of 2.9) and the least familial of the disorders were FTD-MND (10.0%, 3.8) and 
SD (22.2%, 3.8) (Table 4.2.1). 
 
 
!
!
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Table 4.2.1  
Demographic and family history data for the cohort of 225 FTLD patients (n = number of cases, AAO = 
age at onset of symptoms) 
 
Initial 
clinical 
syndrome 
n 
% 
of 
total 
cases 
Average 
AAO 
%male 
Modified Goldman score 
(% of cases) 
% of 
cases 
with 
score 
1-3.5 
Average 
score 
          1 2 3 3.5 4     
SD 36 16.0 57.9 52.8 0.0 5.6 5.6 11.1 77.8 22.2 3.8 
PNFA 45 20.0 61.6 62.2 2.2 1.1 0.0 13.3 73.3 26.7 3.6 
PNFA/CBS 8 3.6 61.3 12.5 12.5 0.0 12.5 12.5 62.5 37.5 3.4 
bvFTD 100 44.4 54.8 64.0 20.0 17.0 11.0 10.0 42.0 58.0 2.9 
FTD-MND 10 4.4 56.7 70.0 0.0 10.0 0.0 0.0 90.0 10.0 3.8 
CBS 17 7.6 57.6 41.2 5.9 11.8 17.6 17.6 47.1 52.9 3.3 
PSP 9 4.0 58.9 55.6 0.0 33.3 0.0 0.0 66.7 33.3 3.3 
Total 225   57.3 58.2 10.2 13.3 7.6 10.7 58.2 41.8 3.5 
 
Genetic analysis 
Mutations were found in the MAPT and GRN genes but no mutations were found in the 
CHMP2B, VCP, TARDBP or FUS genes. In total 20 patients (8.9%) had mutations in MAPT (15 
probands) and 19 patients (8.4%) had mutations in GRN (13 probands). Of the MAPT 
mutations, thirteen (from eight families) had an intronic 10+16 mutation of which seven 
families had previously been described (Janssen et al, 2002). The other previously described 
mutations were an intronic 10+19 mutation as well as deltaK280, L284R, N296N (Spillantini et 
al, 2000), S320F and G389R mutations. A novel MAPT variant was also found, N286N, a 
synonymous change similar to the N296N which is thought to be pathogenic via its effect on 
the splicing of exon 10. Most patients presented with bvFTD (although many developed 
semantic impairment as the disease progressed) apart from the N296N (CBS) and the L284R 
(PSP) mutations. The GRN mutations were ten C31fs mutations (from four families) and two 
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Q130fs mutations (from two families). Other mutations were S203fs, E498fs, Q300X, L469F, 
A199V mutations as well as 1048_1049insG and R493X mutations. Patients were diagnosed 
with bvFTD (C31fs, Q130fs, Q300X), PNFA (C31fs, L469F, R493X, S203fs) or CBS 
(1048_1049insG, A199V, C31fs, E498fs) with two patients having a PNFA/CBS overlap (C31fs, 
E498fs).  
 
Of the 186 patients without a known mutation the number of cases with a family history were 
re-examined and in particular it was looked at whether any of the “familial” cases had post-
mortem confirmation of FTLD pathology (Table 4.2.2). The majority of these cases (125) had a 
modified Goldman score of 4 but four cases with an autosomal dominant family history 
(modified Goldman score of 1) were still without a known mutation (all with bvFTD) and in 
total 61 cases with a modified Goldman score of 1,2,3, or 3.5 were not known to have a 
mutation. These included a small number of cases with either PNFA or SD (with 2 in each 
group having a modified Goldman score of 2). Those cases with a score of 1, 2 or 3 (38 in 
total) were looked at in particular as a score of 3.5 may well represent another family member 
with old-age onset dementia and therefore less likely to be a true familial history of FTLD. Of 
these 38 cases seven had pathological confirmation of disease (6 bvFTD and 1 FTD-MND). All 
of these cases had tau-negative FTLD pathology: 1 case with bvFTD was known to have 
ubiquitin-positive, TDP-43 negative, FUS-negative pathology (FTLD-UPS) without intranuclear 
inclusions similar to the pathology found in the Danish family with a mutation in CHMP2B (but 
in this case without a CHMP2B mutation) but the other six all had FTLD-TDP (i.e. TDP-43 
pathology) with all having type 3 pathology according to consensus criteria (Cairns et al, 
2007). 
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Table 4.2.2  
Number of cases without mutations stratified according to their family history. 
 
 Modified Goldman score (n cases) TOTAL (n) 
 1 2 3 3.5 4  
SD 0 2 2 4 27 35 
PNFA 0 2 0 6 31 39 
PNFA/CBS 0 0 0 1 5 6 
bvFTD 4 15 7 9 39 74 
FTD-MND 0 1 0 0 9 10 
CBS 0 1 2 3 8 14 
PSP 0 2 0 0 6 8 
Total 4 23 11 23 125 186 
 
DISCUSSION 
The results of this study confirm previous findings that FTLD is a highly heritable degenerative 
disorder. However, heritability varies between the different clinical syndromes with SD having 
a much lower percentage of cases with a family history compared with bvFTD. A previous 
study suggested that FTD-MND was the most heritable of the FTLD syndromes (Goldman et al, 
2005) but in this series it was the least heritable, albeit with low numbers in this cohort. 
Inconsistent results with other series may reflect ethnogeographic clustering of particular causal 
mutations. Numbers were also low in the PSP group limiting the ability to interpret these data. 
 
Mutations in MAPT and GRN are relatively common and have a similar prevalence in our 
series. The 10+16 MAPT mutation founder effect in the UK accounts for a relatively higher 
proportion of MAPT mutations compared to other reported series outside of the UK (Table 
4.1.1) but genetic studies seem to show that patients in this series with the GRN C31fs 
mutation are part of the same family, which is likely to at least partly account for the similar 
prevalence of GRN and MAPT mutations in this series. 
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No mutations were found in VCP, CHMP2B or TARDP consistent with previous series 
suggesting that these are rare causes of FTLD. It remains possible that causal mutations in these 
genes are present in unscreened exons of these 3 genes, although the sequencing strategy 
covered all known mutations to date. No mutations were also found in FUS suggesting that 
mutations in this gene are either not causative or are a very rare cause of FTLD. 
 
Taking into account the known mutations many patients were still found to have a strong 
family history suggesting that there are still unknown genes that cause FTLD (Seelaar et al, 
2008). One locus (on chromosome 9) is known for patients with a clinical phenotype of FTD-
MND (Le Ber et al, 2009), however this is associated with type 2 FTLD-TDP. Analysis of the 
pathological cases within this subgroup suggests that there are at least two other groups of 
patients with a family history without a known mutation: those with FTLD-UPS and those with 
type 3 FTLD-TDP without a GRN mutation (some of whom have a clinical phenotype of FTD-
MND). Although similar pathologically to cases with CHMP2B mutations, the single case in 
our series was negative for mutations in this gene. Studies of type 3 FTLD-TDP suggest that 
between 30 and 60% of such patients have GRN mutations but some patients negative for 
GRN mutations still have a family history (Josephs et al, 2007; Geser et al, 2009; Josephs et al, 
2009). There are no known loci associated with such patients suggesting further work needs to 
be done to clarify the genetic cause in this group as well as patients with familial FTLD-UPS.  
 
From the point of view of the language variants, whilst some cases of PNFA are associated with 
GRN mutations, there are still a small number of language cases (both PNFA and SD) with a 
strong family history and without mutations in the known disease-causing genes. Therefore it is 
likely that certain critical genetic determinants of language breakdown are yet to be 
discovered. However, taking these results together as a whole, it is clear that a simple genetic 
(Mendelian) contribution to the development of language syndromes is relatively small. It is 
therefore likely that there are multiple genetic and epigenetic factors that operate in the 
eventual development of a progressive aphasia in a single individual. 
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4.3 A comparison of the neuropsychological and imaging features of progranulin 
and tau mutations 
 
There are few studies looking at the neuropsychological and/or imaging features of both GRN 
and MAPT mutations (Whitwell et al, 2007a; Ghetti et al, 2008; Pickering-Brown et al, 2008; 
Whitwell et al, 2009) although initial reports suggest that GRN mutations are associated with a 
clinical syndrome of bvFTD, PNFA or CBS whilst MAPT mutations are associated with bvFTD 
and later semantic impairment. This study investigated the demographic, neuropsychological 
and imaging features of GRN-associated FTLD in comparison to MAPT-associated FTLD. 
 
METHODS 
Subjects 
In Chapter 4.2 from the total cohort of 225 DNA samples, 20 patients (from 15 families) were 
found to have MAPT mutations and 19 patients (from 13 families) had GRN mutations. Age at 
onset and disease duration data were available from these patients and also six further 
members of MAPT mutation families and six further members of GRN mutation families. A 
retrospective review of the Specialist Cognitive Disorders Clinic database was undertaken to 
assess how many of these patients had cross-sectional neuropsychology and imaging data and 
therefore would be included in the main part of the study. Eleven patients with a MAPT 
mutation (mean (standard deviation) age at baseline scan 53.5 (5.2)) and nine patients with a 
GRN mutation (mean (standard deviation) age at baseline scan 62.9 (6.1)) were included in the 
study: the MAPT mutation group comprised 8 patients with a 10+16 mutation and single 
patients with 10+14, S320F and G389R mutations; the GRN mutation group comprised four 
patients with a C31fs mutation, two patients with a Q130fs mutation and single patients with 
A199V, S203fs and E498fs mutations.  
 
Demographic data for these patients are shown in Table 4.3.1. All patients with MAPT 
mutations presented initially with a bvFTD syndrome whilst patients with GRN mutations 
presented with bvFTD, PNFA or CBS. A control group of fifteen cognitively-normal controls (10 
males, 5 females) were used for comparison in the imaging study (mean (standard deviation) 
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age at baseline scan 57.5 (5.3)). All patients included in the study had at least one volumetric 
brain MRI scan; six patients with a MAPT mutation and four patients with a GRN mutation had 
two scans.  
 
Neuropsychology testing 
Neuropsychological assessment consisted of a battery of cognitive tests. Verbal and visual 
episodic memory had been tested using the Recognition Memory Tests for Words and Faces 
respectively (Warrington, 1984; Warrington, 1996) whilst naming had been assessed with the 
Graded Naming Test (McKenna et al, 1980). Other cognitive domains that had been assessed 
were spelling (Graded Difficulty Spelling Test, Baxter et al, 1994), calculation (WAIS-R 
Arithmetic, Wechsler, 1981) and visuospatial and visuoperceptual skills (subtests of the Visual 
Object and Spatial Perception (VOSP) battery: Warrington et al, 1991). Executive function was 
assessed using a Modified Card Sorting test or the Weigl test (Nelson, 1976; Weigl, 1948). The 
presence or absence of limb apraxia was also noted. Patients were said to have a deficit in a 
particular cognitive domain if they scored below the 5th percentile on the test and their score 
was thought to represent a true deficit in that domain rather than being secondary to other 
factors such as concentration or attention. 
 
Imaging analysis 
Brain image acquisition as well as volumetric whole brain and hemisphere imaging methods 
and voxel-based morphometry methods are as described in Chapter 2. For VBM, linear 
regression models were used to examine differences in GM and WM volume between the 
groups. Voxel intensity, V, was modelled as a function of group, and subject age gender and 
total intracranial volume were included as nuisance covariates.  V=!1 MAPT carriers + !2 GRN 
carriers + !3 controls + !4 age + !5 gender + !6 TIV + µ + " (where µ is a constant, and " is 
error). Separate analyses were performed on the grey and white matter segments. Maps 
showing statistically significant differences between the groups were generated, correcting for 
multiple comparisons in the disease group-control comparisons by thresholding the images of 
t-statistics to control the False Discovery Rate (FDR) at a 0.001 significance level. For disease 
group comparisons no differences were seen at such a strict correction and maps were 
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generated uncorrected at a 0.001 significance level. Statistical parametric maps were displayed 
as overlays on a study-specific template, created by warping all native space whole-brain 
images to the final DARTEL template and calculating the average of the warped brain images.  
 
In order to visualise hemispheric asymmetries, two VBM analyses were performed: firstly with 
all images in their native space; and secondly, with native images flipped in the midsagittal 
plane within SPM5, such that the most severely affected cerebral hemisphere was on the same 
side in each patient. An image was selected for flipping if it had an hemispheric asymmetry 
index outside the control range and more severe right hemisphere atrophy (i.e. images were 
flipped such that any asymmetric atrophy was displayed on the left): four images from the GRN 
group and three from the MAPT group met criteria for flipping 
 
RESULTS  
Age at onset and disease duration 
Age at onset or death were available for 25 GRN mutation carriers and were compared with 26 
MAPT mutation carriers as well as 15 cases with FTLD-U pathology at autopsy (4 familial and 
11 sporadic) but no GRN mutation (Figure 4.3.1). Mean (standard deviation) age at onset for 
GRN was 57 (3) years, eight years later than for MAPT at 49 (2) years (t-test, two-tailed, p = 8.3 
x 10-5). However, age at onset was similar between GRN and FTLD-U with no GRN mutation 
(GRN –ve age at onset 56 (3) years, t-test, two-tailed, p = 0.73). GRN carriers had a much 
shorter clinical duration than other subtypes of FTLD. Mean clinical duration for GRN was 5 
(1) years compared with MAPT 12 (2) years (t-test, two-tailed, p = 7.8 x 10-6) and FTLD-U with 
no GRN mutation 9 (2) years (t-test, two-tailed, p = 0.002). Across these three aetiological 
subgroups, a later age at onset was associated with a shorter clinical duration (p = 0.006). A 
linear regression model was fitted to question the proportion of the variation in clinical 
duration accounted for by aetiological subgroup and/or age at onset. The model with minimal 
residual that best accounted for clinical duration incorporated aetiological subgroup and age at 
onset (p = 6.5 x 10-6), this model accounted for 34% of the variance of clinical duration. 
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Figure 4.3.1 
Age at onset, age at death and duration of disease are shown in the GRN mutation carriers (GRN +ve), 
MAPT mutation carriers (MAPT +ve) and GRN-negative FTLD-U (U+ GRN-ve). The dotted vertical line 
indicates the mean age at clinical onset for each group. Red lines = bvFTD, dark blue lines = PNFA, light 
blue lines = SD, yellow lines = CBS, grey = ‘dementia’ unspecified. 
!
!
!
Clinical features  
In the GRN cohort, the main clinical diagnoses were bvFTD, PNFA and CBS with one patient 
having a PNFA/CBS overlap. Amongst those presenting with behavioural symptoms, the most 
common initial feature was apathy. Other common behavioural features included abnormal 
eating behaviour (generally a sweet tooth) and inappropriate social behaviour with lack of 
insight. Some patients developed disinhibition later in the illness but this was rarely a 
presenting feature. Less common symptoms included loss of empathy, aggression, obsessive 
behaviour (including hoarding), impulsivity and hypersomnolence. One patient had tactile 
hallucinations of insects crawling over his skin with delusions that there were animals present 
in his bed to the extent that he refused to sleep in his bedroom. Many of the patients with 
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bvFTD had decreased quantity of speech without evidence of speech errors, agrammatism or 
articulatory impairment. Six of these patients had become mute when last seen. This language 
impairment would be consistent with dynamic aphasia rather than either the progressive non-
fluent aphasia or semantic dementia subtype of FTLD. None of the patients had evidence of 
motor neuron disease whilst 5 of the patients had features of parkinsonism (56%). 
 
In the MAPT cohort all of the patients had an initial diagnosis of bvFTD with the most common 
initial feature being disinhibition although the other common behavioural features of bvFTD 
were seen as the disease progressed similar to GRN mutations. Delusions and hallucinations 
were not seen in this group and neither was a primary language impairment. However, 6 of the 
patients developed features of parkinsonism (55%) similar in frequency to the GRN cohort. 
 
Neuropsychological features (Table 4.3.1) 
Many patients in both the GRN and MAPT groups performed poorly on tests of episodic 
memory and although failure on these tests could in principle be due to a number of factors 
most of these patients also complained of amnestic symptoms. Executive function was variably 
affected in both groups but naming was more commonly affected in the MAPT mutations group 
with errors being noted to be mainly semantic errors. Data that were available on this group of 
patients suggested that as well as the anomia patients also developed impairment of single 
word comprehension, which together suggest the development of semantic impairment. 
Impaired calculation, limb praxis, spelling, visuospatial or visuoperceptual skills were seen in 
the GRN patients. These features are generally considered markers of parietal lobe dysfunction 
and all GRN cases had at least one such deficit, compared with the MAPT group where only 
one patient had a parietal lobe deficit. To investigate this further the presence of parietal lobe 
deficits in this group were compared with the rest of the DNA sample cohort decribed in 
Chapter 4.2. Neuropsychological data were available for 121 GRN-negative patients from this 
cohort: the presence of dyscalculia, limb apraxia, spelling problems and visuospatial or 
visuoperceptual impairments was specifically assessed. Whilst in the GRN group 100% of the 
patients with definite mutations had at least one deficit attributable to parietal lobe dysfunction, 
in the GRN-ve FTLD-U group there were 25% (4/16) (chi-squared test GRN vs MAPT, 1 d.f., p 
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= 6.8 x 10-6; GRN vs. FTLD-U, 1 d.f., p = 7.0 x 10-6). Looking at the 121 GRN -ve patients by 
clinical diagnosis the percentage of cases with parietal lobe deficits was 100% in CBS (15/15) 
with all having limb apraxia, 32% in the bvFTD group (18/56), 36% in SD (8/22) and 43% in 
PNFA (12/28). This emphasizes that there is greater parietal lobe involvement in GRN-
associated FTLD than in other FTLD groups with the exception of CBS, a disorder known to 
involve frontal and parietal lobes (and clinically, generally defined by the presence of a parietal 
deficit, namely apraxia). 
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Table 4.3.1 Neuropsychological features of MAPT and GRN mutation carriers. Verbal IQ (VIQ) and Performance (PIQ) scores are taken from the WAIS-R.  Recognition 
Memory Test (RMT) for Words and Faces, Graded Naming Test (GNT), Graded Difficulty Spelling Test (GDST), WAIS-R arithmetic and Visual Object and Space 
Perception (VOSP) battery results are quoted in percentile scores where a score below the 5th percentile is considered impaired. Of note, the VOSP scores are 
heterogeneous as different subtests of the battery were used in different patients. Executive function tasks are the Weigl or Wisconsin Modified Card Sorting Tasks 
or the Stroop task and are quoted as pass or fail. Limb apraxia is quoted as present or absent. 
Patient 
Presenting 
syndrome 
Mutation Gender 
Age at 
scan 
Duration 
at scan 
VIQ PIQ 
RMT 
WORDS 
RMT 
FACES 
GNT GDST 
WAIS-R 
arithmetic 
Limb 
apraxia 
VOSP 
Executive 
function 
MAPT1 bvFTD 10+16 M 54.5 7.5 91 96 <5th <5th <5th 10-25th 50-75th - <5th Fail 
MAPT2 bvFTD 10+16 M 58.0 8.0 97 107 <5th <5th <5th 50-75th 50-75th - >50th Pass 
MAPT3 bvFTD S320F M 58.7 7.7 107 128 >75th 5-10th <5th NT >75th - 25-50th Pass 
MAPT4 bvFTD G389R M 46.1 3.1 77 70 <5th <5th <5th 25-50th 25-50th - >10th Fail 
MAPT5 bvFTD 10+16 F 48.8 6.8 83 81 10-25th <5th <5th NT 10-25th - 50-75th Fail 
MAPT6 bvFTD 10+16 F 53.2 3.2 90 84 10-25th <5th <5th 10-25th 25-50th - 25-50th Fail 
MAPT7 bvFTD 10+14 M 50.1 9.1 100 96 <5th <5th <5th NT >75th - NT NT 
MAPT8 bvFTD 10+16 M 52.5 5.5 104 121 5-10th 5-10th <5th NT >75th - >75th Pass 
MAPT9 bvFTD 10+16 M 45.9 8.9 99 93 <5th <5th 5-10th NT >75th - >5th Pass 
MAPT10 bvFTD 10+16 M 60.7 2.7 99 105 <5th <5th <5th NT 50-75th - >10th Fail 
MAPT11 bvFTD 10+16 F 56.8 1.8 85 97 <5th 25-50th 50-75th NT 5-10th - >5th Pass 
GRN1 bvFTD C31fs M 67.4 1.4 84 72 <5th <5th 10-25th 10-25th 10-25th + <5th Fail 
GRN2 bvFTD Q130fs F 65.5 3.5 59 74 <5th <5th <5th 10-25th <5th - <5th Fail 
GRN3 PNFA C31fs F 68.3 2.3 85 108 50-75th 10-25th <5th NT NT + 25-50th Pass 
GRN4 bvFTD Q130fs M 65.9 3.9 107 95 25th 10-25th >75th NT >75th + >5th Fail 
GRN5 PNFA C31fs F 63.0 5.0 84 86 10-25th <5th 25-50th 10-25th <5th + 25-50th Fail 
GRN6 PNFA S203fs M 50.6 2.6 66 98 25-50th >75th <5th <5th <5th - >50th Pass 
GRN7 bvFTD C31fs M 56.4 3.4 88 80 25-50th 25-50th 50-75th NT 10-25th + >50th Fail 
GRN8 PNFA/CBS E498fs F 68.4 6.4 Unable 69 5-10th <5th <5th NT 5-10th + <5th NT 
GRN9 CBS A199V M 60.7 5.7 61 Unable Unable Unable <5th NT <5th + <5th Fail 
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Volumetric imaging data 
 
Whole brain volumes and rate of atrophy 
Baseline brain volumes were smaller in both disease groups compared with healthy controls 
and mean brain volume was significantly smaller in the GRN group compared with the MAPT 
group (Table 4.3.2). Rates of whole brain atrophy were significantly greater in the GRN group 
with no overlap with the MAPT group (Table 4.3.2, Figure 4.3.2).  !
Table 4.3.2  
Volumetric cross-sectional and longitudinal data for whole brain and hemisphere volumes (ap<0.05 
disease group significantly worse than. controls, bp<0.05 GRN mutation group significantly worse than 
MAPT mutation group) 
 
Mean (95% 
confidence 
intervals) 
MAPT mutations GRN mutations Controls 
Whole brain  
volume (ml) 
1117.3 (1079.6, 1162.5)a 996.8 (914.0, 1099.2)a, b 1230.5 (1180.2, 1272.6) 
Whole brain BSI 
atrophy rate 
(%/yr) 
1.4 (0.9, 1.9)a 3.4 (2.8, 4.0)a, b 0.3 (0.1, 0.4) 
Left hemisphere  
volume (ml) 
553.5 (536.4, 573.4)a 496.4 (460.8, 545.4)a, b 605.2 (581.3, 626.3) 
Right hemisphere  
volume (ml) 
552.0 (531.8, 574.9)a 489.8 (437.0, 562.1)a 605.9 (581.6, 625.3) 
Left/right  
hemisphere ratio 
1.00 (0.99, 1.02) 1.03 (0.93, 1.15) 1.00 (0.99, 1.01) 
!
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Figure 4.3.2 
Annualized rates of whole brain atrophy (as measured using the boundary shift integral) in the MAPT 
mutation (diamonds) and GRN mutation (triangles) groups as well as the controls (circles). 
 
 
 
Hemisphere volumes 
Baseline mean left and right hemisphere volumes were smaller in the disease groups than the 
controls and mean left hemisphere volume was significantly smaller in the GRN group 
compared with the MAPT group, with a trend to smaller mean right hemisphere volume in the 
GRN group (p=0.07) (Table 4.3.2, Figure 4.3.3A). The overall mean left/right asymmetry ratio 
was similar in all three groups, however individual cases in the GRN group were highly 
asymmetrical with all cases falling outside of the control range (Figure 4.3.3A), whereas the 
MAPT group were most often symmetrical with a few cases just falling outside the control 
range. Only a single GRN patient (GRN5) fell within the range of values of the MAPT group. 
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Furthermore, in the patients with longitudinal imaging, GRN cases became more asymmetric 
as the disease progressed whilst MAPT patients remained similarly symmetrical (Figure 4.3.3B).  !
Figure 4.3.3 !
Left/right hemisphere volume ratio in the three groups (A) and in patients with longitudinal imaging as a 
function of disease duration (B) 
!
!
VBM data 
 
Grey matter atrophy in disease groups versus controls 
Patterns of grey matter atrophy differed in the MAPT and GRN groups compared with healthy 
controls (Figure 4.3.4). The GRN group analysis on unflipped images showed an overall pattern 
of symmetrical atrophy in a brain network including frontal, temporal and parietal lobes, 
cingulate cortex and thalamus. However, this result obscures any asymmetries in favour of left 
or right hemisphere at individual subject level: after flipping of images so that all patients had 
the most affected hemisphere in the same orientation the true asymmetry of GRN disease was 
apparent (Figure 4.3.4). The most significant areas of grey matter atrophy were in the inferior 
frontal lobe [-40, 21, 4], dorsal insula [-32, 11, 7], superior temporal gyri [-47, 3, -9], middle 
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temporal gyri [-57, -23, -12], dorsal anterior cingulate cortex [-10, 32, 18], precuneus [-11, -
54, 25] and inferior parietal lobe [-47, -54, 22]. In contrast, the MAPT group analysis on 
flipped images revealed symmetrical involvement of a distinct and more ventral network 
including anterior temporal [-36, 10, -25; 36, 10, -26] and medial temporal lobes [-20, -8, -16; 
24, -8, -19], orbitofrontal cortex [-20, 8, -14; 31, 8, -11] and ventral insula [-34, -1, -2; 34, 0, -
1] with less involvement of the anterior cingulate [-11, 29, 19] (Figure 4.3.4).  !
Figure 4.3.4  
VBM analysis on grey matter (GM) regions in GRN- and MAPT-associated FTLD relative to healthy 
controls. The colour bar (lower right) indicates the t score. Left (L) and right (R) markers are shown for 
ease of reference however this analysis was performed on flipped images (see above).  !
!
!
!
White matter atrophy in disease groups versus controls 
In the GRN group compared with controls, the white matter VBM analysis showed most 
significant involvement of areas likely to be within intrahemispheric long association tracts 
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including inferior longitudinal fasciculus [-46, -37, -11], superior longitudinal fasciculus [-30, 
9, 12], inferior fronto-occipital fasciculus [-25, 21, -9] and cingulum [-19, 21, 27]. There was 
additional involvement of the corpus callosum and brainstem tracts, particularly in the pons 
(Figure 4.3.5). In the MAPT group compared with controls, the most significant areas of white 
matter loss lay in the fornices bilaterally [-21, -18, -12; -20, -34, 3] with less marked 
involvement of the uncinate fasciculus [30, 3, -33; -32, -1, -30] (Figure 4.3.5).  
 
Figure 4.3.5  
VBM analysis on white matter (WM) regions in GRN- and MAPT associated FTLD relative to healthy 
controls. The colour bar (lower right) indicates the t score. Left (L) and right (R) markers are shown for 
ease of reference however this analysis was performed on flipped images (see above).  !
!
!!
MAPT v GRN group comparisons 
Comparing the two mutation groups directly in the flipped VBM analysis (Figure 4.3.6), the 
GRN group had more marked and asymmetric grey matter loss in inferior frontal lobe [-40, 2, 
8], dorsal insula [-36, 8, 3], posterior temporal [-46, -36, 10] and inferior parietal [-34, -55, 37] 
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lobes and precuneus [-9, -57, 22], and more marked and similarly asymmetric white matter 
loss in areas likely to be in the superior longitudinal fasciculus [-38, -2, 16] and cingulum [-14, 
29, 24]. The MAPT group had more marked grey matter loss in the anterior and medial 
temporal lobes bilaterally [32, 0, -17; 32, 2, -30; 21, -7, -17; -28, -3, -15] and more prominent 
involvement of the fornices [28, -13, -21; 27, -22, -18] (Figure 4.3.6). 
 
Figure 4.3.6  
VBM analysis comparing grey matter (GM) and white matter (WM) atrophy between GRN- and MAPT-
associated FTLD groups. The top panels show regions where tissue intensity was reduced in the GRN 
group relative to the MAPT group (GRN<MAPT) and bottom panels show regions where tissue intensity 
was reduced in the MAPT group relative to the GRN group (MAPT<GRN). The colour bar (lower right) 
indicates the t score. Left (L) and right (R) markers are shown for ease of reference however this 
analysis was performed on flipped images (see text).  
!
!
!
!
DISCUSSION 
This study shows that GRN and MAPT mutation-associated FTLD differ in their underlying 
clinical, neuropsychological and neuroanatomical patterns. GRN patients presented with 
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bvFTD, PNFA or CBS. No patients with a classic SD syndrome or PSP were found to have 
mutations. Considering the clinical presentation in more detail, GRN patients who present with 
behavioural symptoms commonly have apathy as the initial presenting feature although most 
of the common behavioural symptoms of bvFTD are also seen during the disease. Previous 
case series have described language output impairment as a feature of GRN mutations (Cruts et 
al, 2006; Gass et al, 2006; Snowden et al, 2006; Mesulam et al, 2007; Pickering-Brown et al, 
2008). In our study different language phenotypes were seen within the cohort: many patients 
presenting with bvFTD had decreased spontaneous speech in the absence of speech errors, 
consistent with dynamic aphasia, often becoming mute as the disease progressed (Snowden et 
al, 2006; Pickering-Brown et al, 2008). Other patients presented with PNFA, a primary 
language syndrome known to be heterogeneous in its clinical presentation (Grossman et al, 
2004). In contrast, patients with MAPT mutations all presented with bvFTD. 
 
Patients with pathogenic GRN mutations who had a CBS are described in this series. Some of 
these patients had an overlap of PNFA and CBS: this is a well-described syndrome overlap 
(Graham et al, 2003) although the underlying pathology in many previously reported cases has 
been tau-positive corticobasal degeneration pathology (Knopman et al, 2005). CBS is 
classically described as involving the frontal and parietal lobes both clinically and 
radiologically, differing from other FTLD syndromes with its more posterior cerebral 
involvement. In fact, despite heterogeneity by established clinical criteria, all of the GRN 
patients in this series had evidence of early parietal lobe dysfunction on neuropsychometric 
testing. This has been noted previously (Spina et al, 2007; Le Ber et al, 2007) and study of this 
current cohort confirms the involvement of the parietal lobes early in GRN-associated FTLD 
with much lesser involvement in other genetic and clinical subgroups (except in cases of CBS).  
 
Using convergent imaging techniques this study suggests that GRN and MAPT mutations 
differentially affect neuronal loss at the level of large-scale cortical networks and their white 
matter connections. GRN mutations preferentially affect an asymmetrical distributed network 
of frontal, insular, cingulate, parietal and temporal areas linked by intra-hemispheric long 
association tracts, while MAPT mutations preferentially affect a more restricted but bi-
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hemispheric network of anteromedial temporal and orbitofrontal areas linked via the fornices 
and uncinate fasciculi. Disease evolution is more rapid in GRN- than MAPT-associated FTLD. 
Moreover, the degree of asymmetry increases over time in the GRN- (but not the MAPT-) 
associated cases: in conjunction with the evidence presented here for asymmetric longitudinal 
intrahemispheric volume loss, this increasing asymmetry implies that the pathological process 
in GRN-associated FTLD is focused within the maximally affected hemisphere. The present 
findings help to integrate previous evidence concerning anatomical signatures (Whitwell et al, 
2005; Whitwell et al, 2007a; Whitwell et al, 2009; Ghetti et al, 2008) and brain size (Josephs 
et al, 2007) in GRN and MAPT mutation cases. Further, the findings provide a direct 
demonstration of mutation-specific abnormalities of white matter circuitry in a head-to-head 
comparison of these molecular lesions.  
 
White matter involvement in FTLD has been little studied but long association tracts including 
the anterior cingulum and superior longitudinal fasciculus have been implicated (Seeley et al, 
2008; Borroni et al, 2008c). A diffusion tensor imaging study in presymptomatic patients with 
GRN mutations showed left uncinate fasciculus, arcuate fasciculus (part of the superior 
longitudinal fasciculus), and the left inferior fronto-occipital fasciculus (Borroni et al, 2008c). In 
the present study, the use of an unbiased technique (VBM) has revealed a cluster of white 
matter pathways expressing distinct molecular associations, including pathways (such as the 
fornix) not previously pre-specified in imaging studies of genetic FTLD.  It will be important in 
future studies of genetic FTLD to investigate the complementary information about white 
matter tracts that can be provided by diffusion tractography. 
 
Neural network dysfunction has been proposed to underpin phenotypic features of 
neurodegenerative disease including FTLD (Seeley et al, 2009), and in particular, behavioural 
dysfunction in bvFTD has been ascribed to selective vulnerability within a frontal-insula-
anterior cingulate network (Seeley et al, 2006; Seeley et al, 2007; Seeley, 2008; Seeley et al, 
2008). This network is affected by both GRN and MAPT mutations, suggesting that it is 
vulnerable to different pathological processes in FTLD. However, the most significant areas of 
atrophy here were differentiated according to the underlying molecular abnormality: atrophy in 
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a ventral orbitofrontal-medial temporal-ventral insula network was associated with MAPT 
mutations and atrophy in a more dorsal and asymmetrical anterior cingulate-dorsal insula-
temporal-parietal network was associated with GRN mutations. This suggests that large-scale 
neural network dysfunction is a signature of specific molecular pathologies within the FTLD 
spectrum. The genetically defined networks identified here are aligned with anatomically 
similar functional networks delineated in functional connectivity and resting-state network 
fMRI studies of healthy individuals (Seeley et al, 2009; Damoiseaux et al, 2006; Beckmann et 
al, 2005; Margulies et al, 2007). Network dysfunction here provides a pathophysiological 
bridge between molecular dysfunction and the clinical phenotype in different genetically-
mediated forms of FTLD: clinically, MAPT mutations produce behavioural symptoms 
(especially disinhibition) and later semantic impairment consistent with involvement of the 
ventral behavioural-semantic network (Seeley et al, 2009); while GRN mutations may produce 
bvFTD (with early involvement of the dorsal network in the right cerebral hemisphere), 
progressive aphasia (with early involvement of the dorsal network in the left cerebral 
hemisphere) or a corticobasal syndrome (with early involvement of more posterior parts of the 
dorsal network in either hemisphere). 
 
A crucial unsolved question concerns the mechanisms whereby these different molecular 
lesions produce such strikingly dissimilar patterns of neural network breakdown. There are 
three interrelated pathophysiological issues here: firstly, how one mutation produces 
asymmetrical cerebral damage and another more symmetrical damage; secondly, how these 
distinctive patterns of atrophy are maintained or amplified as the disease evolves; and finally, 
how phenotypic variation arises such that a particular mutation may selectively damage 
different cerebral hemispheres even between members of the same family. The variable clinical 
presentation of genetic FTLD suggests that molecular lesions do not specify a precise initial 
anatomical locus of brain damage: the initiation of disease in a particular brain region may be 
a stochastic event or could reflect hemispheric vulnerability due to developmental or other 
environmental change (Mesulam, 2009). However, the evidence from this study suggests that, 
once initiated, the pattern of disease evolution and the type of evolution that can occur is 
constrained by the underlying molecular abnormality. Particular mutations are likely to exert 
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their effects via the patterns of large-scale network connectivity that exist in the healthy brain, 
with connectivity between homotopic cortical areas (which is variable in different parts of the 
brain) being a crucial factor in linking a particular molecular lesion with symmetrical or 
asymmetrical network involvement (Stark et al, 2008). At a molecular level, GRN and MAPT 
are likely to be differently toxic to neurons: loss of GRN-mediated trophic support (Eriksen et 
al, 2008) might particularly disrupt long axonal connections within a hemisphere, whereas in 
MAPT-associated FTLD, toxic gain of function (Gendron et al, 2009) and the effects of 
diffusible tau with local spread to neighbouring brain regions (Brunden et 2008; Clavaguera et 
al, 2009) might lead to relatively restricted damage maximally affecting nearby synapses and 
local interneuronal populations within a functional brain region. The concept of large-scale 
neural network breakdown linked to specific molecular lesions may be relevant to the 
pathogenenesis of a number of neurodegenerative pathologies. Further work is required to test 
these hypotheses and establish the true status of molecular network dysfunction in the 
pathogenesis of FTLD and indeed, the broader spectrum of neurodegenerative disease. !!!!!!!!!!!!!!!!!
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4.4 Clinico-pathological correlation of language impairment in FTLD 
As discussed in Chapter 3.1 the correlation between clinical syndrome of PNFA and SD and 
the underlying pathology is not one-to-one. Previous studies have identified that SD is mostly 
due to ubiquitin-positive, TDP-positive pathology (Rossor et al, 2000; Davies et al, 2005; Shi et 
al, 2005; Snowden et al, 2007a; Hodges et al, 2007) but the more heterogeneous clinical 
syndrome of PNFA has a wider range of underlying pathologies (Hodges et al, 2004; Shi et al, 
2005; Josephs et al, 2006; Snowden et al, 2007a). This section reviews the underlying 
pathologies in a retrospective cohort of patients with language impairment in FTLD with 
comparison of neuropsychological and imaging features. 
 
METHODS 
A retrospective review of patients with a diagnosis in the FTLD spectrum according to 
consensus criteria who had attended the Specialist Cognitive Disorders Clinic, Queen Square, 
London, UK, and who had donated their brains for post-mortem analysis, was performed. 5 
patients with a diagnosis of FTLD had also had a brain biopsy during life and were also 
examined. Of a cohort of 103 patients, 9 had a diagnosis of PNFA, 24 patients had a diagnosis 
of SD with the other patients having a diagnosis of bvFTD, FTD-MND, CBS or PSP. 
 
All cases had had detailed neuropsychological assessments over the course of the disease. 
Naming was assessed with the Graded Naming Test or the Oldfield naming test (Oldfield et al, 
1965; McKenna et al, 1980) whilst verbal and visual episodic memory were assessed using the 
Recognition Memory Tests for Words and Faces, respectively (Warrington, 1984) and 
executive function was assessed using the Weigl test or a Modified Card Sorting test (Weigl, 
1948; Nelson, 1976). Other cognitive domains assessed included calculation (Graded 
Difficulty Arithmetic Test, Jackson et al, 1986) and visuospatial and visuoperceptual skills 
(subtests of the Visual Object and Spatial Perception (VOSP) battery, Warrington et al, 1991). 
Patients were recorded as having a deficit in a particular cognitive domain if they scored 
below the 5th percentile on the relevant test. Only assessments within the first five years from 
symptom onset were used in order to assess early symptoms. 
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For the SD cohort, volumetric imaging methods were as described in Chapter 2 with measures 
of whole brain, hemisphere volume and left/right hemisphere ratio. Cortical thickness 
estimation was performed as decribed in Chapter 2.  
 
RESULTS 
 
PNFA cohort 
Of the 9 cases with a clinical diagnosis of PNFA, 7 had FTLD-tau pathology, 4 with CBD and 3 
with Pick’s disease, and 2 cases had type 3 FTLD-TDP. 4 of the cases had volumetric MRI 
imaging (2 with CBD and 2 with Pick’s disease) and the cross-sectional imaging patterns in a 
combined cohort of these 4 cases were investigated in Chapter 3.3. A comparison of the 
clinical and neuropsychological data on these patients is shown in Table 4.4.1. Neurologically, 
one of the patients with type 3 TDP pathology had neurophysiological evidence of motor 
neurone disease with two of the patients with CBS pathology had parkinsonism consistent with 
a corticobasal syndrome i.e. an asymmetrical akinetic-rigid syndrome with myoclonus and 
dystonia. There were few behavioural symptoms although some patients developed one of the 
features seen in the behavioural variant of FTLD i.e. apathy, obsessive behaviour or abnormal 
eating behaviour although no patients developed disinhibition. All patients had a mild anomia 
which became worse as the disease progressed with the development of single word 
comprehension difficulties later in the disorder. Memory was relatively intact in most patients 
as was visuospatial skills. Executive dysfunction however was seen in most of the patients and 
dyscalculia was relatively common. Orofacial apraxia was seen in the tau-positive patients but 
not in the TDP-positive patients. 
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Table 4.4.1  
Clinical and neuropsychological features of pathologically-confirmed PNFA patients within first five years of symptom onset, + = present, - = absent.!!
Patient 
Age 
at 
onset 
Total 
duration 
MND Parkinsonism Apathy Disinhibition 
Obsessive 
behaviour 
Abnormal 
eating 
behaviour 
Episodic 
memory 
impairment 
Dyscalculia 
Orofacial 
apraxia 
Limb 
apraxia 
Visuospatial 
impairment 
Executive 
dysfunction 
CBD1 61 6.3 - - - - + - + + NT - - + 
CBD2 65 8.8 - + (CBS) - - - - - - + + - + 
CBD3 59 11.6 - + (CBS) - - - + - + + + - + 
CBD4 60 10.2 - - - - - + - - + + - + 
Pick1 57 10.8 - - + - - - - - + - - + 
Pick2 43 NK - - + - - - + + - - - + 
Pick3 50 NK - - - - - - - + + + - - 
TDP1 64 5.5 - - - - - - + + - + + + 
TDP2 62 2.4 + - + - - - + + - - - + 
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SD cohort  
Of the 24 patients with a clinical diagnosis of SD, 20 had type 1 FTLD-TDP pathology. The 
remaining 4 cases all had FTLD-tau Pick’s disease pathology. Cross-sectional imaging was 
available on 14 cases – 11 with type 1 FTLD-TDP pathology and 3 with Pick’s disease with 
longitudinal imaging available in 8 of the FTLD-TDP patients and all 3 of the Pick’s disease 
patients. The cross-sectional imaging patterns of the 11 cases with Type 1 FTLD-TDP were 
investigated in Chapter 3.3. In this Chapter the imaging (and also the clinical and 
neuropsychological features) in this group were compared with those with Pick’s disease. A 
third disease group comparison consisted of a further five patients in the post-mortem cohort 
with FTLD-tau pathology and MAPT mutations (four 10+16 mutations and one G389R 
mutation) who had been previously identified (during review of their neuropsychometry in 
Chapter 4.3) as having developed semantic impairment during the course of their illness 
(although with an initial bvFTD syndrome at onset) (Figures 4.4.1, 4.4.2 and Table 4.4.2). 3 of 
these patients had longitudinal imaging. 
 
Clinical and demographic features  
The three pathological groups were approximately matched for gender (64% male in the TDP 
group, 67% in the Pick’s disease group and 60% in the MAPT mutation group). Mean age at 
symptom onset and at death was significantly younger (p<0.01) in the MAPT mutation group 
(mean 48.0, standard deviation 6.4) compared with the two groups with a primary SD 
syndrome (TDP 61.2, 6.4; Pick’s disease 55.0, 1.0). Disease duration did not differ 
significantly between groups although there was a trend to longer disease duration in the 
FTLD-tau Pick’s group (TDP 12.4, 2.9; Pick’s disease 14.5, 4.0; MAPT mutations 9.4, 2.9). 
 
All patients developed behavioural symptoms during the disease course although these were 
the presenting features only in the FTLD-tau MAPT mutation group. Despite this behavioural 
features were similar in each group, most commonly disinhibition, obsessiveness and altered 
eating behaviour (usually, sweet tooth) with apathy being uncommon. Only the MAPT 
mutation group developed associated parkinsonism. 
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Neuropsychological features 
All patients had semantic impairment as defined by single word comprehension deficit with 
accompanying anomia. On other cognitive testing there was little difference in terms of 
performance on tests of episodic memory which was usually impaired although with some 
patients having spared visual memory with impaired verbal memory. However patients with 
FTLD-tau Pick’s disease more commonly had dyscalculia, consistent with left parietal lobe 
impairment, and patients with MAPT mutations more commonly had executive dysfunction. 
 
Neuroimaging features 
All three disease groups had smaller mean whole brain volumes than controls but reduced 
volume of the left compared with the right hemisphere (left/right hemisphere ratio of <1) was 
present only in the Type 1 FTLD-TDP and Pick’s disease groups with relatively symmetrical 
hemispheric atrophy in the FTLD-tau MAPT mutation group (Table 4.4.2; Figure 4.4.1). This 
difference in hemisphere asymmetry between the groups was maintained with increasing 
disease duration (Figure 4.4.1): the Pick’s disease group had the most asymmetrical atrophy at 
onset and atrophy became more asymmetrical as the disease progressed. Brain atrophy in the 
Type 1 FTLD-TDP group also become more asymmetrical over time, however atrophy in the 
MAPT mutation group was relatively symmetrical compared to the other groups and remained 
symmetrical as the disease progressed (as already shown above in Chapter 4.3). Of note, 
individually all cases with asymmetrical atrophy and a primary diagnosis of SD had 
predominant involvement of the left hemisphere. 
 
These features were corroborated by the cortical thickness analysis (Figure 4.4.2 and Table 
4.4.2). All three groups showed overlapping involvement of the anterior temporal lobe.  
However, there were distinct profiles of cortical thinning in each of the groups. The FTLD-TDP 
type 1 group had asymmetrical, left greater than right, anterior and inferior temporal lobe 
involvement with lesser involvement of the left orbitofrontal, cingulate and posterior temporal 
lobe. The Pick’s disease group had involvement of similar cortical areas, however frontal and 
parietal lobe involvement was more marked than in the TDP43 group. The MAPT mutation 
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group had predominant involvement of anterior temporal lobes, however this was more 
symmetrical than in the other groups and this group also had bilateral involvement of 
orbitofrontal cortex. !
Figure 4.4.1 
Left/right hemisphere volume ratio as a function of disease duration: TDP type 1 (black diamonds), 
Pick’s disease (grey triangles), MAPT mutations (red squares). The dotted lines represent the upper and 
lower limit of the control ratio. 
 
!!
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Table 4.4.2  
Summary of neuroimaging data: brain volumetry and cortical thickness measures. Mean (standard deviation) 
values shown. 
 
Imaging parameter 
FTLD-TDP  
type 1 
FTLD-tau  
Pick’s  
disease 
FTLD-tau  
MAPT 
mutations 
Controls 
Duration at scan (yrs) 4.7 (2.5) 3.8 (1.4) 4.5 (2.1) N/A 
Baseline volume (ml)     
Whole brain 
1087.4 
(124.9)a 
1021.5 (130.6)a 1137.1 (92.1) 1230.5 (91.6) 
Left cerebral hemisphere 521.8 (55.0)a 474.3 (72.3)a, e 568.9 (39.0) 605.2 (44.0) 
Right cerebral hemisphere 553.5 (64.5)a 533.7 (55.7)a 566.5 (41.4) 605.9 (45.0) 
L/R hemisphere volume 
ratio 
0.94 (0.02)a,c 0.89 (0.05)a, d, e 1.00 (0.03) 1.00 (0.01) 
Atrophy rate (%)     
Whole brain BSI 1.8 (0.3)a 1.9 (1.1)a 1.2 (0.9)a 0.3 (0.2) 
Cortical thickness (mm)     
Left frontal lobe 2.1 (0.2) 1.7 (0.2)a, d 1.9 (0.2)a 2.2 (0.2) 
Right frontal lobe 2.1 (0.2) 1.7 (0.3)a, d 1.9 (0.2)a, f 2.2 (0.2) 
Left temporal lobe: medial 1.5 (0.2)a, c 1.4 (0.4)a, e 1.8 (0.3)a 2.6 (0.4) 
Right temporal lobe: medial 2.0 (0.3)a 2.1 (0.3)a 1.8 (0.3)a 2.6 (0.5) 
Left temporal lobe: lateral 1.7 (0.2)a 1.6 (0.2)a 1.8 (0.2)a 2.3 (0.2) 
Right temporal lobe: lateral 2.1 (0.2)a 1.9 (0.3)a 1.9 (0.2)a 2.3 (0.2) 
Left parietal lobe 1.9 (0.2) 1.6 (0.1)a, d 1.8 (0.2)a 2.0 (0.2) 
Right parietal lobe 2.0 (0.2) 1.8 (0.2) 1.8 (0.2)a 2.0 (0.2) 
 
ap<0.05 disease group significantly worse than controls, bp<0.05 TDP group significantly smaller than 
Pick’s group, cp<0.05 TDP group significantly smaller than MAPT mutation group, dp<0.05 Pick’s group 
significantly smaller than TDP group, ep<0.05 Pick’s group significantly smaller than MAPT mutation 
group, fp<0.05 MAPT mutation group significantly smaller than TDP group !
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Figure 4.4.2  
Cortical thickness maps showing patterns of thinning compared with controls, corrected for multiple 
comparisons at FDR<0.01. Top row: TDP type 1, Pick’s disease and MAPT mutation groups versus 
controls; 2nd and 3rd rows, a conjunction analysis looking at the overlap in patterns of thinning between 
the groups compared with controls. 
 
!
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Table 4.4.3  
Clinical and neuropsychological features of pathologically-confirmed SD patients and five patients with MAPT mutations with semantic impairment, within five years 
of symptom onset, + = present, - = absent.!!
Patient 
Age 
at 
onset 
Total 
duration 
Duration 
at scan 
Parkinsonism Apathy Disinhibition 
Obsessive 
behaviour 
Abnormal 
eating 
behaviour 
Verbal 
memory 
impairment 
Visual 
memory 
impairment 
Dyscalculia 
Visuospatial 
skill 
impairment 
Executive 
dysfunction 
TDP1 59 14.0 4.3 - - - + + + - - - - 
TDP2 62 10.8 7.8 - + - - - + + - - - 
TDP3 64 14.6 9.2 - - + + + + + - - + 
TDP4 55 18.7 5.4 - - + + - + + - - - 
TDP5 67 8.7 3.7 - - + + + + - - - - 
TDP6 64 10.8 2.2 - - - - - + + - - - 
TDP7 69 11.3 1.5 - - + + - NT NT NT NT NT 
TDP8 52 9.9 3.4 - - + + - + + + - - 
TDP9 50 14.4 7.6 - - + + - + + - - - 
TDP10 64 10.3 4.2 - + - + - + + - - - 
TDP11 67 12.3 2.7 - + - + - + + - - - 
Pick1 55 13.0 2.4 - - - - - + + + - + 
Pick2 54 19.0 3.9 - - + + + + - + - - 
Pick3 56 11.5 5.2 - - + + - + - + - - 
MAPT1 47 13.7 7.5 - - + + + + + - - + 
MAPT2 43 6.3 3.1 - + + + + + + - - + 
MAPT3 42 10.4 5.8 + - + + - + + - - + 
MAPT4 50 8.1 3.2 - - + - - + + - - + 
MAPT5 58 8.4 2.7 + + + + + + + - - + 
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DISCUSSION 
This study has investigated the clinico-pathological features of PNFA and SD syndromes. In 
both syndromes, tau and TDP pathology is seen although in PNFA, tau predominates and in 
SD, TDP predominates.  
 
PNFA was associated in this study with CBD or Pick’s pathology most commonly, particularly 
when there was orofacial apraxia or a parkinsonian syndrome. The one patient with motor 
neurone disease had TDP pathology as would be predicted from previous studies although in 
this case type 3 pathology was seen rather than type 2 pathology which is more commonly 
associated with FTD-MND. Further studies of the neurolinguistic and neurological features in 
relation to the neuroanatomical findings in a larger case series will be required to understand 
the differences between the different pathologies causing a nonfluent aphasia. 
 
Consistent with previous evidence the most common pathological substrate of SD was Type 1 
FTLD-TDP: patients in this group had a relatively uniform clinico-anatomical syndrome typical 
of that previously described in SD, with semantic impairment at presentation and later 
behavioural symptoms but few other cognitive deficits and relatively circumscribed, 
asymmetric anteroinferior temporal lobe involvement. The group with FTLD-tau Pick’s disease 
had a broadly similar SD syndrome but with early prominent dyscalculia clinically and more 
extensive neuroanatomical involvement of the frontal and parietal lobes on neuroimaging and 
neuropathological analysis. The MAPT mutation group presented with bvFTD: this group had 
involvement of the anterior temporal lobes in common with the other two groups, but this was 
more symmetrical and there was also substantial orbitofrontal lobe involvement. These 
findings underline the potential for clinical and anatomical overlap amongst SD-like 
syndromes within the FTLD spectrum. All three groups here had prominent involvement of the 
left anterior temporal lobe neuroradiologically, while the extent of right anterior temporal lobe 
involvement was more variable: the consistent involvement of the left anterior temporal lobe 
supports a core role for this region in the pathogenesis of verbal semantic impairment (Hodges 
et al, 2007), which was a defining clinical feature of all cases in this study. The timing of onset 
of behavioural symptoms varied between the three groups here, however similar behavioural 
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features emerged in all groups during the disease course. These features, most notably 
disinhibition, obsessive behaviour and abnormal eating behaviour, are consistent with the 
present neuroimaging findings: together, the behavioural and anatomical findings suggest 
involvement of a common orbitofrontal-insular-striatal network (Liu et al, 2004; Woolley et al, 
2007). Early bilateral involvement of this network in patients with MAPT mutations would 
account for the prominent behavioural changes and associated parkinsonism in this group.  
 
Several caveats need to be considered when interpreting the present findings. Opportunities 
for anatomical and pathological correlation are limited, and case numbers in this (as in 
previous) series are small. The study was retrospective; accordingly, nonverbal semantic and 
other neuropsychological functions could not be systematically assessed. Furthermore, cortical 
regions beyond the temporal lobe are increasingly involved as SD evolves (as shown in 
Chapter 3.3), implying that anatomical differentiation may be clearer early in the course. 
Taking these caveats into account, this study supports a core syndrome of semantic 
impairment and left anterior temporal lobe damage which defines typical SD in association 
with FTLD-TDP type 1 pathology, and a spectrum of less common ‘halo’ cases with additional 
clinical manifestations, distinct patterns of (extra-temporal) tissue damage and 
histopathological features of tauopathy.  
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Chapter 4 summary 
This Chapter provides new information about the underlying genetics and pathology of 
language impairment in FTLD. The initial study in Chapter 4.2 shows as hypothesized that SD 
and PNFA can be familial although much less than bvFTD. SD is the less familial of the two 
syndromes and no mutations in the known genes that cause FTLD were found. PNFA can be 
familial in some instances and often due to mutations in the progranulin gene. Importantly, 
mutations in this gene, discovered only recently as causing FTLD, are the first gene mutations 
shown to cause a primary progressive aphasia. Pathogenic mutations in the MAPT gene do not 
seem to cause a primary progressive aphasia (usually presenting with bvFTD) but can cause 
semantic memory impairment later in the disease. Comparison of the neuroanatomy of this 
group with GRN mutations in Chapter 4.3 shows a more symmetrical atrophy pattern 
predominantly affecting anterior and medial temporal lobes, overlapping with the classical 
pattern of atrophy seen in SD. In Chapter 4.4 this comparison is shown with pathologically-
confirmed SD patients showing the overlap but differences between MAPT mutations and SD 
caused by TDP pathology or tau-positive Pick’s disease pathology. Chapter 4.3 shows that 
GRN mutations appear to cause a relatively distinct clinico-anatomical phenotype with 
markedly asymmetrical atrophy that extends back to involve the parietal lobes relatively early. 
In this sense the term frontotemporal lobar degeneration does not fully account for the features 
seen in GRN mutation-associated neurodegenerative disease. Chapter 4.4 shows that both 
PNFA and SD can be associated with tau-positive and TDP-43-positive pathology although 
PNFA is more commonly associated with tau-positive pathology and SD is predominantly 
associated with TDP-43-positive pathology. Preliminary study of the neuroanatomy of different 
SD clinico-pathological syndromes in Chapter 4.4 suggests that the groups may be 
distinguished by the extent to which frontal and parietal lobes are affected early on in the 
disease (early parietal lobe involvement more likely with Pick’s disease than TDP pathology in 
these cases). 
 !!
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5. Heterogeneity of the nonfluent progressive aphasia 
variants 
Chapter 3 investigated the imaging features of the two canonical subtypes of PPA, namely SD 
and PNFA. However more recent work has attempted to refine the classification of PPA with 
several papers describing a third, essentially nonfluent, subtype, known as the 
logopenic/phonological variant of PPA (LPA) (Gorno-Tempini et al, 2004a; Gorno-Tempini et 
al, 2008; Wilson et al, 2009b). Less commonly, other progressive aphasia phenotypes have 
also been described such as progressive anomia or non-fluent anomic aphasia (Snowden et al, 
2003; Snowden et al, 2007b; Pickering-Brown et al, 2008), progressive mixed aphasia 
(Grossman et al, 2004; Alladi et al, 2007) and phonological buffer disorder (Kartsounis et al, 
2007). This clinical syndromic heterogeneity is also matched by the pathological and genetic 
heterogeneity of PPA as described in Chapter 4: post-mortem series have shown both tau-
positive and ubiquitin-positive, TDP-43 positive FTLD pathology as well as Alzheimer disease 
(AD) pathology (Galton et al, 2000; Hodges et al, 2004; Josephs et al, 2006; Snowden et al, 
2007a; Mesulam et al, 2008), whilst genetically, GRN mutations can cause PPA (Snowden et 
al, 2006; Snowden et al, 2007b; Mesulam et al, 2007). This chapter aims to explore the 
heterogeneity of the nonfluent progressive aphasia variants by examining a prospective series 
of 33 patients with PPA. Following a review of the literature (5.1) this chapter investigates the 
clinical, neuropsychological and imaging features in this group particularly in the 24 patients 
with a “nonfluent aphasia” (i.e. excluding 9 patients with a diagnosis of SD) (5.2 and 5.3). 
Subsets of this larger group are investigated in more detail in the three other sections of this 
chapter: PPA associated with progranulin mutations (5.4), Alzheimer pathology (5.5) and 
atypical parkinsonian disorders (5.6). 
 
The specific hypotheses of Chapter 5 are: 
1. There are multiple clinical subtypes of the nonfluent progressive aphasias that can be split 
based on the presence of agrammatism and apraxia of speech. 
2. More specific clinical subtypes will map onto more well-defined genetic and pathological 
causes. 
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3. Progranulin-associated primary progressive aphasia will be associated with a nonfluent 
form that has other features such as parietal lobe involvement. 
4. Nonfluent aphasias associated with apraxia of speech will be associated with the atypical 
parkinsonian disorders, corticobasal syndrome and progressive supranuclear palsy. 
 
 !!!!!!!!!!!!!!!!!!!!!!!!
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5.1 Overview of previous studies 
The best described of the non-PNFA, non-SD phenotypes is logopenic or 
logopenic/phonological aphasia (LPA). Although initially reported in early descriptions of PPA 
(Mesulam, 1982; Mesulam 2001; Kertesz, 2003), it was first described in detail by Gorno-
Tempini and colleagues in 2004 (Gorno-Tempini et al, 2004a) and then expanded upon by the 
same group in a series of follow-up studies (Rosen et al, 2006; Amici et al, 2006; Gorno-
Tempini et al, 2008; Rabinovici et al, 2008; Brambati et al, 2009a; Wilson et al, 2009b). The 
disorder has been characterized as a primary phonological loop deficit resulting in impaired 
verbal short term (phonological) memory, impaired sentence repetition and comprehension 
with sparse spontaneous speech and frequent prolonged word-finding pauses. The most 
significantly atrophied areas in LPA are the left posterior superior temporal and inferior parietal 
lobes and to a lesser extent posterior cingulate and middle/inferior temporal lobe disease, 
although the extent to which atrophy spreads beyond these areas has been unclear (Gorno-
Tempini et al, 2008; Rabinovici et al, 2008; Wilson et al, 2009b). Small post-mortem and 
amyloid imaging studies have emphasized an association of LPA with AD pathology (Mesulam 
et al, 2008; Rabinovici et al, 2008) and this is consistent with the literature on atypical 
language variants of AD (Galton et al, 2000; Croot et al, 2000; Alladi et al, 2007; Stopford et 
al, 2007; Stopford et al, 2008) in which the phenotype described in many cases is similar to the 
LPA syndrome. With this said, the clinico-pathological correlation is not straightforward as AD 
pathology has also been associated (albeit less commonly) with other PPA phenotypes (Knibb 
et al, 2006; Gerstner et al, 2007; Rabinovici et al, 2008; Pereira et al, 2009). Pathologically-
confirmed imaging studies of this group are limited although one retrospective study of patients 
with progressive aphasia and AD pathology, some of whom would have fit proposed criteria 
for LPA, showed left temporo-parietal lobe atrophy, similar to to the previous clinical studies 
(Josephs et al, 2008b). 
 
Aphasia associated with GRN mutations has been little studied. Early descriptions suggested 
that these patients had a “nonfluent aphasia” (Baker et al, 2006; Cruts et al, 2006; Snowden et 
al, 2006; Mesulam et al, 2007; Pickering-Brown et al, 2008; Cruchaga et al, 2008) although 
one detailed case study has described progressive anomia without motor speech impairment 
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and subsequent development of repetition and reading deficits (Snowden et al, 2003; Snowden 
et al, 2007b). General neuroimaging features of patients with GRN mutations have been 
described in Chapter 4 however there have been few studies purely looking at patients with 
PPA and GRN mutations.  
 
There are a number of other speech and language syndromes that have been described that do 
not clearly fit into the current scheme of the progressive aphasias. As none of these has any 
described pathological or genetic associations, it remains unclear exactly how they are related 
to SD, PNFA or LPA. Some progressive articulatory disorders associated with cortical disease 
have been described as “progressive dysarthria” (Soliveri et al, 2003), “slowly progressive 
anarthria” (Broussolle et al, 1996; Lucchelli et al, 2005) and “pure progressive aphemia” 
(Cohen et al, 1993). Whilst it is clear that dysarthria commonly occurs as an accompaniment to 
apraxia of speech and aphasia in PNFA (Gorno-Tempini et al, 2004a; Ogar et al, 2007), it 
remains unclear whether isolated “cortical dysarthrias” eventually progress into the same 
syndrome, or whether they remain isolated (and if so, what the pathological cause is). 
Similarly, progressive impairment of prosody is also described both in isolation (Ghacibeh et 
al, 2003; Luzzi et al, 2008), and as part of PPA syndromes (Tsao et al, 2004). A further 
“aphasia” is that of so-called “dynamic aphasia”, a disorder of verbal planning which has been 
described as a progressive disorder independent of a widespread apathy or abulia (Warren et 
al, 2003). 
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5.2 Neuropsychological studies of PPA subtypes 
As described above, the nonfluent variants of PPA seem to be more heterogeneous than SD. 
This heterogeneity is in both the clinical and neuropsychological features as well as the genetic 
and pathological associations. This study of a prospective cohort of patients with PPA was 
designed to investigate such heterogeneity. 
 
METHODS 
33 consecutive patients with a progressive language disorder as the leading feature at 
presentation (a diagnosis of PPA according to current criteria: Mesulam, 2001; Mesulam, 2003) 
and not fulfilling criteria for an alternative dementia syndrome were recruited to the study. All 
patients initially had a structured clinical history and neurological examination. Based on this 
initial assessment and independent of any brain imaging findings, nine patients were diagnosed 
with SD (Neary et al, 1998; Adlam et al, 2006). The remaining 24 patients had nonfluent 
speech: these patients are the main focus of this study. 18 cognitively-normal control subjects 
matched for gender and age also participated. All patients and controls underwent a 
neurological examination: this was normal in all but three patients, one of whom had a 
corticobasal syndrome (asymmetrical akinetic-rigid syndrome with limb apraxia and dystonia) 
and two who had a progressive supranuclear palsy syndrome (axial rigidity with a supranuclear 
gaze palsy). Genetic screening for mutations in GRN and MAPT was performed in all patients: 
three patients were found to have mutations in GRN with all other patients negative for either 
GRN or MAPT mutations. Examination of cerebrospinal fluid had been undertaken in nine 
patients as part of their initial clinical assessment: this revealed a CSF profile of total tau/A!42 
levels consistent with AD in five cases (i.e. high total tau and low A!42: Hulstaert et al, 1999). 
 
Spontaneous speech analysis 
The initial step in the study was to analyze the spontaneous speech of the patients. This was 
performed in order to classify the patients into groups according to the presence or absence of 
agrammatism and apraxia of speech (AOS). These features were chosen because they have 
been considered in previous studies (and also previously defined criteria) to be the primary 
causes of speech impairment in the nonfluent aphasias (Neary et al, 1998; Gorno-Tempini et 
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al, 2004a; Josephs et al, 2006). As described in Chapter 2 a sample of spontaneous speech was 
obtained by asking all of the subjects to talk about their last holiday and to describe the Cookie 
Theft Scene from the Boston Diagnostic Aphasia Examination (Goodglass et al, 1983). 
Examples from four of the patients are given below (Figure 5.2.1). !
Figure 5.2.1 
Examples of spontaneous speech from nonfluent aphasic patients (total time in seconds for which the 
patients spoke in each example is given in parentheses, speech production errors are italicized) 
 
Patient 1 
• The washing up... the spilding...  the sink... and the children... is is...  getting on the chair... on the stool  and 
the... flowing over sink...  over...  wiping up... (58s) 
• Last holiday...  Christmas time...  it was the last holiday we had taken...  we end up getting the  last holiday...  
by car... by coach...  the holiday is the ... (76s) 
 
Patient 2 
• On the left hand side...  two children are... are...  trying to get to the... cookie jar  the...  daughter is holding 
her hand up to receive a cookie while her b... brother has climbed up on a stool to reach the cookie jar...  the 
lid is open but the poor boy is about to fall... d... down because the three-legged stool is about to... overturn...  
a fitted kitchen with c... cupboards under and over (60s) 
• Together with my wife we flew to Prague and stayed in the Paris hotel which is an  ar... ar...art deco  styled 
hotel... we walked in the ancient square and were sur... prised to see and hear that there were or...ches... tras 
playing classical music...  we thoroughly enjoyed our four days in Prague and then flew on to visit our son in 
Warsaw...  Poland...  we had been there before but it was nice to... to see his family and we fleb flew back to 
England re..refreshed and exho..lorated by the experience (62s) 
 
Patient 3 
• Not so good...  and this thing’s gone down...  and it’s gone the wrong way...  on that way...  and this woman is 
fall down...  there to lose this...  and that’s about it really (22s) 
• Well, we’ve been to France... we’ve got a place now in France at the end...  which is very good...  we were 
there for a week...  first thing in the morning...  that’s all I think really...  we got the trine...  the top thing (55s) 
 
Patient 4 
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• We went to America and I can’t remember whereabouts in there ... and that was in...  that was this year... 
no...  last holiday...  America...  by plane...  in the city...  we went into a city...  we stayed...  further on...  
then we...  cause we knew somebody... that was there...  so that’s where we stopped...  with them (65s) 
• Somebody is going to fall off...  with a cookie jar...  and he’s going to fall off and his sister is trying to find ik...  
get his...  one of those cookies to give her...  and then the water’s all over there... because it’s  just you 
know...  they didn’t turn the tap off and she’s looking there but she doesn’t realize that she’s got all this water 
coming down there (50s) !
The samples were recorded and subsequently transcribed and analysed for:  
a. Number of agrammatic (morphological or syntactic) errors made per minute, and 
b. Presence or absence of apraxia of speech defined as a motor speech disorder with the 
features of hesitancy, effortfulness with articulatory groping, phonetic errors and 
dysprosody (Croot, 2002; Ogar et al, 2005) – all of these features were required to be 
present for AOS to be defined as being present. 
 
Speech was also analyzed for a number of further measures including: 
1) Number of words produced per minute  
2) Number of speech production errors produced per minute. However, because of 
difficulties in reliably classifying speech production errors as phonemic (errors in the 
selection of speech sounds to be executed) versus phonetic or apraxic (errors in the 
execution of a programmed speech sound) these were not analyzed separately.  
3) Word-finding pauses: the distribution of inter-word intervals in the speech sample was 
analysed using a customised routine running under Matlab® which measured intervals 
between vocalisations (both within and between sentences).  
4) Patients who have difficulty finding words often use more high frequency (common) words 
and less low frequency (less common) words and so the mean frequency rating of the 
nouns used by patients in speech was investigated. Frequency ratings were based on the 
CELEX database (Baayen et al, 1993) with scores converted to a mean log score as word 
frequencies from this scale varied between 10 and 100,000.  
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From this initial spontaneous speech analysis four groups of patients were identified: those with 
AOS with and without agrammatism, and those without AOS with and without agrammatism: 
these are shown in Table 5.2.1 as well as the other spontaneous speech data and compared to 
the cognitively-normal control group and the disease-control group of SD patients (for whom 
spontaneous speech data was available in 8 out of 9 patients, mean (standard deviation) 
disease duration of 5.0 (1.1) years) using linear regression models within STATA 10.0. !
Table 5.2.1  
General demographic and spontaneous speech data (AOS = apraxia of speech, Agramm = agrammatism. 
Examples given in Figure 5.2.1 correspond with AOS with agrammatism (Patient 1), AOS with no 
agrammatism (Patient 2), no AOS with agrammatism (Patient 3), no AOS and no agrammatism (Patient 
4). *p<0.05 disease group worse than controls) 
 
AOS No AOS 
Test Controls SD 
Agramm No agramm Agramm No agramm 
Number of patients 18 8 10 4 3 7 
Age 67.9 (5.4) 57.6 (9.4) 69.0 (5.6) 78.5 (4.4) 62.0 (8.6) 65.2 (6.4) 
Gender (M:F) 9:9 3:5 8:2 2:2 2:1 4:3 
Agrammatic 
errors/min 
0.0  (0.0) 0.0 (0.0) 3.7 (0.9)* 0.0 (0.0) 2.7 (0.7)* 0.0 (0.0) 
Speech rate 
(words/min) 
133.9 (22.9) 127.5 (26.6) 30.8 (15.1)* 49.5  (21.9)* 44.9 (14.4)* 63.1 (19.5)* 
Speech production 
errors/min 
0.0 (0.0) 0.0 (0.0) 1.9 (1.7)* 0.2 (0.2) 0.9 (0.1)* 0.3 (0.4) 
Mean pause length (s) 1.0  (0.2) 1.0  (0.1) 1.5 (0.3)* 1.3 (0.2)* 1.9 (0.3)* 1.5 (0.3)* 
Frequency rating of 
nouns used (log 
score) 
1.8 (0.1) 2.1 (0.2)* 1.9 (0.2) 1.9 (0.2) 2.4 (0.3)* 2.0 (0.2)* 
Frequency rating of 
verbs used (log score) 
2.4 (0.2) 2.6 (0.3) 2.9 (0.2)* 2.6 (0.2) 3.0 (0.0)* 2.9 (0.2)* 
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• Both groups with AOS had reduced speech rate and increased mean pause length 
compared with controls and made speech production errors. The range of noun use (noun 
frequency) was similar to controls. However, the group with agrammatism had significantly 
more speech production errors and a trend to lower speech rate and longer mean pause 
duration than the group without agrammatism. Furthermore, there was a higher mean verb 
but not noun frequency than controls in the AOS/agrammatism group suggesting a 
tendency to use more common verbs (the reverse pattern to the SD group).  
• Patients with no AOS/agrammatism differed from the AOS/agrammatism group in having a 
significantly longer mean pause length and a higher mean frequency of nouns used (i.e. a 
tendency to use more common nouns, similar to the SD group) although they also had a 
higher mean frequency of verbs used than controls.  
• The no AOS/no agrammatism group had reduced speech rate, occasional speech 
production errors and longer mean pause duration compared both with controls and SD; 
similar to the no AOS/agrammatism group, there was a higher mean noun and verb 
frequency.  
 
Disease duration and disease severity 
One of the problems of comparing patients with PPA cross-sectionally is that within a single 
study patients will be at a variety of different stages of the disease. This is compounded by the 
fact that the different clinico-pathological syndromes are likely to progress at different rates 
between syndromes and also for a given syndrome in different patients. We therefore initially 
compared disease duration from first symptom onset with disease severity as measured by both 
the Mini-Mental State Examination (Folstein et al, 1975) and the Clinical Dementia Rating 
(Morris, 1993) sum-of-boxes (Table 5.2.2). Although patients within each group had decreasing 
MMSE and increasing CDR-sum-of-boxes with increased disease duration, for the same disease 
duration patients without AOS had a lower MMSE and higher CDR-sum of boxes, and therefore 
could be classified as “more severe” on this basis.  !
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Table 5.2.2  
Disease severity data 
 
AOS No AOS 
Test Controls 
Agrammatism No agrammatism Agrammatism No agrammatism 
Disease duration (yrs) N/A 6.1 (1.7) 3.3 (1.6) 4.3 (0.5) 4.4 (1.1) 
MMSE (/30) 29.7 (0.8) 24.0 (5.4)* 25.3 (6.9) 13.7 (8.4)* 15.9 (5.8)* 
CDR-sum of boxes 0.0 (0.0) 3.0 (1.5)* 1.4 (0.9)* 4.5 (1.3)* 4.6 (1.1)* 
 
*p<0.05 disease group worse than controls 
!
With these four groups defined, all of the patients went on to have further neuropsychological 
testing including the specifically designed battery of neurolinguistic tests discussed in Chapter 
2. Patients were also assessed on tests of executive function (Nonverbal fluency task from the 
D-KEFS executive function battery (Delis et al, 2001), episodic memory (Camden Pictorial 
Recognition Memory Test, Warrington, 1996), visuoperceptual skills (the Object Decision 
subtest of the Visual Object and Space Perception Battery, VOSP, Warrington, 1991). Limb 
apraxia was noted as part of the structured neurological examination.  
 
Disease severity (MMSE) was adjusted for in subsequent statistical analyses comparing disease 
groups. Using STATA 10.0 linear regression models were used to compare performance on 
neuropsychological tests between groups (95% bootstrap confidence intervals with 1000 
replicates). Wilcoxon signed-rank tests were used for within disease group comparisons. 
 
RESULTS (Table 5.2.3)  
 
Naming and single word comprehension 
The AOS with agrammatism group and two groups without AOS were significantly anomic 
compared to controls with a trend to greater anomia in the groups without AOS compared to 
those with AOS. A similar pattern was seen on tests of noun comprehension although verb 
comprehension was only significantly worse than controls in the no AOS/agrammatism group 
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(with a trend to better performance on nouns compared to verbs in this group). Word-picture 
matching was significantly worse than controls in all groups apart from the AOS/no 
agrammatism group with significantly worse performance in the no AOS/agrammatism group 
compared to the AOS groups. 
 
Verbal short-term memory, sentence comprehension and grammar 
Compared with controls, all groups apart from the AOS/no agrammatism group had decreased 
digit span with significantly lower digit span in the agrammatism-only group compared with 
the two groups with AOS.  Performance on the modified PALPA55 subtest was impaired in all 
groups compared with controls. The AOS/agrammatism group performed significantly worse 
on comprehension of passive reversible than active non-reversible sentences (p=0.01, 
suggesting a true grammatical comprehension deficit). The no AOS/agrammatism performed 
poorly on all sentences but there was a trend to better performance on the passive reversible 
sentences compared to active non-reversible sentences (p=0.10). The no AOS/no agrammatism 
group performed similarly on all sentences and did not benefit from the effect of non-
reversibility in simpler active sentences. Verb tense comprehension was affected similarly in all 
groups apart from the AOS/no agrammatism group who performed normally. 
 
Speech repetition 
The AOS/agrammatism and the two groups without AOS performed worse than controls on all 
tests although the AOS/no agrammatism group performed worse than controls only on the 
nonword and cliché repetition tasks. The no AOS/no agrammatism group performed 
significantly worse on sentence repetition compared to cliché, nonword or word repetition 
with a similar trend in the no AOS/agrammatism group but no significant differences between 
words and sentences in the AOS groups.  
 
Reading and spelling 
Word and nonword reading was impaired in all groups although most significantly in the no 
AOS/agrammatism group. Irregular word reading was also most affected in the no 
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AOS/agrammatism group. Spelling was significantly worse than controls in all groups apart 
from the AOS/no agrammatism group. 
 
Other cognitive domains 
Executive function was impaired in all but the AOS/no agrammatism group who did not show 
impaired function relative to controls on any of the tests. Episodic memory was impaired 
relative to controls only in the no AOS/no agrammatism group. Limb apraxia was present in all 
patients in the two groups without AOS but only in 70% of the AOS with agrammatism and 
25% of the AOS without agrammatism.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  125 
Table 5.2.3  
Neurolinguistic and neuropsychological data 
 
AOS No AOS 
Test Controls 
Agramm 
No  
agramm 
Agramm 
No  
agramm 
NAMING AND SINGLE WORD COMPREHENSION 
Graded Naming Test (/30) 25.2 (2.2) 9.1 (8.5)* 16.0 (11.0) 1.3 (2.3)*,c,d 1.5 (1.8)*,f,g 
Simple naming test (/20) 19.7 (0.7) 12.1 (6.5)* 14.3 (7.0) 2.3 (4.0)*,c,d 5.1 (4.2)*,f,g 
Noun synonyms (/25) 24.3 (0.8) 19.6 (2.4)* 22.5 (2.6) 15.7 (4.6)*,d 16.6 (1.6)*,f,g 
Verb synonyms (/25) 23.2 (1.6) 20.1 (4.3) 22.0 (3.6) 12.0 (2.6)*,c,d,e 19.0 (3.5) 
Word-picture matching (/30) 28.3 (0.9) 24.7 (4.4)* 27.3 (2.2) 16.6 (5.6)*,c,d 21.1 (2.7)*,f,g 
VERBAL SHORT-TERM MEMORY, SENTENCE COMPREHENSION AND GRAMMAR  
Digit span forwards 6.9 (0.6) 4.9 (1.4)* 5.5 (1.7) 2.0 (1.0)*,c,d 4.0 (1.8)* 
PALPA 55 (modified version) – total (/24) 23.4 (0.8) 18.4 (4.4)*,a 22.0 (1.2)* 13.3 (5.5)*,d 13.3 (6.3)*,g 
Passive reversible (%) 97.9 (4.8) 66.4 (32.3)* 87.5 (14.4) 45.8 (19.1)*,d 41.1 (28.6)*,g 
Passive non-reversible (%) 95.8 (9.6) 75.0 (26.4)* 87.7 (14.4) 58.3 (28.9)* 60.7 (31.8)* 
Active reversible (%)  99.3 (2.9) 81.4 (20.6)* 93.8 (7.2) 54.2 (26.0)*,d 64.3 (33.4)*,g 
Active non-reversible (%) 
95.8 (9.6) 90.0 (12.9) 100.0 (0.0) 75.0 (25.0) 
60.7 
(24.4)*,f,g 
Verb tense comprehension test (/20) 19.8 (0.4) 16.5 (3.5)*,a 19.5 (0.6) 15.0 (3.6)*,d 14.9 (2.7)*,g 
SPEECH REPETITION 
Single word repetition (% correct) 100.0 (0.0) 63.8 (39.8)*,a 98.8 (1.6) 48.9 (14.6)*,d,e 85.2 (17.7)* 
Nonword repetition (% correct) 100.0 (0.0) 57.0 (37.9)* 73.8 (22.1)* 45.0 (20.0)*,e 79.3 (19.9)* 
Cliché repetition (% correct) 100.0 (0.0) 53.0 (44.7)*,a 93.3 (5.8)* 6.7 (11.5)*,c,d,e 61.4 (44.1)* 
Novel sentence repetition (% correct) 100.0 (0.0) 56.0 (44.8)*,a 100.0 (0.0) 3.3 (5.8)*,c,d,e 45.7 (41.2)*,g 
READING AND SPELLING 
Schonell Reading Test (% correct) 99.2 (1.6) 61.1 (29.8)* 84.5 (16.6)* 
17.7 
(27.2)*,c,d,e 
73.7 (14.7)* 
Irregular word reading test (% correct) 94.3 (5.6) 51.3 (27.5)*,a 83.3 (18.3) 8.9 (7.7)*,c,d,e 44.8 (22.0)*,g 
Graded Difficulty Nonword Reading Test 
(% correct) 
98.6 (3.3) 40.0 (31.9)* 68.8 (30.1)* 23.3 (32.1)* 42.5 (36.2)* 
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Graded Difficulty Spelling Test (/30) 26.0 (2.7) 11.9 (10.4)* 18.3 (13.3) 1.0 (1.7)*,c,d 5.8 (5.6)* 
OTHER COGNITIVE DOMAINS 
D-KEFS Nonverbal Fluency (scaled score) 10.7 (3.0) 6.3 (2.6)* 8.0 (2.4) 5.0 (3.6)* 3.7 (1.8)*,f,g 
Camden Topographical Memory Test (/30) 29.7 (0.8) 29.3 (0.8) 29.8 (0.5) 25.3 (8.1) 25.3 (4.2)*,f,g 
VOSP Object decision subtest (/20) 17.5 (2.3) 16.8 (2.4)b 15.3 (3.2) 18.7 (0.6) 16.0 (2.4)h 
ABA-2 subtest 3A limb praxis (/50) 49.9 (0.2) 41.9 (11.7)* 43.8 (9.0) 28.0 (16.6)* 39.8 (6.9)* 
!
*p<0.05 disease group worse than controls , ap<0.05 AOS/agrammatism worse than AOS/no agrammatism, bp<0.05 
AOS/agrammatism worse than No AOS/agrammatism, cp<0.05 No AOS/agrammatism worse than 
AOS/agrammatism, dp<0.05 No AOS/agrammatism worse than AOS/no agrammatism, ep<0.05 No 
AOS/agrammatism worse than No AOS/no agrammatism, fp<0.05 No AOS/no agrammatism worse than 
AOS/agrammatism gp<0.05 No AOS/no agrammatism worse than AOS/no agrammatism  hp<0.05 No AOS/no 
agrammatism worse than No AOS/agrammatism. 
!
Summary of findings in each group 
AOS/agrammatism 
This group had reduced speech rate with speech production errors and increased pause length 
with nonfluency due to the dual deficits of AOS and agrammatism. These features 
distinguished the speech of these patients from the SD group, with in addition reduced verb but 
normal noun frequency (completing a double dissociation with SD). Other key features were 
anomia, impaired sentence comprehension (particularly for more complex sentences), 
impaired speech repetition that was similarly severe for both words and sentences, impaired 
reading (particularly nonwords), and in addition executive dysfunction and limb apraxia. There 
was also evidence of a mild single word comprehension deficit, particularly in more severely 
affected patients. This profile is consistent with previous descriptions of PNFA. Of note, the 
three patients with parkinsonism all fell within this group. 
 
AOS/no agrammatism 
This group had shorter mean disease duration than the AOS/agrammatism group and showed a 
trend towards a qualitatively similar though less severe profile of deficits. Mean speech rate 
was reduced and pause length prolonged in relation to both healthy controls and the SD group. 
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Despite the absence of expressive agrammatism, this group performed significantly worse than 
controls on the PALPA55 sentence comprehension test (suggesting a deficit of receptive 
grammar). These patients also had mild dyslexia (affecting nonwords). These features suggest 
that this “pure AOS” group may represent an earlier stage of PNFA prior to development of 
expressive agrammatism, though this remains unresolved in the absence of longitudinal data. 
 
No AOS/agrammatism 
These patients were more severely affected than the two groups with AOS (based on MMSE 
and CDR scores) with impairments on most linguistic tests. However, speech rate and speech 
production errors were similar to the groups with AOS. In addition, visual object perception 
and episodic memory were preserved, indicating a pre-eminently aphasic syndrome. The most 
notable linguistic problems were profound anomia, impaired single word comprehension 
(particularly verbs), severely reduced digit span (phonological short term memory deficit), 
impaired sentence comprehension and repetition, and severe dyslexia. Expressive 
agrammatism was found on formal speech analysis but difficult to assess at the bedside 
because of the slow speech rate and word-finding pauses. This group comprised the patients 
with GRN mutations.  
 
No AOS/no agrammatism 
The most prominent features in this group were anomia, decreased forward digit span, 
impaired sentence comprehension (both simple and complex), impaired sentence repetition 
with relatively spared single word repetition, dyslexia (particularly for nonwords) and relatively 
intact single word comprehension. These features are consistent with current descriptive 
criteria for LPA. In addition (and in comparison to the no AOS / agrammatism subgroup), these 
patients had extra-linguistic deficits of episodic memory, and object decision). Of note, most 
patients in this group had CSF biomarkers consistent with AD pathology. 
 
DISCUSSION 
Four distinct syndromic groups within a cohort of patients with non-fluent PPA are described in 
this study. The groups were delineated using an initial classification from spontaneous speech 
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based on the presence or absence of AOS and expressive agrammatism and subsequent 
detailed linguistic analysis. These groups comprised an AOS only group, an AOS plus 
agrammatism group, an agrammatism only group and a group without AOS or agrammatism. 
The AOS groups together constitute the majority of patients with what is probably best 
described as PNFA or PNFA/AOS. It remains unclear whether the AOS group without 
agrammatism represent a less severe form of PNFA, consistent with the observation that 
agrammatism may supervene later in the course of progressive AOS, or whether ‘pure AOS’ 
constitutes a pathophysiologically distinct group within the PPA spectrum. The group without 
AOS or agrammatism has a syndrome equivalent to LPA as described by other research groups 
(Gorno-Tempini et al, 2004a; Gorno-Tempini et al, 2008): this syndrome is likely to be 
underpinned by AD pathology in a high proportion of cases, consistent with the CSF data here. 
The agrammatism-only group is more problematic: while the presence of agrammatism would 
tend to align such cases with PNFA this syndrome has some linguistic and neuropsychological 
similarity to LPA (including long word-finding pauses, a severe phonological verbal short 
memory deficit, impaired sentence processing and non-linguistic dominant parietal lobe 
features). All patients in this group here had GRN mutations, suggesting that GRN mutations 
may lead to a distinct aphasia syndrome albeit overlapping PNFA/AOS and LPA. If indeed 
agrammatism is a defining feature of GRN-associated PPA, this supports recent work suggesting 
that TDP-43 pathology may be a substrate for agrammatic PPA (Deramecourt et al, 2010), 
though this group may include both cases with GRN mutations and other patients lacking such 
mutations. More fine-grained analyses of expressive agrammatism in PPA may allow further 
clinically meaningful subdivisions of this potentially broad category (e.g., an association with 
tau pathology, Mesulam et al, 2008; Knibb et al, 2009). 
 
This study underlines the importance of an initial clinical assessment of the patient’s 
spontaneous speech, and in particular the presence or absence of AOS and agrammatism, in 
classifying non-fluent PPA syndromes at presentation. However, this is not to imply that 
clinical characterisation of PPA syndromes is straightforward: analysis of spontaneous speech 
may be difficult where this is severely impoverished. It is likely that a particular syndrome will 
change in character as disease evolves: disease duration and severity therefore need to be 
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taken into account. Moreover, there is a need for new operational and clinical measures of 
PPA that can characterise positively the no AOS/no agrammatism group defined ‘negatively’ 
here, and potentially, other less common PPA syndromes not captured by the simple 
classification scheme presented here. This category might, for example, encompass the 
controversial entity of ‘cortical anarthria’ (Kertesz et al, 2003).  
 
This study further illustrates that a number of standard neuropsychological measures are of 
limited use in differentiating PPA syndromes. However, within particular cognitive domains, 
certain features may allow more detailed neuropsychological stratification of these syndromes. 
Consistent with previous work (Rhee et al, 2001; Gorno-Tempini et al, 2004a; Grossman et al, 
2005; Gorno-Tempini et al, 2008; Peelle et al, 2007) this study indicates sentence 
comprehension deficits may occur in the nonfluent PPA spectrum. The LPA (no AOS/no 
agrammatism) group here exhibited more severe deficits of sentence syntax and verb tense 
processing than the groups with AOS, and in contrast to the patients with AOS, showed 
impaired processing of both simple (active) and complex (passive) sentences with limited 
sensitivity to non-reversibility (a semantic cue based on agency). Considering the PPA spectrum 
as a whole, various deficits may potentially contribute to impaired sentence processing, 
including impaired verbal working memory as well as primary grammatical or semantic deficits 
(Fiebach et al, 2001; Friederici e tal, 2002). These potential mechanisms of impaired sentence 
comprehension remain to be elucidated fully. 
 
The different syndromes have distinct patterns of speech repetition that may help to distinguish 
them. Previous studies have suggested that patients with LPA have significantly worse 
performance on sentences compared to single words (Gorno-Tempini et al, 2008) and this 
pattern was also seen in the LPA (no AOS/no agrammatism) group here. A similar but more 
severe dichotomy between single word and sentence repetition was seen in the GRN (no 
AOS/agrammatism) group. In comparison to these groups without AOS, the AOS/agrammatism 
group performed similarly on words, nonwords, clichés and sentences while the AOS/no 
agrammatism group showed deficits of nonword and cliché repetition.  
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Our findings further highlight dyslexia and dysgraphia as key components of the nonfluent PPA 
variants: performance on nonwords was worse for both the AOS groups and the LPA (no 
AOS/no agrammatism) group, in keeping with a phonological dyslexia (Brambati et al, 2009). 
In the GRN (no AOS/agrammatism) group reading of all word types was affected, suggesting a 
more severe dyslexia. Cognitive domains beyond language may provide further information: 
episodic memory impairment (on the relatively easy test used here) was a consistent feature 
only of the LPA (no AOS/no agrammatism) group. 
 
This study has the limitations of small case numbers, absence of a longitudinal arm to track the 
evolution of deficits, and lack of pathological correlation. This study has focused on a relatively 
small number of neurolinguistic measures with clear clinical relevance. More fine-grained 
psycholinguistic analyses (for example, to characterise motor speech deficits, and intra- versus 
inter-sentential pauses) may further refine the distinction between PPA subgroups. These 
caveats notwithstanding, the findings provide a rationale for future studies of the nosology of 
PPA syndromes. It is likely that there are at least three nonfluent PPA syndromes and that these 
are distinct rather than variations on a single continuum (Knibb et al, 2009; Deramecourt et al, 
2010). The PNFA/AOS syndrome can be associated with a corticobasal or progressive 
supranuclear palsy syndrome during life (Josephs et al, 2006) and based on previous evidence 
is most commonly underpinned by tau pathology, while the LPA syndrome without AOS or 
agrammatism is closely associated with AD pathology, and GRN-associated aphasia has TDP-
43 pathology. The phenotype of GRN-associated aphasia is of neurobiological interest since it 
is associated with a specific molecular dysfunction. Though detailed neuropsychological 
studies are few, previous reports include descriptions of a syndrome of progressive “non-fluent 
anomic aphasia’ (Snowden et al, 2007): clearly, additional unidentified factors are likely to 
influence the particular phenotype of GRN aphasia, and it is not suggested that there is a 
precise correspondence between GRN mutations and the no AOS/agrammatism aphasia 
syndrome delineated here. The GRN-aphasia syndrome may bear some neuropsychological 
and neuroanatomical similarity to LPA, however there are certain key points of distinction. 
While detection of expressive agrammatism may be difficult at the bedside, for the reasons 
outlined above, our findings suggest that additional neurolinguistic features may help 
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discriminate this GRN-associated aphasia syndrome from cases of LPA (e.g., impaired single 
word comprehension). It is unlikely that the GRN-associated no AOS/agrammatism group 
simply represents a more severe syndrome than LPA: both groups without AOS here had very 
similar disease durations and disease severity as indexed by MMSE and CDR. Detailed 
neuropsychological evaluation may be required to differentiate the GRN-associated and AD-
associated syndromes and this could in turn potentially help guide investigation of patients 
with PPA. Systematic, hypothesis-led longitudinal neurolinguistic analyses with 
neuroanatomical, genetic and pathological correlation in larger patient cohorts will be 
important directions for future work.   
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5.3 Imaging of PPA subtypes 
Chapter 5.2 investigated the neurolinguistic and cognitive features of nonfluent aphasias. The 
evidence from this seems to show that there are at least three different nonfluent disease 
groups: PNFA (both groups with AOS), LPA (no AOS/no agrammatism) and GRN-PPA (no 
AOS/agrammatism). However, Chapter 5.2 did not investigate the neuroanatomical differences 
between these groups. Hence the patients studied above went on to have structural MR 
imaging with the complementary techniques of volumetric measurement, cortical thickness 
analysis and voxel-based morphometry used in this Chapter to investigate the neuroanatomical 
features of the nonfluent variants in comparison to the control group and the patients with SD.  
 
METHODS 
Brain image acquisition is as described in Chapter 2 with volumetric measures as described in 
Chapter 2 apart from volumetric analysis of specific subcortical structures (hippocampus, 
amygdala, caudate and brainstem) which were performed using the Freesurfer image analysis 
suite version 4.0.3 (http://surfer.nmr.mgh.harvard.edu/) (Fischl et al, 2002). For volumetric 
measures, the groups were compared statistically by looking at the two-tailed contrasts 
between the group means using a linear regression model in STATA 10.0. Cortical thickness 
methods are as described in Chapter 2. In this study, cortical thickness was modelled as a 
function of group, controlling for age, gender and total intracranial volume by including them 
as nuisance covariates.  Contrasts of interest between the estimates of the group parameters 
were assessed using two-tailed t-tests. Maps showing statistically significant differences 
between each disease group and healthy controls were generated and corrected for multiple 
comparisons to control the False Discovery Rate (FDR) at a 0.001 significance level. Voxel-
based morphometry was performed as described in Chapter 2. In this study, voxel intensity was 
modelled as a function of group, and subject age, gender and total intracranial volume were 
included as nuisance covariates. Separate analyses were performed on the grey and white 
matter segments. Maps showing single-tailed statistically significant differences between the 
groups were generated, correcting for multiple comparisons in the disease group-control 
comparisons by thresholding the images of t-statistics to control the False Discovery Rate (FDR) 
at a 0.05 significance level. Statistical parametric maps were displayed as overlays on a study-
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specific template, created by warping all native space whole-brain images to the final DARTEL 
template and calculating the average of the warped brain images. 
 
RESULTS 
 
Volumetric analysis 
All PPA groups had asymmetrical predominantly left-sided cerebral atrophy i.e. mean left/right 
hemisphere ratio less than one in each group (Table 5.3.1). However, hemispheric asymmetry 
was most marked in the GRN-PPA group (being significantly more asymmetric than all other 
disease groups). LPA was similar to the SD group in terms of asymmetry (left/right hemisphere 
ratio=0.94) and significantly more asymmetric than PNFA. 
 
Subcortical volumetric data showed smaller caudate volumes bilaterally in the PNFA group 
compared to controls (with a trend to smaller brainstem volume also) In the LPA group, the left 
caudate, hippocampus and amygdala were significantly smaller than controls while only the 
left hippocampus was significantly smaller in the GRN-PPA subgroup. The SD group had 
smaller left hippocampal and bilateral amygdalae volumes in compared to controls. 
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Table 5.3.1  
Volumetric data for whole brain, left and right cerebral hemisphere, caudate, hippocampus and 
amygdala volumes as a percentage of total intracranial volume (TIV) 
 
Cerebral region volumes 
(as a percentage of TIV) 
Mean (standard deviation) 
SD PNFA GRN-PPA LPA Controls 
Number of subjects 9 14 2 7 18 
Whole brain  68.1(3.8) 64.2 (5.7)a,d 63.2 (0.8) 65.6 (6.4) 70.1 (4.0) 
Left hemisphere  32.7 (2.0) 31.1 (2.9)a 28.3 (0.2)a 31. (3.1)a 34.4 (1.9) 
Right hemisphere  34.7 (1.8) 32.2 (2.8)a,d 33.9 (0.3) 33.5 (3.2) 34.6 (2.0) 
Left/right hemispheric ratio 0.94 (0.01)a,b 0.97 (0.04)a 0.83 (0.00)a 0.94 (0.02)a 1.00 (0.01) 
Brainstem 1.26 (0.11) 1.20 (0.15) 1.21 (0.07) 1.23 (0.03) 1.27 (0.10) 
Left caudate  0.20 (0.03) 0.19 (0.03)a 0.19 (0.01) 0.19 (0.02)a 0.22 (0.03) 
Right caudate 0.22 (0.03) 0.20 (0.02)a  0.24 (0.01) 0.21 (0.03) 0.23 (0.04) 
Left hippocampus 0.13 (0.04)a,b,c 0.20 (0.03) 0.15 (0.02)a 0.18 (0.02)a 0.22 (0.03) 
Right hippocampus 0.21 (0.03) 0.22 (0.03) 0.21 (0.00) 0.22 (0.02) 0.24 (0.03) 
Left  amygdala  0.04 (0.02)a,b,c 0.08 (0.01) 0.07 (0.02) 0.07 (0.02)a 0.08 (0.01) 
Right amygdala 0.07 (0.02)a,b,c 0.08 (0.01) 0.11 (0.00) 0.08 (0.03) 0.09 (0.01) 
!
Statistically significant differences between the groups are represented by superscript letters:  ap<0.05 disease 
group significantly worse than controls, bp<0.05 SD worse than PNFA, cp<0.05 SD worse than LPA, dp<0.05 PNFA 
worse than SD. 
!
Cortical thickness analysis 
Compared with healthy controls, cortical thinning was predominantly left-sided in all groups 
(Figure 5.3.1, Table 5.3.2).  
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Table 5.3.2 
Cortical thickness data for the frontal, temporal and parietal lobes !
Cortical thickness in each 
lobe (mm)  
Mean (standard deviation) 
SD PNFA GRN-PPA LPA Controls 
Left  
2.2 (0.1) 2.0 (0.2)a,d 1.9 (0.1)a 2.0 (0.1)a 2.2 (0.1) 
Frontal 
Right 
2.3 (0.1) 2.1 (0.1)a,d 2.3 (0.0) 2.1 (0.1)a 2.2 (0.1) 
Left 1.7 (0.2) a,b 2.1 (0.3)a 1.6 (0.4)a 1.9 (0.1)a 2.4 (0.1) 
Temporal 
Right 2.2 (0.2)a 2.2 (0.2)a 2.5 (0.1) 2.2 (0.1)a 2.4 (0.1) 
Left 2.0 (0.1) 1.8 (0.2)a,d 1.8 (0.1)a 1.7 (0.1)a  2.0 (0.1) 
Parietal 
Right 2.1 (0.1) 1.9 (0.2)a,d 2.2 (0.1) 1.9 (0.1)a 2.0 (0.1) 
 
Statistically significant differences between the SD, PNFA, LPA and control groups are represented by superscript 
letters: ap<0.05 disease group significantly worse than controls, bp<0.05 SD worse than PNFA, cp<0.05 SD worse 
than LPA.  
 
In the PNFA group there was maximal involvement of the left inferior frontal (pars triangularis 
and pars opercularis), superior frontal, insular and superior temporal cortex with lesser 
involvement of the anterior parietal lobe. The LPA and GRN-PPA groups revealed overlapping 
but distinct patterns compared to controls: both groups had mid to posterior temporal lobe and 
inferior frontal involvement but in the LPA group there was greater temporo-parietal junction 
and frontal atrophy and in the GRN-PPA group there was more anterior temporal atrophy 
(Figure 5.3.1). As shown previously, the SD group showed involvement of the antero-inferior 
temporal lobes (left greater than right and particularly the temporal pole, parahippocampal and 
entorhinal cortex) and to a lesser extent the left frontal lobe (particularly orbitofrontal cortex).  
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Figure 5.3.1 
Cortical thickness maps showing patterns of cortical thinning in disease groups compared to healthy 
controls. For each disease panel, left hemisphere sections are shown above and right hemisphere 
sections below. Maps are thresholded at p<0.001 after FDR correction over the whole brain volume.  
The coloured bar represents FDR corrected p-values.  
 
 
 
Comparing the disease groups there were no differences at the statistical level of p<0.001 FDR 
corrected but at less stringent level of p<0.05 FDR corrected there were differences between 
the groups. The LPA group had more marked thinning of left anterior parietal cortex and 
extensive cortical areas in the right cerebral hemisphere than the GRN-PPA group, while the 
GRN-PPA group had more marked thinning of left anterior temporal cortex than the LPA group 
(Figure 5.3.2). 
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Figure 5.3.2 
Cortical thickness maps showing patterns of cortical thinning in between disease-group differences. 
For each disease panel, left hemisphere sections are shown on the left and right hemisphere sections 
on the right. Maps are thresholded at p<0.05 after FDR correction over the whole brain volume. The 
coloured bar represents FDR corrected p-values. !
!!
VBM analysis 
The VBM analysis corroborated the findings of the cortical thickness analysis with similar 
findings in the SD and PNFA groups compared to controls (Figure 5.3.3). Patterns of grey 
matter atrophy overlapped in the LPA and GRN-PPA groups, but the LPA group had greater 
posterior (particularly parietal) [-47, -47, -13; -46, -53, 6] involvement while the GRN-PPA 
group had greater anterior temporal lobe [-43, 3, -31] involvement (Figure 5.3.3). The findings 
differed from the cortical thickness measures in showing greater overlap between the LPA and 
GRN-PPA groups in posterior temporal, inferior parietal and inferior frontal lobe areas.  
 
 
  138 
Figure 5.3.3  
VBM analysis on grey matter regions in PPA groups relative to healthy controls. For each axial section, 
the left hemisphere is shown on the left; sagittal sections are through the left hemisphere. Maps are 
thresholded at p<0.05 after FDR correction over the whole brain volume.  Grey matter differences are 
colour coded (red-yellow) in terms of t-score as indicated on the colour bar (right). !
!!
Comparing the disease groups there were no significant differences following FDR correction. 
Comparison at less stringent statistical level of p<0.001 showed some differences between 
disease groups. The LPA group had greater parietal [-36, -51, 35] and inferior frontal [-36, 0, 
21] atrophy than the SD group, and greater left inferior temporal [-43, -22, -25] involvement 
than the PNFA group; whilst the GRN-PPA group had greater inferior frontal [-38, 24, 12] and 
precuneus [-10, -54, 18] involvement than the SD group, and greater temporal lobe [-45, -21, -
21; -32, -18, -17] involvement than the PNFA group (Figure 5.3.4). Compared to the GRN-PPA 
group, the LPA group had greater atrophy in biparietal [37, -28, 46; -26, -21, 58] and right 
posterior temporal [63, -28, 11] cortices, while the GRN-PPA group had greater atrophy of left 
anterior temporal [-49, 12, -22] and inferior temporal [-34, -18, -30] and left orbitofrontal 
cortex [-13, 42, -13] than the LPA group (Figure 5.3.4). 
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Figure 5.3.4  
VBM analysis on grey matter regions in disease group comparisons.  For each axial section, the left 
hemisphere is shown on the left. Maps are thresholded at p<0.001 uncorrected.  Grey matter 
differences are colour coded (red-yellow) in terms of t-score as indicated on the colour bar (lower right). !
!!
The white matter analysis revealed distinct patterns of tract involvement in each of the three 
groups: in the SD group, there was involvement of white matter tracts predominantly in the left 
temporal lobe including the fornix [-26, -36, -8], inferior longitudinal fasciculus [-62, -28, -18] 
and uncinate fasciculus [-34, 1, -24] (Figure 5.3.5); in the PNFA group, there was maximal 
involvement of a left frontal lobe white matter region [-39, -10, 31] likely to represent part of 
the superior longitudinal fasciculus (Figure 5.3.5); and in the GRN-PPA group there was most 
marked involvement of intrahemispheric long association tracts including inferior longitudinal 
fasciculus [-49, -36, -16], superior longitudinal fasciculus [-38, 9, 12], inferior fronto-occipital 
fasciculus [-19, -40, -5] and cingulum [-11, 31, 15], and also involvement of the corpus 
callosum and brainstem tracts. The GRN group showed greater involvement of dorsal fronto-
parietal tracts  [-39, -45, 18] than the SD group, greater involvement of temporal lobe tracts [-
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44, -24, -18; -44, -4, -22] than the PNFA group, and greater involvement of both fronto-parietal  
[-33, 19, 16; -33, -45, 19] and temporal lobe tracts [-44, -24, -18; -44, -4, -22] than the LPA 
group. The LPA group had no significant white matter involvement relative to either healthy 
controls or the disease subgroups.  !
Figure 5.3.5  
VBM analysis on white matter regions in PPA subgroups relative to healthy controls.  For each axial 
section, the left hemisphere is shown on the left; sagittal sections are through the left hemisphere. For 
control comparisons, maps are thresholded at p<0.05 after FDR correction over the whole brain 
volume; for disease group comparisons, maps are thresholded at p<0.001 uncorrected.  White matter 
differences are colour coded (red-yellow) in terms of t-score as indicated on the colour bar (right).The 
LPA subgroup showed no significant areas of white matter loss relative to other disease groups at the 
prescribed threshold. !
!!
DISCUSSION 
Allowing for the different modalities used and the limited spatial resolution of smoothed data 
which preclude fine-grained anatomical correlation, complementary volumetric, cortical 
thickness and morphometric techniques here have shown a broadly convergent pattern of 
findings. Although there is overlap between LPA and GRN-PPA, there are distinct patterns of 
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atrophy with more posterior temporo-parietal junction and frontal lobe involvement in LPA and 
more anterior temporal lobe involvement in GRN-PPA. These neuroanatomical findings are 
consistent with differences in the neuropsychological profiles of these two groups shown in 
Chapter 5.2. Cortical atrophy in the LPA group here appears more extensive than previously 
reported (Gorno-Tempini et al, 2004a; Gorno-Tempini et al, 2008): this may have been a 
correlate of relatively more severe disease in the group studied here. However, interpretation of 
severity effects is problematic where severity measures are closely correlated with the specific 
effects of the disease process: clues that severity is not the entire explanation for the extensive 
left hemispheric damage in the LPA group are the somewhat shorter mean disease duration and 
asymmetry of anatomical damage, suggesting that the disease process in these cases 
preferentially affects a distributed left hemisphere network.  
 
The findings in these prospectively studied SD and PNFA groups corroborate the work of 
previous studies as well as that described in Chapter 3, and provide further information about 
the integrity of white matter pathways that are likely to be critical in binding cortical areas into 
distributed networks that mediate particular language functions (Scott et al, 2003; Spitsyna et 
al, 2006; Awad et al, 2007; Seeley et al, 2009). In SD there was asymmetrical, left greater than 
right anterior temporal lobe atrophy with less marked involvement of orbitofrontal cortex 
(Galton et al, 2001; Rosen et al, 2002a). In PNFA there was left inferior frontal lobe, insula and 
superior temporal lobe atrophy with less marked involvement of the caudate and anterior 
parietal lobe (Nestor et al, 2003; Gorno-Tempini et al, 2004a; Ogar et al, 2007). White matter 
disease has been little studied in SD and PNFA, however one diffusion tensor imaging study in 
a mixed “temporal variant” FTLD cohort (Borroni et al, 2007) showed involvement of white 
matter tracts, including inferior longitudinal fasciculus, inferior fronto-occipital fasciculus, 
callosal and superior longitudinal fasciculus. The present study with stratification of PPA 
subgroups is consistent both with previous neuroanatomical findings and with the distinctive 
neuropsychological profiles of SD and PNFA. In SD, there was predominant involvement of 
anterior temporal cortices and white matter tracts (fornix, inferior longitudinal fasciculus and 
uncinate fasciculus) implicated in semantic processing (Spitsyna et al, 2006); while in PNFA, 
there was predominant involvement of inferior frontal, insular and parieto-temporal cortices 
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and dorsal white matter tracts (including the superior longitudinal fasciculus) implicated in 
speech production (Scott et al, 2003).  
 
LPA is defined by the presence of a primary language disorder with the key constellation of 
impoverished though non-effortful spontaneous speech marred by prominent word-finding 
pauses and less prominent phonemic errors, anomia, impaired sentence comprehension and 
impaired repetition particularly of sentences (Gorno-Tempini et al, 2004a; Gorno-Tempini et 
al, 2008). This language disorder is associated with reduced digit span (indicative of a 
phonological store deficit). Although a primary defect of phonological working memory has 
been proposed in LPA (Gorno-Tempini et al, 2008), it is unlikely that the primary cognitive 
defect in this degenerative syndrome is restricted to a single information processing module. 
For example, anomia and word-finding pauses might reflect a primary word retrieval deficit or 
a more specific phonological access deficit linked to disruption of inferior parietal or posterior 
superior temporal lobe areas, while limb apraxia is likely to reflect involvement of a distinct 
network mediating the control of voluntary action that includes the left parietal lobe. The 
pattern of deficits in LPA suggests involvement of the left parieto-temporal junction and 
functional connections in the dorsal language processing stream linking to inferior frontal areas 
(Awad et al, 2007; Wong et al, 2009). This pattern is likely to be relatively specific for LPA: a 
similar pattern has emerged in previous neuroanatomical studies of the syndrome (Gorno-
Tempini et al, 2004a; Gorno-Tempini et al, 2008), and furthermore, direct comparison with SD 
and PNFA cases here revealed distinct group-specific patterns of atrophy.  
 
The finding that the majority of the LPA cases had CSF biomarkers in keeping with AD 
pathology is consistent with a previous study in which 64% (7/11 cases) of patients with LPA 
had AD pathology: most of the other cases had FTLD-U pathology, though further genetic 
analysis was not undertaken (Mesulam et al, 2008). If LPA signals an atypical language 
presentation of AD in a high proportion of cases, it is noteworthy that the pattern of anatomical 
changes delineated here could be interpreted as a highly asymmetrical variant of the 
anatomical profile described in typical amnestic AD, with involvement of the medial temporal 
lobe, temporo-parietal junction and precuneus (Scahill et al, 2002). Indeed, language 
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dysfunction and parietal signs frequently develop in the course of typical amnestic AD (Croot 
et al, 2000; Harasty et al, 2001; Taler et al, 2008b) and an atypical language variant of AD has 
been described, of which many cases appear to have had an LPA syndrome (Galton et al, 
2000; Alladi et al, 2007). 
 
In this study, two patients had GRN mutations, which have been shown previously to be 
associated with asymmetrical hemispheric cortical atrophy frequently involving the parietal 
lobe (Le Ber et al, 2008; Whitwell et al, 2009). The neuroimaging signature of GRN-PPA was 
strikingly asymmetric, with more severe anterior temporal lobe involvement (and more severe 
white matter involvement) than with LPA. This neuroanatomical correlate implicates the 
ventral language processing pathway linking the posterior superior temporal lobe with more 
anterior temporal areas in the dominant hemisphere (Spitsyna et al, 2006), suggesting that 
GRN-PPA may be a dual-pathway disease although caution is clearly required in interpreting 
these findings, due to the small number of patients studied. 
 
In summary, the nonfluent variants have neuroanatomical profiles that are consistent with the 
clinical and neuropsychological features of the syndromes. The LPA and GRN-PPA profiles 
overlap with PNFA but are distinguished chiefly by more extensive involvement of posterior 
elements of the language network. As with any disorder producing aphasia, the nonfluent 
variants provide information about the organisation of language networks that is 
complementary to functional imaging studies in healthy subjects, by delineating areas that are 
critical for (rather than simply associated with) particular functions. Both the LPA and GRN-
PPA syndromes are clinico-anatomical entities that have a profile of brain damage 
complementary to the previously described disorders of SD and PNFA (described in detail in 
Chapter 3).  
 
 
!
!
!
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5.4 Case studies in progranulin-associated primary progressive aphasia 
Two of the patients with GRN mutations described in Chapters 5.2 and 5.3 were studied in 
greater detail: Case 1 was symptomatic at first assessment and was studied in detail using a 
series of neuropsychological tests to further elucidate some of the underlying cognitive deficits; 
however, Case 2 had been followed for a number of years prior to the onset of this study as a 
presymptomatic member of an autosomal dominant FTLD family and during the period of this 
study she was assessed three further times becoming symptomatic between the first and second 
of these assessments thus allowing a unique opportunity to study presymptomatic and early 
neuroanatomical and neuropsychological deficits in GRN-PPA. 
 
5.4.1: CASE 1 
 
Clinical details  
A 62-year-old right-handed male retired shopkeeper, GAA, presented with a three year history 
of progressive word-finding difficulty. He would break off in mid-sentence, unable to find the 
words to finish, and would often say the opposite of what he meant (e.g. ‘yes’ for ‘no’, ‘left’ for 
‘right’, ‘small’ for ‘big’). His speech became very sparse and he would overuse stereotyped 
phrases such as ‘at some stage’ and ‘it’s aggravation’. He had difficulty repeating things told to 
him, understanding complex instructions and remembering messages. Early on in the illness he 
developed problems with arithmetic and subsequently also with reading, writing and spelling. 
He had no other cognitive symptoms. However, his family had noted he had become more 
socially withdrawn in recent years and less motivated. There was no family history of dementia 
in his parents (his mother died at the age of 80 of cancer and his father died at 70 of cardiac 
disease) however two of his mother’s sisters developed dementia in their 80’s and his mother’s 
father had died after some time in a psychiatric hospital.  
 
On examination he scored 19/30 on the MMSE (Folstein et al, 1975) and 13/18 on the Frontal 
Assessment Battery (Dubois et al, 2000). There was mild bilateral ideomotor and ideational 
limb apraxia. The general neurological examination was unremarkable. He had a Clinical 
Dementia Rating (CDR)-total of 0.5 and CDR-sum of boxes of 4.0 (Morris, 1993). On a 
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behavioural assessment, his total Neuropsychiatric Inventory score (Cummings et al, 1994) was 
13, scoring 6 on depression/dysphoria, 2 on anxiety, 3 on apathy/indifference and 2 on 
irritability/lability subscales.  
 
Brain MRI was performed three years after symptom onset (Figure 5.4.1). This showed 
asymmetric atrophy predominantly involving the left cerebral hemisphere and accentuated in 
the temporal lobe (particularly the superior and lateral temporal cortex) and parietal lobe 
(supramarginal and angular gyri) with additional left prefrontal lobe atrophy. Changes of 
cerebrovascular disease were minimal. Following this study, he required a permanent 
pacemaker for cardiac conduction disease, precluding serial MR imaging.  
 
Figure 5.4.1  
Coronal T2 magnetic resonance sections of GAA’s brain (left hemisphere shown on the right) three 
years after symptom onset, showing predominantly left fronto-temporo-parietal atrophy 
 
 !
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A blood sample was obtained as part of a study into the genetics of young-onset dementia.  All 
13 exons of the GRN gene were sequenced in at least one direction. Analysis of 
electropherogram traces revealed the R493X mutation, the most common GRN mutation 
reported to date (Rademakers et al, 2007).  
 
Neuropsychological and neurolinguistic functions were investigated in detail between 36 and 
42 months following symptom onset. 
!
General neuropsychology  
There was a large discrepancy between GAA’s very impaired verbal IQ score and average 
performance IQ score (on WAIS-III, Wechsler, 1981) (See Table 5.4.1). He was tested on four 
separate tests from The Camden Memory Tests battery (Warrington, 1996): his performance 
was below the 5th percentile on a test of verbal memory whereas visual memory was intact 
(10th to 25th percentile on a recognition memory test for faces, 95th percentile on a 
topographical recognition memory test and an errorless performance on a pictorial recognition 
memory test). Executive functions were relatively intact on two separate tests and performance 
was normal on tests of visuoperceptual and visuospatial skills (Warrington et al, 1991). 
However he was unable to score on the Graded Difficulty Calculation Test (Jackson et al, 
1986).  
 
 !!!!!!!!!
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Table 5.4.1  
General neuropsychological assessment of case GAA 
 
Test Score 
Percentile 
score 
General intelligence   
WAIS III verbal IQ 53  
WAIS III performance IQ 102  
Episodic memory   
Short Recognition Memory Test for Words 18/25 <5th 
Short Recognition Memory Test for Faces 20/25 10-25th 
Topographical Recognition Memory test 28/30 95th  
Pictorial Recognition Memory test 30/30 >10th% 
Executive function   
Trail Making Test A scaled score 7 10-25th  
Trail Making Test B scaled score 10 50th 
D-KEFS Design Fluency composite scaled score 8 10-25th 
Visuoperceptual/visuospatial skills   
Visual Object and Space Perception battery (VOSP) test 3  Object decision 19/20 >75% 
VOSP test 5  Dot counting 10/10 >5% 
Arithmetic   
Graded Difficulty Calculation Test 0/24 <5th !
Speech assessment 
Propositional speech 
GAA’s propositional speech was gravely impaired. He volunteered little spontaneous speech. 
At his first clinical assessment he was asked to describe his last holiday: 
“I went to… the USA… for… (long pause) Boston… round there… we did round 
there… (long pause) we you-sted the… (long pause) all.” (48 seconds) 
When asked to describe the Cookie Theft Scene from the Boston Diagnostic Aphasia 
Examination (Goodglass et al, 1983) he volunteered: 
“This is falling out… they wanted that… they falling that… this was water… (long 
pause) that’s about it I think… this was… this was along there… that’s about it.” (30 
seconds) 
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Analysis of these two short samples of spontaneous speech (total time 1.3 minutes) revealed a 
speech rate of 33 words/minute (in nine cognitively-normal male controls with mean age 68, 
who spoke for an average of 2.6 minutes, the range was 102-148 words/minute). The mean log 
frequency of the words (based on the CELEX database, Baayen et al, 1993) used was 3.41 
(control range 2.24 to 2.73), mean log frequency of nouns (also based on CELEX database) 
used was 2.58 (control range 1.63 to 1.97) and noun imageability (based on the MRC 
database) was 596 (control range 509 to 574). There were no features of speech apraxia and 
the speech diadochokinetic rate was normal (Apraxia Battery for Adults-2 subtest 1: Dabul, 
2000). There were relatively few speech production errors although there were rare phonemic 
and semantic errors. Although GAA’s spontaneous speech was sparse and assessment for the 
presence of agrammatism was therefore difficult, there were nevertheless occasional clearly 
agrammatic errors, e.g. “we did round there” and “they falling that”. GAA was unable to 
perform sentence completion tasks given a sentence frame, even when the completing word 
was high probability  (e.g. He loosened the tie around his [neck]). On a second assessment six 
months after the initial assessment, GAA’s spontaneous speech was even more severely 
impoverished – attempting to describe his last holiday he said: 
“It’s aggravation… (long pause) it’s… can’t do the… (long pause) along there… can’t 
do… it’s aggravation” (45 seconds) 
Describing the Cookie Theft Picture he said: 
“That along there… along there, that’s… that’s…(long pause) see I don’t these… (long 
pause) I know what it is but I can’t do it, you know, it’s aggravation” (35 seconds) 
 
Detailed linguistic assessment 
Naming 
GAA was severely anomic scoring below the 1st percentile on the Graded Naming Test 
(McKenna & Warrington, 1980) (see Table 5.4.2). On a category naming test comprising high 
frequency nouns (Crutch et al, 2007) he had more difficulty with body parts than with animals, 
objects or colours. On a test comparing the naming of nouns (objects) and verbs (action 
pictures) matched for frequency using the CELEX database, performance was more impaired for 
verbs than nouns ("2=4.33, p=0.04). On analysis of errors made, he would commonly provide 
  149 
no answer, but when attempting an answer made mainly phonemic errors (e.g. ‘cheet’ for 
sheep; ‘flad’ for flag, ‘theeze’ for tweezers) and only occasional semantic (descriptive) errors 
(e.g. ‘red bits’ for bird (robin)).  !
Table 5.4.2  
Detailed linguistic assessment: naming 
 
Test Score 
Percentile score/ 
normal range (NR) 
Graded Naming Test 4/30 <5th  
Category naming test 23/40  
Animals 7/10 NR 8-10 
Objects 6/10 NR 10 
Colours 7/10 NR 9-10 
Body parts 3/10 NR 10 
Matched noun and verb naming test   
Nouns 6/20 NR 18-20* 
Verbs 1/20 NR 18-20* 
 
*Normal range based on a cognitively-normal control sample of 18 patients (9 male, 9 female) with an average age of 
67.9. !
Speech repetition 
GAA’s repetition of both single words and sentences was impaired (See Table 5.4.3). Single 
word repetition showed a small but non-significant frequency effect (43/60 high frequency; 
35/60 low frequency, "2=2.34, p=0.13) and a significant effect of syllable length (31/40 one 
syllable words; 28/40 two syllable words; 19/40 three-syllable words, "2=8.57, p=0.01) (see 
Table 4.3.3). Analysis of his 42 repetition errors revealed 11 items with no response (26%) and 
31 phonological errors (11 substitutions (26%), 11 omissions (26%), 3 additions (7%), 1 
transposition (2%) and 5 with multiple errors).  There were also errors repeating nonwords 
(13/20). Sentence repetition was severely impaired (0/10): GAA was unable to repeat any of 10 
short sentences or 10 clichés. In general he provided no response, however examples of errors 
made included: 
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IT WAS TOO HOT  too hot 
DEAF AS A POST  deaf as a front 
 
Table 5.4.3  
Detailed linguistic assessment: single word repetition 
 
Test*    
Single word repetition: 78/120 1 syllable 2 syllable 3 syllable 
High frequency 17/20 16/20 10/20 
Low frequency  14/20 12/20 9/20 
 
*Ceiling performance for all repetition tasks in cognitively-normal controls 
!
Single word comprehension  
GAA’s performance was assessed on a series of single word comprehension tests, some of 
which involved direct matching between a word and target, and other tests which involved a 
degree of associative knowledge. GAA’s performance on these comprehension tasks was 
variable (See Table 5.4.4). Thus his performance on the verbal (spoken and written input) 
version of the Pyramids and Palm Trees test (Howard et al, 1992) was impaired, and 
furthermore significantly inferior to his performance on the visual version of the task which was 
within the normal range (Sign test: N=11, x=2, p=0.03). Similarly he had difficulty on the 
verbal version of the Camels and Cactus test (Bozeat et al, 2000) compared with his normal 
score on the visual version (Sign test: N=17, x=4, p=0.03).  GAA also attempted the short 
version of the British Picture Vocabulary Scale (Dunn et al, 1982), and he scored below the 5th 
percentile with both written word and spoken word presentation. By contrast, on a test of 
semantic knowledge that probed attributes of size and weight in animals and objects 
respectively (Warrington et al, 2007) he scored at a normal level on both the verbal and visual 
versions of the test. He was also assessed on the Category Specific Names Test assessing single 
word comprehension (McKenna, 1998): this test comprises arrays of five pictures selected from 
4 categories, graded in difficulty so that the range of items encompasses very low frequency 
objects: on each section of this test (both spoken and written name to picture matching), he 
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scored above the average level. He also attempted four graded 2-choice (spoken and written) 
synonym comprehension tests, involving concrete and abstract nouns and verbs (Warrington et 
al, 1998; Manning et al, 1995). He was clearly impaired on both the verb versions of the test 
(scores not meaningfully different from chance) but within the normal range for both concrete 
and abstract nouns. He performed well on the Graded Naming Test presented as a forced 3-
choice recognition task in which he was presented simultaneously with a spoken and written 
definition for each item (e.g. “What is the large canvas covered frame upon which children can 
bounce and jump? – TARPAULIN, TAMBOURINE or TRAMPOLINE”). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  152 
Table 5.4.4  
Detailed linguistic assessment: single word comprehension 
 
Test Score 
Percentile score/ 
normal range (NR) 
Pyramids and Palm Trees test   
Verbal* (3 words) 43/52 NR 49-52 
Visual (3 pictures) 50/52 NR 49-52 
Camels and Cactus test   
Verbal* (5 words) 46/64 NR 56-63  
Visual (5 pictures) 55/64 NR 51-62 
British Picture Vocabulary Scale (short)   
Written word to picture matching 21/32 <5th  
Spoken word to picture matching 24/32 <5th  
Size/Weight Attribute test   
Verbal Animals 30/30 NR 26-30 
Visual Animals 29/30 NR 27-30 
Verbal Objects 27/30 NR 26-30 
Visual Objects 29/30 NR 26-30 
Category Specific Names Test   
Written presentation   
Fruit 30/30 Control mean 25.0# 
Animals 30/30 Control mean 28.3# 
Praxic objects 26/30 Control mean 29.2# 
Non-praxic objects 30/30 Control mean 26.8# 
Spoken presentation   
Fruit 25/30 Control mean 24.8# 
Animals 30/30 Control mean 28.2# 
Praxic objects 30/30 Control mean 29.2# 
Non-praxic objects 29/30 Control mean 26.7# 
Warrington synonyms test*   
Concrete nouns 21/25 50-75th  
Abstract nouns 18/25 10-25th  
Concrete verbs 15/25 Control mean 22+ 
Abstract verbs 15/25 Control mean 20+ 
Graded Naming Test from description (forced choice of 3 words)*  23/30  
 
*presented simultaneously in both spoken and written form, #based on control sample of 10 subjects from McKenna 
& Parry, 1994, +based on control sample of 3 subjects from Manning & Warrington, 1995 
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Sentence comprehension and grammar 
GAA’s performance was below the 5th percentile on the Test of Reception of Grammar (TROG, 
Bishop, 1989). On a further set of 24 sentences taken from PALPA55 (Kay et al, 1992) his 
performance was significantly worse on reversible than nonreversible sentences and on passive 
than active sentences. Furthermore, performance was worse for sentences containing 
directional motion verbs (where one of the distractors was the opposite motion e.g. push versus 
pull) compared with sentences with non-directional verbs. GAA’s comprehension of verb tense 
was explored using an adapted version of the Lesser/Parisi and Pizzamiglio syntax test (Lesser, 
1974; Parisi et al, 1970) comprising 20 pairs of pictures which differ in whether the agent is 
doing something/has done something (present/past comparison, 10 items) or whether the agent 
is doing something/is about to do something (present/future comparison, 10 items). He scored 
16/20 on this task scoring equally on the present/past and present/future items (healthy controls 
score at or near ceiling on this test).  GAA was also tested on a grammaticality judgment test 
which was an adapted version of the Test for Syntactic Abilities (Quigley et al, 1978): this test 
entails a two-alternative forced choice on two sentences (presented simultaneously both 
visually and aurally), one of which is grammatical and the other agrammatical. The 
agrammatical sentences contained a variety of errors including incorrect verb tense, 
addition/substitution/deletion of function words and incorrect word order. GAA scored 79% on 
this test making 23 errors of which 15 were errors made on incorrect verb tense (See Table 
5.4.5). 
 !!!!!!!
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Table 5.4.5  
Detailed linguistic assessment: sentence comprehension and grammar 
 
Test Score Percentile score/ 
normal range* 
(NR) 
Test for the Reception of Grammar (TROG) 45/80 <5th  
PALPA 55 (modified version) 17/24 NR 22-24* 
Reversible 63%  
Non-reversible 88%  
Passive  58%  
Active 83%  
Directional 50%  
Non-directional 75%  
Verb tense comprehension test 16/20 NR 19-20* 
Test of syntactic abilities (modified) 85/108  
 
*Normal range based on a cognitively-normal control sample of 18 patients (9 male, 9 female) with an average age of 
67.9. 
!
Reading 
GAA was able to read single letters fairly competently with only 1 error from 25 letters (See 
Table 5.4.6). However he had great difficulty reading both real words and nonwords (Snowling 
et al, 1996). Investigating his real word reading further, he had similar difficulty reading regular 
and irregular words. He had greater difficulty with abstract words than concrete words and 
with increasing word length. A battery of 275 3-letter words was also administered to examine 
reading errors: he read 77% of the words correctly, with 62 errors in total. Included in this test 
were 55 3-letter function words: there were errors on 29% of these words (compared with 21% 
errors on the other 220 content words). There was a mixture of error types across the reading 
subtests, comprising mainly phonological (e.g. ‘opperosite’ for opposite) and visual (e.g. 
‘December’ for decent) errors but also occasional regularisation (e.g. ‘gem’ with hard ‘g’ for 
gem), and semantic errors (e.g. ‘salt’ for sour). 
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Writing and spelling 
GAA’s spelling was severely impaired. He was unable to score on the written Graded Difficulty 
Spelling Test (Baxter et al, 1994) (see Table 5.4.6). His attempts for the first four items were 
‘ONE’ for TWO, ‘BULL’ for WORLD, ‘SEA’ for SAID and ‘NICE’ for SHOE. On a further set of 
3–letter words he scored equally poorly on both regular and irregular words and oral and 
written spelling were comparably affected. He made seven errors on oral spelling, comprising 
five no responses and the errors ‘SIK’ for SEA and ‘SAT’ for CAP; and six errors on written 
spelling, comprising single letters: ‘S’ for SON and SAW, ‘M’ for CUP, ‘W’ for LOG and ‘M’ for 
BAR. On attempting to write single letters to dictation he was able to produce only five of 25 
letters.  
 
GAA was asked to construct grammatical sentences containing each of 10 written target words. 
He made no attempt for three words (‘new’, ‘radio’, ‘tree’), and for the remaining seven words 
produced the following: 
 
EARLY  Early a clock eight 
CAUGHT Caught a sam  
PUSHED Pushed on door 
SMALL  Small emp  
WALKED Walked a patio 
THROW Throw on door 
BLUE   Blue door 
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Table 5.4.6  
Detailed linguistic assessment: literacy skills 
 
Test Score* 
Reading  
Single letter reading 24/25 
National Adult Reading Test 0/50 (<1st %) 
Graded difficulty nonword reading test 2/20 (<10th %) 
Coltheart irregular vs regular word reading test 31/78 
Irregular words 15/39 
Regular words 16/39 
Concrete/abstract reading test 47/72 
Abstract words 18/36 
Concrete words 29/36 
High frequency words 23/36 
Low frequency words 24/36 
1 syllable length 21/24 
2 syllable length 17/24 
3 syllable length 9/24 
Writing/Spelling  
Sentence construction 0/10 
Graded difficulty spelling test 0/30 (<1st %) 
3-letter word spelling test 7/20 
Regular words 5/10 
Irregular words 2/10 
Oral spelling 3/10 
Written spelling 4/10 
Single letter writing 5/25 
 
*All cognitively-normal adults score at a ceiling level on tests apart from the NART, Graded difficulty nonword 
reading test and Graded difficulty spelling test. 
!
Short term memory 
GAA’s digit span, assessed as part of the WAIS-III, was severely impaired (See Table 5.4.7). His 
auditory-verbal digit span, auditory-verbal letter span, auditory-verbal word (3-letter, one-
syllable) span, visual-verbal digit span and spatial span were subsequently compared. In each 
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condition, eight trials were presented with 1, 2 or 3 items. GAA was unable consistently to 
repeat more than 1 item for spoken digits, letters or words. Performance was better for visually 
presented digits, for which he was occasionally able to repeat 3 items. Furthermore, in stark 
contrast to his performance on the auditory tasks, his spatial span (assessed with the Corsi 
block-tapping test, Corsi, 1972; Kessels et al, 2000) was within the normal range – he was able 
to point without error to 3 blocks, scored 4/8 completely correct trials (24/32 positions) with 
four blocks and 1/8 completely correct trial (22/40 positions) with five blocks.  
 
Table 5.4.7  
Short term memory assessment 
 
Task 1 item 2 items 3 items 
Auditory-verbal digit span 6/8 1/8 (5/16) Unable 
Phonologically similar 1/8 
(6/16) Auditory-verbal letter 
span 
7/8 
Phonologically dissimilar 0/8 
(3/16) 
Unable 
Auditory-verbal word 
span 
5/8 0/8 (3/16) Unable 
Visual-verbal digit span 7/8 6/8  (14/16) 2/8 (15/24) 
Spatial span 8/8 8/8 (16/16) 8/8 (24/24) 
 
8 stimuli for each task at each level. Scores are shown as total completely correct out of 8 and in brackets the total 
number of items in the correct position (out of 16 for 2 items and 24 for 3 items). !
DISCUSSION 
This case report describes in detail the pattern of neuropsychological and linguistic deficits in a 
patient with GRN-associated PPA. The salient clinical features were sparse, slow and 
impoverished spontaneous speech with word-finding pauses. The profile of neuropsychological 
deficits comprised severe anomia, poor verbal short-term memory and impaired sentence 
comprehension, associated with dyslexia, dysgraphia and dyscalculia. By contrast certain (non-
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associative) aspects of single word comprehension, nonverbal memory and visual perceptual 
skills were well preserved. The constellation of neuropsychological findings in GAA constitutes 
a distinctive pattern of cognitive impairment and preservation: the clear verbal modality 
specificity of GAA’s language deficits indicates preferential involvement of the dominant 
hemisphere, while the association of dyslexia, dysgraphia and dyscalculia constitutes a 
classical left parietal syndrome; the lobar localisation for other features, such as anomia and 
impaired phonological memory, is less clear. This neuropsychological syndrome overlaps in a 
number of respects with previous descriptions of the LPA syndrome (Gorno-Tempini et al, 
2008) while the presence of grammatical errors in spontaneous speech and markedly impaired 
speech repetition suggests an additional overlap with the PNFA syndrome. However, the 
cognitive profile exhibited by GAA should not be regarded simply as a variant or a composite 
of other PPA syndromes: key features of this profile in relation to LPA and PNFA are 
summarised in Table 5.4.8.  !!!!!!!!!!!!!!!!!!
  159 
!
Table 5.4.8  
Comparison of neuropsychological features in GAA compared to LPA and PNFA 
 
Neuropsychological 
feature 
GAA LPA PNFA 
Spontaneous 
speech 
Slow, sparse 
spontaneous speech with 
word-finding pauses 
Slow spontaneous 
speech with word-
finding pauses 
Speech characterized 
by hesitancy and 
effortfulness due to 
apraxia of speech 
and/or agrammatism 
Naming Severely anomic Anomic Mildly anomic 
Single word 
repetition 
Moderately impaired 
Relatively intact 
(compared to sentence 
repetition) 
Mild to moderately 
impaired 
Sentence 
repetition 
Severely impaired Impaired Impaired 
Single word 
comprehension 
Impaired for associative 
verbal semantic tasks 
Relatively intact 
Intact early in the 
course 
Sentence 
comprehension and 
grammar 
Severely impaired 
Possible true 
grammatical deficit 
(expressive and 
receptive) 
Impaired Impaired 
Reading 
Deep/phonological 
dyslexia 
Phonological dyslexia 
Little studied but 
phonological dyslexia 
described 
Verbal short-term 
memory 
Severely impaired Severely impaired Usually intact early 
Episodic memory 
Impaired verbal, intact 
nonverbal 
Few studies but 
evidence of mild verbal 
impairment 
Intact 
!
Anatomically, although detailed correlation was not possible, cerebral atrophy in this case 
involved the left posterior temporal/anterior parietal region and also left inferior frontal areas 
(Figure 5.4.1). According to the current dual stream model of cortical language processing, a 
ventral pathway involved in processing word meaning links the superior temporal gyrus to 
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middle and inferior temporal gyri, temporal pole and inferior frontal cortex; while a dorsal 
pathway involved in articulation-to-sound mapping links the superior temporal gyrus with 
inferior parietal and inferior frontal cortices (Hickok et al, 2004; Warren et al, 2005; Saur et al, 
2008). Following this formulation, and taking the neuropsychological and neuroimaging 
evidence into account, it is proposed that GRN-associated PPA in this case is likely to reflect 
involvement of both the dorsal and ventral language pathways, with a key site of overlap in the 
region of the temporo-parietal junction. The evidence is now considered for this claim in more 
detail. 
 
GAA had progressive anomia. While this is likely to be attributable at least in part to impaired 
word retrieval, a verbal semantic deficit may also have contributed. GAA’s variable 
performance on single word comprehension tests is relevant both to neuropsychological 
theories of semantic knowledge as well as to how such a syndrome would fit into current PPA 
classifications. He had no difficulty with the Size/Weight Attribute Test of conceptual 
knowledge and more impressively he scored at a high level on both the spoken and written 
word versions of the Category Specific Names Test probing knowledge of low frequency items. 
Furthermore, on a synonyms test of concrete noun comprehension his performance was at an 
average level. By contrast, on word-picture matching tests such as the British Picture 
Vocabulary Scale where the mapping between word and target picture is less direct, his 
performance was impaired. He was also impaired on verbal (spoken and written word to word) 
matching tasks such as the verbal versions of the Pyramids and Palm Trees and Camels and 
Cactus tests whilst exhibiting normal performance on the visual versions. How can one explain 
the profile of dissociated verbal semantic impairments observed in GAA?  
 
Considering first the word-picture matching tests, one could suggest that GAA’s weaker 
performance is observed on those tasks involving some degree of associative rather than direct 
semantic matching. Such tasks are likely to involve executive control processes, as suggested 
by Jefferies et al, 2006. However, a primary deficit in executive control would not easily 
explain the difference between GAA’s performance on verbally and visually mediated versions 
of these associative tasks. This visual advantage is in contrast to the pattern of performance 
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described in stroke patients (Jefferies et al, 2006; Corbett et al, 2009), and belies the equal 
semantic control demands of the visual and verbal versions of this task. Another possibility is 
that GAA has mildly impaired lexical semantics, such that response selection among closely 
related alternatives is required to expose degraded semantic representations; or alternatively, 
an intact semantic store but a deficit in linking phonological representations of words with their 
meanings, which is exposed when the semantic targets are more closely related. Picture-
picture matching might provide additional information or cues unavailable from the written or 
spoken word, with correspondingly better performance on visual than verbal matching tasks. 
An explanation of this kind would be in line with evidence from studies of focal lesions such as 
stroke affecting associative cortical areas in the region of the temporo-parietal junction (Hillis, 
2007). Moreover, degraded access to semantic stores resulting from posterior temporal-inferior 
parietal lobe atrophy would be consistent with functional imaging evidence in healthy subjects 
suggesting that the extraction of meaning from both spoken and written language may require 
connectivity between posterior and anterior temporal lobe areas in the ventral language stream 
(Spitsyna et al, 2006).  
 
A test such as Pyramids and Palm Trees seems to call for manipulation of verbal concepts and 
contexts (e.g. in order to decide whether “cat” or “dog” is the correct answer when presented 
with “mouse”, one must not only comprehend individual concepts but also activate the salient 
relationships between target and response i.e. “hunter/hunted” rather than “both animals” or 
“don’t bark” etc.). The further possibility is therefore raised that the dissociation between verbal 
and non-verbal comprehension performance observed in GAA may arise from a selective 
deficit of verbal reasoning. ‘Verbal reasoning’ is itself an under-specified term: it is used here to 
embrace several potentially relevant processes, such as inference or abstraction of a semantic 
relationship that is not directly implied by the stimuli. That such processes can be specific to 
the verbal modality is supported by the existence of a selective deficit of verbal message 
formulation in patients with so-called “dynamic aphasia” (Costello et al, 1989; Warren et al, 
2003). The present study does not disambiguate any deficit in verbal reasoning from a mild 
deficit of lexical semantics (indeed, that distinction is difficult even in principle). However, 
processes such as verbal inference are likely to involve fronto-parietal circuitry (Reverberi et al, 
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2007), raising the possibility that the associative verbal semantic deficit identified in GAA 
might implicate either the dorsal or the ventral language pathway (or indeed, a conjoint deficit 
attributable to temporo-parietal junction damage). 
 
GAA showed evidence of an impaired phonological store (poor verbal short term memory). His 
auditory verbal span was not entirely intact even for single items (digits, letters or words), while 
visual verbal span was only marginally better. This contrasted with his normal visuospatial 
span. In addition, GAA’s performance was impaired on tests not only of receptive grammar 
(e.g. TROG, PALPA55) but also grammaticality judgement tests (e.g. Test of syntactic abilities). 
Previous evidence suggests that although they may cause deficits in sentence comprehension 
tasks, auditory verbal span deficits are neither necessary nor sufficient to produce such deficits 
in receptive grammar and grammaticality judgements (e.g. Shallice et al, 1977; Caplan et al, 
1999). It is proposed that GAA has a double deficit affecting both his auditory verbal short term 
memory and the systems mediating receptive grammar. This would also be consistent with the 
distributed pattern of left cerebral atrophy with left temporo-parietal emphasis in this case: the 
phonological store is likely to be mediated by anterior inferior parietal and posterior superior 
temporal areas whilst sentence and grammatical processing are associated with inferior frontal 
and posterior superior temporal areas (Vigneau et al, 2006; Buchsbaum et al, 2008). Sentence 
comprehension has been studied in LPA with suggestions that deficits are secondary purely to 
phonological store deficits (Gorno-Tempini et al, 2008). However, there have been no previous 
studies attempting to dissociate a true receptive grammatical deficit from a phonological store 
deficit in LPA (e.g. on a grammaticality judgment test). Similarly, it has been difficult to 
characterize any expressive agrammatism in LPA, as speech tends to be sparse with prolonged 
pauses. In this study there was some evidence for agrammatism in GAA’s spontaneous speech 
and further evidence in his production of very simple or agrammatic sentences in writing. This 
may represent a further distinction from the LPA syndrome, (suggesting an overlap with the 
classical PNFA syndrome) but again, will require further study, particularly with detailed 
quantitative analysis of spontaneous speech and writing in this group. 
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With further regard to his deficit of receptive grammar processing, GAA had particular 
difficulty with comprehension of verb tense which, in conjunction with poor performance on 
verb naming and verb comprehension tasks, suggests a relatively selective deficit of verb 
(versus noun) processing. Anatomically, verb processing is thought to rely on left dorsal 
language pathway areas including left prefrontal cortex (Damasio et al, 1993) and 
posterolateral temporal cortex (Grossman et al, 2002), consistent with the pattern of atrophy 
seen here. Of note, a selective deficit in verb processing has been previously described in a 
familial ubiquitin-positive inclusion dementia (Bak et al, 2006): although the genetic diagnosis 
in this previous case was not defined, considered together these observations raise the 
possibility that defective verb processing may be a signature of GRN mutations in PPA. 
 
GAA exhibited additional deficits of literacy skills that provide further evidence of deficient 
phonological processing. His reading deficit shows the typical pattern of deep/phonological 
dyslexia affecting regular and irregular real words as well as nonwords, the errors produced 
being a mixture of phonological, visual and more rarely regularisation and semantic errors, 
with better performance reading concrete compared to abstract words (Coltheart, 1980; Crisp 
et al, 2006). Similarly his pattern of spelling deficits indicates phonological dysgraphia in both 
oral and written modes. The presence of phonemic errors would be consistent with a deficit of 
phonological transcoding, which may result from damage to the left temporo-parietal junction. 
Patients with LPA have previously been described as having phonological dyslexia (Brambati et 
al, 2009a) and a more general deficit of phonological processing (Gorno-Tempini et al, 2008).  
 
It is worth considering how this neurolinguistic and anatomical formulation may relate to other 
clinical features in this case and in previous descriptions of GRN-associated disease. GAA did 
not exhibit neurological signs of parkinsonism (described in around a third of GRN mutation 
cases) or motor neurone disease (a rare feature) (Baker et al, 2006; Cruts et al, 2006). However, 
GAA did display evidence of apathy and depression as well as increased anxiety and 
irritability: such behavioural changes have been previously reported with GRN mutations 
(Snowden et al, 2006) and indeed, the most common clinical phenotype of GRN mutations is 
progressive personality change (behavioural variant frontotemporal dementia) as described in 
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Chapter 3. Similar behavioural symptoms have been described in association with both PNFA 
and LPA (Rosen et al, 2006). In anatomical terms, such complex behaviours are likely to 
depend on distributed circuitry and might therefore be vulnerable to disease processes that 
strike long intra-hemispheric pathways linking frontal and anterior temporal cortices with more 
posterior areas, as it is proposed may underpin the GRN-associated aphasic syndrome here. 
 
This case has highlighted certain neuropsychological differences with respect to previous 
descriptions of either the LPA or PNFA syndromes (Gorno-Tempini et al, 2004a: Gorno-
Tempini et al, 2008; Brambati et al, 2009a: see Table 4.4.8), in particular, the early occurrence 
of single word comprehension deficits and, in comparison to LPA, expressive agrammatism. 
The patient had asymmetric left temporal and parietal atrophy and involvement of the key left 
temporo-parietal junction zone would be predicted to correlate with involvement of 
functionally connected regions in the left inferior frontal and anterior temporal lobes via the 
dorsal and ventral speech processing pathways demonstrated in functional imaging studies in 
healthy subjects (Scott et al, 2003) and implicated in clinical aphasia syndromes of vascular 
disease (Hillis, 2007; Jefferies et al, 2006).  
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5.4.2: CASE 2 
This section describes the clinical, neuropsychological and radiological profile of a member of 
the DRC255 family (found to have a mutation in GRN) who had been followed over a thirteen-
year period, from an early presymptomatic stage through the development of a progressive 
aphasia. 
 
Clinical details 
Case PAF is a right-handed woman followed from 55-years-old as part of a prospective 
longitudinal clinical and MRI study of asymptomatic individuals at-risk of developing familial 
autosomal dominant FTLD. She underwent a series of assessments comprising eight visits in 
total, each involving detailed clinical and neuropsychological evaluation and volumetric brain 
MRI. 
 
Clinical assessment 
Each assessment included a structured clinical interview and neurological examination 
including assessment of limb and orofacial apraxia. The Mini-Mental State Examination 
(MMSE) (Folstein et al, 1975) and Frontal Assessment Battery (FAB) (Dubois et al, 2000) were 
also performed. 
 
Neuropsychological assessment 
General intellectual function was tested with the WAIS (Weschler, 1981) and the VESPAR 
(Langdon et al, 1995). Episodic memory was tested using the Recognition Memory Test for 
Words and Faces (Warrington, 1984) and a test of paired associate learning (Warrington, 
1996). Language function was tested using the Graded Naming Test (McKenna et al, 1980), 
Warrington Concrete Synonyms Test (Warrington et al, 1998) and a test of polysyllabic word 
repetition. Other cognitive domains assessed included calculation (Graded Difficulty 
Arithmetic Test: Jackson et al, 1986), visuospatial and visuoperceptual skills (subtest 2 of the 
Visual Object and Spatial Perception (VOSP) battery: Warrington et al, 1991) and executive 
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function (Modified Card Sorting test: Nelson et al, 1976). In the last four assessments tests of 
basic and complex facial emotion recognition were also performed (Ekman test of facial 
emotion recognition: Ekman et al, 1976; Gray et al, 1997; and the ‘Reading the Mind in the 
Eyes’ Test Revised Version: Baron-Cohen et al, 2001). The last test was originally devised as an 
‘advanced’ test of mentalising ability (the ability to interpret others’ mental states, or ‘Theory of 
Mind’: Baron-Cohen et al, 1997). Findings on longitudinal neuropsychological assessment are 
summarised in Table 5.4.9. Six months after the last annual assessment a more fine-grained 
assessment of language functions was performed using a range of neurolinguistic instruments 
(summarised in Table 5.9.10). These instruments were designed to analyse in detail the basis 
for any aphasic deficit.  
 
Brain imaging 
Eight T1-weighted MRI brain volumes were acquired. The first four scans and the last four 
scans were acquired on two different scanners, however both were 1.5T GE Signa (General 
Electric, Milwaukee, WI). Of note, the 5th scan was acquired prior to a scanner upgrade. All 
scans were processed using the MIDAS software tool (Freeborough et al, 1997a). A semi-
automated technique of brain segmentation was performed for each scan followed by an affine 
(12 degrees of freedom) registration in order to align the repeat scan onto the baseline image 
where both images were taken on the same scanner (Woods et al, 1998). Whole brain atrophy 
rates were calculated over the inter-scan intervals using the brain boundary shift integral 
(Freeborough et al, 1997b) and regional atrophy was assessed using a fluid registration 
technique producing a voxel compression map (Freeborough et al, 1998, Fox et al, 2001) as 
described in chapter 2. Hemispheric volumes were also calculated as described in chapter 2. A 
similar procedure was performed in order to separate the lateral ventricles into right and left 
sides.  
 
RESULTS 
Clinical and neuropsychological findings 
For the initial four visits PAF remained well with no cognitive symptoms and scored normally 
on neuropsychological assessment. She was lost to follow up for the next seven years but 
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returned for assessment 10 years after her first assessment. At this appointment (visit 5) she did 
not complain of any symptoms and again scored normally on detailed testing apart from a 
slightly reduced verbal fluency (9 ‘S’ words in one minute) on the FAB. However a year later, 
at visit 6, although she still had no cognitive complaints, neuropsychometry revealed evidence 
of decline in naming and calculation (although the absolute scores still remained within 
normal limits) (Table 5.4.9). 
 
At the next visit one year later (Visit 7, 12 years since the initial visit, when PAF was aged 67) 
she complained of cognitive symptoms for the first time with the onset over the previous six 
months of word-finding difficulty. MMSE score at this time was 28/30. Verbal fluency was 
reduced on the FAB (6 ‘S’ words in one minute) and there were difficulties with sentence 
repetition. Graded Naming Test score was now below the 5th percentile (10/30) and further 
decline was evident on testing of calculation. Performance had now also deteriorated on a test 
of verbal comprehension but remained normal (with no deterioration in performance) on tests 
of executive function and visuoperceptual skills. Imitation of meaningless hand positions was a 
little clumsy but the neurological examination at this time was otherwise normal.  
 
At visit 8, 18 months after symptom onset, word-finding had continued to deteriorate and PAF 
had developed speech production impairment with phonemic paraphasias and agrammatism. 
Her family reported that she had become more apathetic over the previous year and spent most 
of the time in her house. MMSE score was now 22/30 and verbal fluency was again reduced. 
There was also now mild bilateral ideomotor and ideational limb apraxia although the rest of 
the neurological examination remained normal. Naming had further deteriorated with the 
patient now scoring below the 1st percentile (3/30). Verbal memory difficulties had become 
more apparent with deterioration in performance on both the paired associate learning task 
and the Recognition Memory Test for Words. 
 
PAF’s ability to recognize both simple and complex facial emotions deteriorated from the 
baseline score at visit 5, 18 months prior to symptom onset (Table 5.4.9). On the ‘Reading the 
Mind in the Eyes’ test performance fell from a score of 26/36 which was within an age and sex-
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matched normal range (24-34/36) to a score of 22/36 the following year, still six months prior 
to symptom onset. Eighteen months after symptom onset performance fell further to 18/36. On 
a test of basic facial emotion recognition based on the Ekman emotional faces stimulus set 
(Gray et al, 1997) the patient scored below the age and sex-matched control range (>20/24) 
even 18 months before symptom onset (19/24) and performance continued to deteriorate over 
the next three visits. By 18 months after symptom onset she scored only 11/24. Performance 
was at chance (3/16) for negative emotions (fear, disgust, anger, sadness) but normal (8/8) for 
positive emotions (happiness, surprise).  
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Table 5.4.9 
Summary of neuropsychological assessments 
 
Assessments 1 2 3 4 5 6 7 8 
Years from baseline 0 1 2 3 10 11 12 13 
Years from symptom onset -11.5 -10.5 -9.5 -8.5 -1.5 -0.5 +0.5 +1.5 
MMSE 30 29 NT 29 30 30 28 22 
FAB NT NT NT NT 15 15 17 15 
Verbal IQ 98 109 103 105 105 112 94 85 
Performance IQ 95 88 107 109 104 108 106 108 
Verbal memory (/50)a 42 44 45 43 41 42 43 38* 
Visual memory (/50)b 40 42 46 42 44 46 41 44 
Paired associate learning (/8) NT NT NT NT 8 8 8 5* 
Naming (/30)c 25 23 28 26 26 22 10** 3*** 
Word comprehension (/25)d 24 22 21 24 23 24 21 21 
Word repetition (/15) NT NT NT NT 15 15 15 15 
Calculatione 22/24 19/24 18/24 19/24 8/12 7/12 5/12 6/12 
Visuospatial/perceptual skillsf 26/30 26/30 28/30 27/30 13/15 12/15 12/15 12/15 
Executive functiong pass pass pass pass pass pass pass pass 
Complex facial emotion recognition (/36)h   NT NT NT NT 26 22 22 18 
Simple facial emotion recognition (/24)i NT NT NT NT 19 18 17 11 
 
a and b Warrington Recognition Memory Test for Words (a) and Faces (b); c Graded Naming Test; d Warrington 
Concrete Synonyms Test; e Graded Difficulty Arithmetic Test: total test score out of 24, addition subsection out of 
12; f Silhouettes subtest 2 of Visual Object and Spatial Perception (VOSP) battery: total test score out of 30, objects 
only out of 15; g Modified card sorting test; h The ‘Reading the Mind in the Eyes’ Test Revised Version: control range 
24-34 based on a sample of 18 cognitively-normal females with an average age of 67.5; i Ekman test of facial 
emotion recognition: control range 20-24 based on a sample of 18 cognitively-normal females with an average age 
of 67.5. ***<1st percentile; ** =1st to <5th percentile; * =5th to <25th percentile; NT = not tested 
!
!
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Detailed language assessment  
In order to delineate her language difficulties more precisely, PAF underwent more detailed 
neurolinguistic assessment six months after visit 8 and two years after the onset of symptoms 
(Table 5.4.10). Simple auditory perception as assessed using a phoneme discrimination task 
was intact (Kay et al, 1992). Although still scoring within the normal range there was evidence 
of deterioration on a test of single word comprehension (Warrington et al, 1998) from the 50th 
percentile six months previously to the 10th percentile. The patient could now only name two 
items on the Graded Naming Test, scoring below the 1st percentile (McKenna et al, 1980). On 
a simpler novel test of noun and verb naming she managed to name 14/20 nouns and 13/20 
verbs. On all tests of naming she produced multiple phonemic errors. Single word repetition 
(11 errors/150 words) and sentence repetition (4 errors/20 sentences) were impaired. When 
asked to construct a written sentence based around a single word there were grammatical 
errors in 4 out of 10 written sentences produced. She also had difficulty judging whether 
sentences were grammatical or not (10 errors/30 sentences). Reading was also affected (61/100 
words on the Schonell reading test (IQ equivalent 79) Nelson et al, 1975). There was evidence 
of a phonological dyslexia with difficulty reading non-words (12/20 on the Graded Nonword 
Reading Test; Snowling et al, 1996) but no regularisation errors. Spelling was relatively intact 
(25-50th percentile on the Graded Difficulty Spelling Test; Baxter et al, 1994). 
 
At this assessment, the patient was also noted to have a decreased forwards digit span of 4, 
consistent with dominant parietal lobe involvement, and a backwards digit span of 3. Praxis 
assessment using subtest 3 from the Apraxia Battery for Adults (ABA2 – Dabul, 2000) revealed 
moderate limb apraxia (36/50) and mild orofacial apraxia (42/50). 
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Table 5.4.10 
Detailed neurolinguistic analysis (2 years after symptom onset) 
 
 Score Normal range#/percentile score 
Phoneme discrimination 
(modified version of PALPA 3) 
34/36 Normal range 33-36 
Synonyms test 
Concrete words 
Abstract words 
TOTAL score 
 
17/25 
16/25 
33/50 
 
10th percentile 
10th percentile 
10th percentile 
Sentence comprehension 
(modified version of PALPA 55) 
15/24 Normal range 21-24 
Grammaticality judgment 
test 
20/30 Normal range 25-30 
Graded naming test 2/30 <1st percentile 
Noun and verb naming 14/20 (nouns) 
13/20 (verbs) 
Normal range 18-20 
Normal range 19-20 
Polysyllabic word repetition 139/150 Normal score 150 (all controls score at 
ceiling) 
Sentence repetition 16/20 Normal score 20 (all controls score at ceiling) 
Sentence completion 16/20 Normal range 19-20 
 
Schonell reading test 61/100 5-10th percentile 
Graded nonword reading test 12/20 Normal range 15-20 
Graded difficulty spelling test 17/30 25-50th percentile 
Written sentence construction  6/10 Normal range 8-10 
 
# Normal ranges based on a control sample of 18 cognitively-normal people with an average age of 67.4 consisting 
of 10 males and 8 females. 
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Brain imaging findings (Figures 5.4.2, 5.4.3 and 5.4.4) 
There were no significant changes beyond normal ageing seen over the first four scans. 
However, there was a significant decrease in brain volume (Figs 5.4.2 and 5.4.4) between the 
4th and 5th visit (i.e. between 9 years pre-symptoms and 18 months pre-symptoms). The 5th scan 
(Fig 5.4.2b) showed asymmetrical frontal, temporal and parietal lobe atrophy predominantly 
affecting the left cerebral hemisphere. Progressive atrophy in a similar distribution was present 
on the 6th scan (6 months prior to onset of symptoms: Fig 5.4.2c).  Further analysis of the 
change between the 6th and 7th scans (6 months after the onset of symptoms) with image 
registration based on a fluid model resulting in voxel compression maps (as described in 
Chapter 2; Fox et al, 2001) (Fig 5.4.3) provided further information about the detailed 
distribution of volume change within the hemisphere. There was progressive regional atrophy 
involving the left frontal, temporal and parietal lobes (Figure 5.4.3a). In the frontal lobes there 
was atrophy of the medial superior frontal and frontopolar regions, and involvement of the 
anterior cingulate gyrus. There was marked atrophy of the left temporal pole. The left middle 
and inferior temporal and fusiform gyri were significantly affected, with some atrophy of left 
amygdala, hippocampus and superior temporal gyrus. In the parietal lobes there was relatively 
selective atrophy of the left angular gyrus posteriorly. There was also evidence of left caudate, 
pallidal and thalamic atrophy.  Registration of the 7th and 8th scans (6 and 18 months 
respectively after onset of symptoms) showed a similar pattern but now also with involvement 
of the right hemisphere (Figure 5.4.3b). The most severe change across scans involved 
prefrontal and inferior parietal areas as well as orbitofrontal and inferior temporal areas in the 
left hemisphere. !
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Figure 5.4.2   
Series of five registered T1-weighted MRI images from 8.5 years pre-symptom onset to 1.5 years after symptoms in case PAF: a) Symptom onset -8.5 years; b) Symptom onset -1.5 
years; c) Symptom onset -6 months; d) Symptom onset + 6 months; e) Symptom onset + 1.5 years 
 
2a    2b    2c    2d    2e 
 
 
       
          Symptom onset -8.5 years               Symptom onset -1.5 years       Symptom onset -6 months                 Symptom onset +6 months         Symptom onset +1.5 years 
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Figure 5.4.3 
Sagittal and coronal MRI images in case PAF with voxel-compression-mapping overlay over time period:  a, Symptom onset -6 months to +6 months ; b, Symptom onset +6 months to 
+1.5 years 
 
  
 
 
 
      20%                                        0                                20% 
expanding contracting 
  175 
Figure 5.4.4 shows the change in whole brain (a) and individual hemisphere (b) in graphical 
form. These allow quantification of the regional changes observed on the longitudinal images 
(Figs 5.4.2 and 5.4.3), with involvement of the left hemisphere seen to precede that of the right 
by a number of years. Between the 7th and 8th scans, in addition to a general decrease in left 
hemisphere volume, there is also evidence of right hemisphere involvement (see also Figure 
5.4.3b).    !
Figure 5.4.4 
Whole brain (a) and hemisphere (b) volumes from baseline to 13 years after baseline. 
 
a 
!
b 
!!
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DISCUSSION 
This study describes the presymptomatic clinical, cognitive and imaging changes in GRN-
associated PPA with a longitudinal analysis of a member of family with the C31fs mutation in 
the GRN gene over a thirteen year period from an initial asymptomatic phase through to the 
establishment of clinical disease. Evidence of neuropsychological impairment and brain 
atrophy predated the onset of clinical symptoms by at least 6 months and 18 months 
respectively. In keeping with the cognitive and behavioural phenotype described in the 
previous GRN case in Section 5.4.1 a progressive aphasia and parietal lobe deficits were early 
and salient features in this case. Brain imaging in this case further emphasizes that posterior 
atrophy including temporo-parietal junction areas are an early feature of disease and that 
atrophy is strikingly asymmetrical early in disease (see figures 5.4.2 and 5.4.3).  
 
Correlation of longitudinal clinical, neuropsychological and brain imaging evidence in the 
present case allows us to analyse in greater detail the anatomical and pathophysiological 
effects of GRN-associated disease. Early, strikingly asymmetric involvement of the left cerebral 
hemisphere is a feature both of the cognitive phenotype and the neuroanatomical phenotype as 
assessed on serial MRI (Borroni et al, 2008a). The most severe deficits implicate dominant 
frontal lobe mechanisms mediating word retrieval and propositional speech, parietal lobe 
mechanisms mediating praxis, speech repetition and calculation, and orbitofrontal:anterior 
temporal lobe mechanisms involved in emotion processing (it is noteworthy that the tests used 
to assess emotion recognition in this study both required verbal mediation). The 
neuroanatomical distribution of heaviest disease burden followed the pattern predicted from 
the neuropsychological profile, with earliest and maximal change in prefrontal, inferior 
parietal, orbitofrontal and inferior temporal cortical areas in the left hemisphere. Furthermore, 
these areas form part of non-contiguous but anatomically and functionally linked intra-
hemispheric networks, or pathways: a dorsal pathway linking prefrontal and parieto-temporal 
areas, implicated in the programming of speech and voluntary action (Warren et al, 2005) and 
a ventral pathway (or pathways) linking anterior and inferior temporal areas with inferior 
frontal areas, implicated in different aspects of semantic knowledge, emotion and social 
behaviour (Scott et al, 2003; Adolphs, 2003). Anatomical linkages between the components of 
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these functional pathways have been demonstrated in human tractography and functional 
imaging studies (Catani et al, 2005) and are supported by an extensive literature in non-human 
primates, suggesting that such pathways process distinct aspects of visual and other sensory 
information and behaviour (Ungerleider et al, 1982; Rauschecker et al, 2000).  
 
This case (as well as Case 1 above) also suggests that the pathophysiological profile of GRN-
associated disease arises from progressive breakdown of functionally linked intra-hemispheric 
networks. This would account both for the early involvement of anatomically remote (but 
linked) anterior and posterior areas within a hemisphere, and the striking asymmetry of disease 
burden which can remain largely restricted to a single hemisphere for many years. The 
functional correlates of damage involving the pathways of the right hemisphere are less clear 
than those of left hemisphere disease, but are likely to include deficits of goal-directed 
behaviour (Warren et al, 2005), as observed in other patients with GRN-associated FTLD. At a 
neuronal level it remains to be explained why GRN mutations cause such a phenotype and 
little is known about the normal role of GRN. However, given that GRN acts on wound healing 
and inflammation in the periphery (Ahmed et al, 2007), and has neurotrophic properties in 
vitro (Daniel et al, 2000), it is likely to act as a CNS growth factor. As suggested in Chapter 4, 
one could speculate that asymmetry in the clinical manifestations of GRN null mutation might 
be caused by asymmetrical expression of GRN from the wild-type allele or asymmetrical 
expression of factors that modify the downstream pathogenesis. The breakdown of functionally 
linked networks might be accounted for by interdependency of these neural systems on GRN 
for survival. Future work is needed including larger longitudinal case series, more detailed 
analysis of non-verbal and behavioural deficits in these patients and the use of complementary 
metabolic and functional imaging modalities to assess GRN-associated cerebral dysfunction 
directly.  
!
!
!
!
!
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5.5 Alzheimer pathology and primary progressive aphasia 
As discussed in Chapters 5.1 and 5.2, whilst most cases of PPA have a pathological substrate 
within the frontotemporal lobar degeneration spectrum, i.e. associated with tau- or TDP-43-
positive cellular inclusions (Knibb et al, 2006; Snowden et al, 2007a), it has long been 
recognised that PPA syndromes may be associated with Alzheimer’s disease (AD) pathology 
(Pogacar et al, 1984; Green et al, 1990; Kempler et al, 1990; Karbe et al, 1993; Greene et al, 
1996; Li et al, 2000; Clark et al, 2003) and in recent years more detailed series have been 
reported (Galton et al, 2000; Croot et al, 2000; Davies et al, 2005; Knibb et al, 2006; Alladi et 
al, 2007; Josephs et al, 2008b; Mesulam et al, 2008). Some studies have suggested that the 
most common aphasia phenotype of AD is LPA (Gorno-Tempini et al, 2008; Rabinovici et al, 
2008; Mesulam et al, 2008), however both PNFA and SD have also been reported, as have 
syndromes that do not fit clearly into a single category, so-called “mixed” aphasia (Knibb et al, 
2006; Alladi et al, 2007). The study described in this Chapter aimed to review the clinical, 
neuropsychological and cross-sectional neuroimaging features of a retrospective series of 
fourteen patients with a clinical diagnosis of PPA and AD pathology either demonstrated 
directly or presumed on the basis of cerebrospinal fluid (CSF) biomarker profile and compare 
them to previously published series of PPA patients with either pathologically-confirmed AD or 
a positive PIB-PET scan suggestive of AD. 
 
METHODS 
A retrospective review of patients with a diagnosis in the PPA spectrum who had attended the 
Specialist Cognitive Disorders Clinic, Queen Square, London, UK, and who had donated their 
brains for post-mortem analysis or who had had a brain biopsy during life was performed. 
Those who also had either AD pathology at post-mortem/cerebral biopsy were included. In 
total, 9 patients had pathologically-confirmed Alzheimer’s disease (seven who came to post-
mortem and two with a cerebral biopsy). Also included in this study were the five patients 
described in Chapters 5.2 and 5.3 who had CSF biomarker data consistent with Alzheimer 
pathology (raised CSF total tau level with reduced amyloid A!42 fraction: Hulstaert et al, 
1999). Clinical notes and neuropsychological data were reviewed in all cases. The clinical 
diagnosis at the time the patient was assessed and a revised clinical diagnosis based on current 
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criteria were recorded in each case. Demographic, clinical and pathological data for patients 
are presented in Table 5.5.1; neuropsychological data are presented in Table 5.5.2. 
 
Brain image acquisition and volumetric measurements were performed as in Chapter 2. The 
two disease groups and the healthy control group were compared statistically based on 
contrasts between the group means using a linear regression model in STATA 10.0. Changes in 
imaging patterns with severity were investigated using cortical reconstruction and thickness 
estimation methods as described in Chapter 2.3. Performance on the Graded Naming Test 
(McKenna et al, 1980) (i.e. degree of anomia) was used as a measure of disease severity, 
splitting the group according to their score: group 1 (moderately anomic: 9 patients) scored > 0 
(mean 7.7, standard deviation 9.2) and group 2 (severely anomic: 4 patients) were unable to 
score. One patient with greater right than left hemisphere atrophy was not included in this 
analysis. Effect size maps were generated based on the difference in mean thickness in each of 
these severity subgroups and in the whole group, comparing each to the controls and 
expressing the disease-control difference as a percentage of the mean control group thickness.  !
RESULTS 
 
Clinical and neuropsychological features 
All patients had language impairment as their primary presenting feature. This was usually 
difficulty finding words although one patient complained of a return of a childhood stutter 
shortly before the onset of word-finding difficulties. Spontaneous speech was relatively 
nonfluent and occasional phonemic errors were made by all patients, with occasional 
emergence of neologistic jargon errors. None of the patients was described as having had 
apraxia of speech. All of the patients who came to post-mortem or had a cerebral biopsy had 
initially received a diagnosis of PPA, PNFA or language variant frontotemporal lobar 
degeneration although prior to death the diagnosis in two of these cases was changed to 
atypical language variant of AD. The five patients with CSF biomarkers consistent with AD 
were ascertained more recently and had been diagnosed with LPA. On review of the clinical 
notes of the seven patients who came to post-mortem and the two patients with cerebral 
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biopsy-proven AD, all of those cases would also have met criteria for LPA. A family history of 
dementia was present in only two cases: these patients each had a single parent with a 
diagnosis of Alzheimer’s disease in the eighth decade. Myoclonus was noted in two patients 
and two patients developed generalized seizures. One patient exhibited axial rigidity late in the 
course of the disease; no other features of parkinsonism or motor neurone disease were present 
in this series. Behavioural impairment was unusual early in the illness but aggression, anxiety 
and irritability were noted in some patients later in the course. 
 
Neuropsychological assessment showed severely impaired digit span in all but three patients, 
who scored in the low (but not defective) range. Naming was in the impaired range at initial 
assessment in over half of the patients and became impaired in all cases as the disease 
progressed. Single word comprehension was impaired in the more severely affected patients. 
None of the patients complained of episodic memory impairment at presentation, however 
verbal memory was impaired in eight of eleven patients tested while visual memory was 
affected less frequently (five of fourteen patients). Reading was affected in most patients and 
some were noted to have a phonological dyslexia. Limb apraxia and dyscalculia were noted in 
most patients however visuospatial skills were intact in all but one severely affected patient. 
Executive dysfunction was also seen in most patients.  
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Table 5.5.1  
Demographic, symptom and pathology data: shaded cases are patients with CSF data consistent with AD, non-shaded cases are pathologically-confirmed cases 
 
Patient 
Age at 
Onset 
(years) 
Total 
duration 
(years) 
First symptom Other linguistic symptoms 
Neurological and 
behavioural symptoms 
CSF Tissue pathology 
AD-PPA1 
59 9.3 
Word-finding difficulty 
Phonemic errors, later 
comprehension problems 
Myoclonus and seizures N/A 
Braak VI, CERAD frequent plaques, Reagan 
high 
AD-PPA2 
54 8.1 
Word-finding difficulty 
Phonemic errors, sentence 
repetition impairment 
Seizures 
 
N/A 
Braak VI, CERAD frequent plaques, Reagan 
high. 
Mild cerebral amyloid angiopathy AD-PPA3 50 6.3 Word-finding difficulty Phonemic errors Myoclonus N/A 
Severe pathology  frequent plaques and 
tangles. Extensive amyloid angiopathy. 
AD-PPA4 
62 5.2 
Return of childhood 
stutter 
Word-finding difficulty, 
phonemic and jargon errors 
Nil other noted N/A 
Braak VI, CERAD frequent plaques, Reagan 
high. 
Severe cerebral amyloid angiopathy AD-PPA5 66 9.7 Word-finding difficulty 
Phonemic errors, sentence 
repetition impairment 
Nil other noted N/A 
Braak VI, CERAD frequent plaques, Reagan 
high. 
Severe cerebral amyloid angiopathy AD-PPA6 50 7.2 Word-finding difficulty 
Phonemic and jargon errors, 
later comprehension problems 
Later aggressive 
behaviour 
N/A 
Braak VI, CERAD frequent plaques, Reagan 
high. 
AD-PPA7 
54 8.9 
Word-finding difficulty Phonemic errors 
Later axial rigidity 
Later aggressive 
behaviour 
 
N/A 
Braak VI, CERAD frequent plaques, Reagan 
high. 
AD-PPA8 
50 N/A 
Word-finding difficulty Phonemic errors Anxiety N/A 
Cerebral biopsy: Frequent plaques and 
tangles 
AD-PPA9 
48 N/A 
Word-finding difficulty Phonemic errors Nil other notes N/A 
Cerebral biopsy: Frequent plaques and 
tangles 
AD-PPA10 
60 N/A 
Word-finding difficulty Phonemic errors 
Later anxiety, irritability 
and disinhibition 
tau>1200 ng/l, 
A!42 195 ng/l 
N/A  
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AD-PPA11 
53 N/A 
Word-finding difficulty Phonemic errors Irritability 
tau 1146 ng/l , 
A!42 250 ng/l 
N/A  
AD-PPA12 
63 N/A 
Word-finding difficulty Phonemic errors Anxiety and apathy 
tau 1124 ng/l , 
A!42 299 ng/l  
N/A  
AD-PPA13 
59 N/A 
Word-finding difficulty Phonemic errors 
Irritability, restlessness 
and agitation 
tau 986 ng/l , 
A!42 138 ng/l  
N/A  
AD-PPA14 
58 N/A 
Word-finding difficulty 
Phonemic and jargon errors, 
later comprehension problems 
Anxiety 
tau 986 ng/l , 
A!42 130 ng/l  
N/A  
!
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Table 5.5.2 
Neuropsychological data 
 
Patient 
Duration  
at  
assessment 
MMSE VIQ PIQ Naming 
Single word 
comprehension 
Digit 
span 
forwards 
Verbal 
memory 
Visual 
memory 
Reading 
Limb 
praxis 
Calculation 
Visuospatial 
skills 
Executive 
function 
AD-PPA1 4.1 17 
 
61 74 - - - + + - (phon) - - + + 
AD-PPA2 3.7 26 83 99 + + - - + NT - - + - 
AD-PPA3 2.8 17 66 64 + + - - + NT - - + - 
AD-PPA4 3.2 4 Unable Unable - - - - - - (phon) - - - - 
AD-PPA5 4.0 21 84 68 - + + - - + - - + - 
AD-PPA6 3.1 27 79 122 + + - + + - (phon) NT + + + 
AD-PPA7 3.1 20 70 107 - + - + + - NT - + + 
AD-PPA8 2.3 18 61 79 + + - - + + - + + - 
AD-PPA9 2.3 NT 85 91 + + - - + - - + + - 
AD-PPA10 5.4 8 NT NT - - - NT + - (phon) - - + - 
AD-PPA11 3.0 21 79 80 + + + - - + - - + - 
AD-PPA12 3.1 17 81 84 - + + - - - (phon) - - + - 
AD-PPA13 3.9 16 62 77 - - - NT + - (phon) - - + - 
AD-PPA14 4.8 8 NT NT - - - NT - - (phon) - - + - 
 
+ represents intact function, - represents impaired function i.e. a score below the 5th percentile on testing; for reading score (phon) represents the presence of a phonological dyslexia; 
NT = not tested   Verbal IQ (VIQ) and Performance (PIQ) scores are taken from the WAIS-R.  Verbal and visual memory were tested with the Warrington Recognition Memory Test for 
Words and Faces, naming with the Graded Naming Test, single word comprehension with the WAIS-R vocabulary subtest or Warrington synonyms test, reading with the National Adult 
Reading Test or Schonell reading test, visuospatial skills with the Visual Object and Space Perception battery, digit span with the WAIS-R digit span subtest, calculation with the Graded 
Difficulty Calculation Test (GDCT) and executive function with the Weigl or Wisconsin Modified Card Sorting Tasks or Stroop task.  
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Pathological features 
Six of the seven patients who came to post-mortem had severe Alzheimer pathology with Braak 
stage VI and CERAD frequent plaques. For the seventh case, no staging information was 
available but it had been reported as showing severe Alzheimer pathology with frequent 
plaques and tangles. Four cases were also noted to have cerebral amyloid angiopathy. The two 
patients who had cerebral biopsies were noted to have frequent amyloid plaques and 
neurofibrillary tangles.  
 
Neuroimaging features 
Volumetric MRI data for patients and an age- and gender matched group of 20 cognitively-
normal controls are presented in Table 5.5.3: whole brain and hemisphere volumes were 
smaller than controls and there was evidence of left/right hemispheric asymmetry at group 
level and in all but one of the individual patients; one (right-handed) patient showed reverse 
asymmetry. Asymmetry became more marked with increasing disease duration (Figure 5.5.1, 
R=0.55, p=0.04).  
 
Table 5.5.3 
Volumetric cross-sectional data 
 
 Controls AD-PPA 
Number of subjects 23 14 
Duration of disease at scan N/A 4.1 (1.0) 
Age at baseline scan (years) 63.5 (7.3) 60.2 (6.2) 
Brain volume (ml) 1160.1 (96.5) 1083.7 (109.1)a 
Left hemisphere volume (ml) 570.9 (46.7) 526.4 (57.0)a 
Right hemisphere volume (ml) 571.3 (46.9) 547.9 (50.6) 
Left/right hemisphere ratio 1.00 (0.01) 0.96 (0.03)a 
 
ap<0.05 AD-PPA significantly worse than controls !
  185 
 
Figure 5.5.1  
Asymmetry ratio (left:right hemisphere volumes) as a function of disease duration in years  
 
!!
In the cortical thickness analysis versus healthy controls group 1 (with less severe disease) 
showed areas of cortical thinning predominantly in the left hemisphere, most marked in the 
inferior parietal and posterior superior temporal lobes (Figure 5.5.2). Other areas involved in 
the left hemisphere were posterior cingulate, precuneus, medial temporal lobe and prefrontal 
cortex. In the right hemisphere, only the posterior cingulate and precuneus and a small area in 
the medial temporal lobe were affected. In group 2 with more severe anomia, cortical thinning 
remained asymmetrical but was more extensive within both hemispheres. In the left 
hemisphere there was additional involvement of anterior superior and middle temporal lobe, 
posterior medial temporal lobe and inferior frontal lobe areas (Figure 5.5.2). In the right 
hemisphere there was involvement of areas similar to those initially involved in the left 
hemisphere, i.e. lateral parietal, posterior superior temporal, posterior cingulate, precuneus, 
medial temporal and prefrontal cortices. 
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Figure 5.5.2  
Patterns of cortical thinning in the AD-PPA groups versus healthy controls, categorized by severity of 
anomia: group1 (less severe: A), group 2 (most severe: B), For each hemisphere, the top panels are 
lateral views, the bottom panels medial views. Percentage thinning maps are shown; the coloured bar 
represents percentage values. 
 
 
 
Review of previous cases of PPA with AD pathology 
Previous series from five research groups have reported PPA patients with either pathologically-
confirmed AD or a positive PIB-PET scan showing amyloid deposition (Galton et al, 2000; 
Croot et al, 2000; Davies et al, 2005; Kertesz et al, 2005; Knibb et al, 2006; Alladi et al, 2007; 
Josephs et al, 2008; Mesulam et al, 2008; Gorno-Tempini et al, 2008; Rabinovici et al, 2008; 
Pereira et al, 2009). Prior to the detailed description of LPA (Gorno-Tempini et al, 2004a), 
patients with both PNFA and SD were reported with AD pathology but since its recognition 
LPA has been the clinical syndrome most closely associated with AD pathology: in one series 
all patients with LPA versus one of six patients with PNFA and one of five patients with SD had 
positive PIB-PET scans (Rabinovici et al, 2008).  It is unclear whether older series included 
patients that would now be described as having LPA. Some studies of PNFA patients with 
motor speech deficits (e.g. apraxia of speech) show an association with FTLD-tau rather than 
AD pathology (Josephs et al, 2006), while a clinical syndrome of SD has been associated 
chiefly with type 1 TDP rather than AD pathology (Alladi et al, 2007; Snowden et al, 2007). 
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The SD syndrome underpinned by AD may be associated with asymmetrical temporal lobe 
atrophy focused on the left hippocampus and superior temporal lobe, rather than the temporal 
pole and anteroinferior temporal lobe as in classical SD caused by TDP pathology (Pereira et 
al, 2009; Chan et al, 2001b).!!
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Table 5.5.4 
Previously reported series of patients with a primary progressive aphasia and Alzheimer pathology 
 
Series 
N with  
pathologically-confirmed AD 
PPA diagnosis %male 
Age at 
onset 
Duration 
Age at 
death 
Pereira et al, 2009* 3 3 SD 66.7 NA NA NA 
Rabinovici et al, 2008^ 0 but 6 with positive PIB-PET scan 4 LPA, 1 SD, 1 PNFA NA NA NA NA 
Gorno-Tempini et al, 2008^ 0 but 4 with positive PIB-PET scan 4 LPA 25.0 NA NA NA 
Mesulam et al, 2008 11 7 LPA, 1 SD, 3 “mixed” 63.6 61.8 (10.8) NA 73.2 (7.0) 
Josephs et al, 2008 5 
5 "fluent aphasia"  
("1 or 2  may meet criteria for logopenic PPA") 
60.0 69 (12) NA 77 (13) 
Alladi et al, 2007* 19 
12 PNFA, 2 SD, 5 "mixed" 
(“ mixed” cases include 3 LPA, 2 atypical SD with phonological deficits) 
NA 65.7 (8.1) 7.4 (2.9) NA 
Knibb et al, 2006* 12 7 PNFA, 5 SD NA NA NA NA 
Kertesz et al, 2005 8 8 PPA (including PNFA and LPA) NA NA NA NA 
 
*from same research group and cases may overlap in different series. Note earlier series which include AD-PPA cases are Davies et al, 2005; Croot et al, 2000 and Galton et al, 2000 
^from same research group and cases may overlap in different series 
NA  not available 
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DISCUSSION 
This study describes a series of fourteen patients with PPA in association with proven or 
probable AD pathology. The key clinical features of the cases in this series were initial 
presentation with word-finding difficulty, and relatively non-fluent spontaneous speech with 
occasional phonemic errors but without motor speech impairment. Reviewing the diagnoses in 
this series revealed that all cases fulfilled (or would likely have fulfilled) descriptive criteria for 
LPA (Gorno-Tempini et al, 2004a; Gorno-Tempini et al, 2008).  The neuropsychological 
findings of impaired digit span, dyscalculia, limb apraxia and phonological dyslexia were 
consistent with LPA (Amici et al, 2006; Brambati et al, 2009a). However, verbal memory, 
although not a presenting feature in any of the patients, was also affected in most cases: this 
feature has not been emphasised in previous studies of LPA. In contrast, visuospatial processing 
(a right hemisphere function) was generally well preserved. Cross-sectional brain imaging 
revealed asymmetrical left-sided atrophy predominantly affecting the posterior superior 
temporal lobe and inferior parietal lobe but also the posterior cingulate, precuneus and medial 
temporal lobe: these features corroborate previous neuroanatomical findings in LPA (Gorno-
Tempini et al, 2004a; Gorno-Tempini et al, 2008). In more severe disease there was evidence 
of atrophy spread to the left frontal lobe, more anterior left temporal lobe areas as well as 
posterior superior temporal lobe, inferior parietal lobe and posterior cingulate areas within the 
right hemisphere.  
 
The nosology of language impairment with AD pathology remains controversial. Such patients 
have been classified either as having the clinical/neuropsychological description of PPA (with 
LPA the most common phenotype) or having the predictive clinico-pathological description of 
an atypical ‘language variant’ within the AD spectrum. However, there should not be any 
conflict between these two descriptions as they are essentially at two different levels of 
classification. With this said, predicting which patients with a PPA syndrome will have AD 
pathology is not always easy during life (in the absence of a PIB-PET scan or CSF markers 
suggestive of AD): while the extent of involvement of other cognitive domains may be helpful, 
the present evidence suggests that the presence and severity of extra-linguistic impairments 
depends on disease stage. Furthermore, the clinical salience of these additional impairments is 
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variable: in this series, a number of patients who performed poorly on episodic memory tasks 
did not complain of amnestic symptoms, whereas two patients who came to post-mortem 
exhibited widespread cognitive impairment prompting a reformulation of the clinical diagnosis 
as an atypical language variant of AD. It seems that the presenting syndrome at early disease 
stage is likely to provide the more rational basis for classifying language dysfunction associated 
with AD, particularly as language impairments are very common as ‘typical’ AD advances. 
This distinction is clinically important, as recognition of PPA features that predict AD pathology 
could help direct the use of investigations such as CSF and PIB-PET, and ultimately, the 
selection of patients for clinical trials and disease-modifying therapies.  
 
An outstanding neurobiological question concerns the overlap of LPA/atypical language-
presentation AD with typical amnestic AD (and with other atypical variants of AD such as 
posterior cortical atrophy). Neuropsychologically, there are few data to compare amnestic-
onset AD with atypical language variants but studies of language impairment in typical AD 
have shown that patients can be logopenic with an early anomia, and that phonological and 
semantic impairments also occur (Harasty et al, 1999; Harasty et al, 2001; Garrard et al, 2001; 
Blair et al, 2007; Taler et al, 2008a; Chertkow et al, 2008; Peters et al, 2009). Motor speech 
impairment (apraxia of speech) has been reported only rarely in association with AD (Gerstner 
et al, 2007). From an anatomical perspective, LPA is associated with asymmetrical atrophy 
compared to the relatively symmetrical atrophy of amnestic AD (Gorno-Tempini et al, 2004a). 
However, certain key areas of atrophy or cortical thinning are implicated in both LPA-AD and 
typical AD, i.e. the temporo-parietal junction, the precuneus and the medial temporal lobe 
(Scahill et al, 2002). The present study has certain limitations, including relatively small patient 
numbers, retrospective ascertainment, and most importantly, lack of uniform histopathological 
confirmation. Taking these caveats into account, the present evidence in conjunction with 
previous work suggests that the LPA syndrome might be regarded, very broadly, as a ‘uni-
hemispheric’ presentation of AD: further detailed longitudinal prospective studies comparing 
amnestic and language presentations of AD are needed in order to elucidate the 
pathophysiological mechanisms that instigate and sustain neuropsychological and anatomical 
asymmetry. It will also be useful to investigate the neuropathological findings of a 
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prospectively studied cohort of patients with detailed neurolinguistic testing to identify 
associations between pathology and different PPA syndromes. 
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5.6 Atypical parkinsonian disorders and nonfluent aphasia 
The overlap of nonfluent aphasia and corticobasal syndrome (CBS) has been well-described 
(Graham et al, 2003) but more recently, cases have been reported with a progressive 
supranuclear palsy (PSP) syndrome. This has both clinical and neurobiological importance: 
clinically it is important to recognize that a PSP syndrome may later develop in nonfluent 
aphasia in order to provide useful prognostic information, whilst neurobiologically it is 
important to study how language impairment develops in what is classically considered a 
‘subcortical dementia’ and how the neuroanatomy of aphasia in PSP compares with other 
related syndromes. This study aimed to investigate prospectively the clinical, 
neuropsychological and neuroimaging features of patients presenting with PNFA who 
subsequently developed characteristic features of PSP. The clinical and neuroanatomical 
characteristics of these cases were compared with established cases of PNFA without PSP 
syndrome and with pathologically confirmed classical PSP (Richardson’s syndrome, PSP-RS) 
cases without speech or language impairment.  
 
METHODS 
This study was performed subsequently to Chapters 5.2 and 5.3 with fourteen consecutive 
patients presenting with a clinical syndrome of PNFA investigated. 
 
Clinical assessment 
All patients had a structured clinical history, neurological examination, Mini-Mental State 
Examination (MMSE, Folstein et al, 1975) and Frontal Assessment Battery (FAB, Dubois et al, 
2000). Clinical features of a PSP syndrome at presentation or developing subsequently were 
recorded (Litvan et al, 1996; Litvan et al, 2003): these cases are referred to hereafter as ‘PSP-
PNFA’, while ‘PNFA’ is used to refer to those cases not developing a PSP syndrome. All 
patients with clinical features of PSP-PNFA were further assessed using the activities of daily 
living (part II) and motor (part III) components of the Unified Parkinson’s Disease Rating Scale 
(UPDRS). In addition the severity of any gaze abnormality was assessed (Payan et al, 2002; 
Blain et al, 2006). 
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Neuropsychological assessment 
A neuropsychological battery with a neurolinguistic focus was administered to all patients and 
to 14 cognitively-normal control subjects (matched for age and gender; Table 5.6.1). 
Background neuropsychological tests comprised a general (nonverbal) intelligence test 
(Raven’s Advanced Progressive Matrices, Raven et al, 2003) and tests assessing focal cognitive 
domains including episodic memory (Camden Pictorial Recognition Memory Test, Warrington, 
1996), visuoperceptual skills (the Object Decision subtest of the Visual Object and Space 
Perception Battery, VOSP, Warrington et al, 1991) and executive function (Trail Making Test, 
Reitan, 1959).   Limb apraxia was assessed as part of the clinical examination. 
 
The neurolinguistic component of the battery assessed a number of key speech and language 
functions. Spontaneous speech was analysed from a sample obtained by asking subjects to talk 
about their last holiday and to describe the Cookie Theft Scene from the Boston Diagnostic 
Aphasia Examination (Goodglass et al, 1983). This sample was recorded and subsequently 
transcribed and analysed for the number of words produced per minute, number of speech 
production (i.e. phonemic or phonetic) errors and agrammatic (incorrect tense/plural) errors 
made per minute and presence and severity of AOS (mild, moderate or severe). Naming was 
assessed using the Graded Naming Test (McKenna et al, 1980) whilst comprehension was 
evaluated using the Warrington synonyms test for single words (Warrington et al, 1998) and a 
shortened version of the PALPA55 test for sentences (Kay et al, 1992). Repetition of mono- and 
polysyllabic words and sentences was also tested. Reading was assessed using a 30-item 
irregular word reading test as well as the Graded Nonword Reading Test (Snowling et al, 
1996), and spelling was evaluated with the Graded Difficulty Spelling Test (Baxter et al, 1994). 
Comparisons between the groups were performed using a linear regression model (STATA 
10.0). 
 
Brain imaging analysis  
All patients and control subjects had volumetric T1-weighted MR brain images as described in 
Chapter 2. Five patients with pathologically-confirmed PSP-RS without a PNFA syndrome 
during life who had been imaged on the same scanner with the same MRI volumetric protocol 
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constituted an additional comparison group. This group comprised four males and one female 
with a mean age at scan of 68.9 years (standard deviation 4.0). Estimated mean duration from 
symptom onset was 4.4 (standard deviation 1.3) years. Image analysis was performed as 
described in Chapter 2 with whole brain volumes measured. Manual segmentation of the 
midbrain was conducted to determine the midbrain volume (Paviour et al, 2006). Brain and 
midbrain volumes were expressed as a percentage of the total intracranial volume.  
 
Cortical reconstruction and thickness estimation was performed as described in Chapter 2. A 
vertex-by-vertex analysis using a general linear model was performed to examine differences in 
cortical thickness between the disease groups and the control group.  Cortical thickness, C, 
was modelled as a function of group, controlling for age and gender by including them as 
nuisance covariates. Contrasts of interest between the estimates of the group parameters were 
assessed using two-tailed t-tests. Maps showing statistically significant differences between the 
groups were generated and for the comparison with controls, corrected for multiple 
comparisons by thresholding the images of t-statistics to control the False Discovery Rate (FDR) 
at a 0.05 significance level.  
 
Literature review 
In order to assess the present series in relation to previously reported cases of PSP with PNFA, a 
search of the published literature using the MEDLINE internet database 
(www.ncbi.nlm.nih.gov/sites/entrez/) was conducted and the keywords “PSP”, “progressive 
supranuclear palsy”, “gaze palsy”, “PNFA”, “FTLD”, “PPA”, “apraxia of speech”, “progressive 
aphasia” and “aphasia”, in isolation and in combination. For all papers identified, the clinical 
details of all cases with pathological confirmation were abstracted. Age at onset, disease 
duration and age at death were recorded as well as clinical features at presentation and later in 
the disease course. Whether the cases would meet current research criteria for a diagnosis of 
PSP (Litvan et al, 2003) was also recorded. 
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RESULTS 
 
Clinical features 
Four of 14 patients presenting with PNFA exhibited clinical features of PSP. Each of these 
patients had initially developed speech production impairment and only later in the disease 
course developed features of PSP. Over the same time period two other patients with PNFA 
developed features of a corticobasal syndrome (Boeve et al, 2003b). The group of PSP-PNFA 
cases and the group of other PNFA cases were comparable in terms of age, gender, and clinical 
disease duration (Table 5.6.1). Features of the four PSP-PNFA cases are summarized in Table 
5.6.4. In these cases the mean time from onset of language symptoms to development of 
features of PSP was 4.9 years (range 3.0 to 8.5 years) for gaze palsy and 4.0 years (range 1.0 to 
8.0 years) for falls. The patients with PSP-PNFA had mean (standard deviation) scores of 20.0 
(6.3) for UPDRS part II and 30.5 (15.8) for UPDRS part III compared to the scores for the five 
patients with pathologically proven PSP of 18.0 (7.2) for part II and 17.2(7.2) for part III. The 
four PSP-PNFA subjects had clear supranuclear abnormalities of their eye movements with 
slow and hypometric vertical and horizontal saccades of similar severity to the cases with 
pathologically proven PSP. 
 
Neuropsychological assessment  
The pattern of neuropsychological and neurolinguistic deficits exhibited by patients with PSP-
PNFA was similar to other PNFA patients (Tables 5.6.1 and 5.6.2). On the general 
neuropsychological assessment (Table 5.6.1), relative to healthy controls both groups had 
impaired executive function and reduced digit span but intact visuoperceptual skills. The PSP-
PNFA group had mildly impaired performance on a recognition memory task, and a higher 
incidence of limb apraxia than the other PNFA cases. On the detailed neurolinguistic 
assessment (Table 5.6.2), spontaneous speech analysis was broadly similar in both disease 
groups. PSP-PNFA and PNFA cases showed similar mean severity of apraxia of speech and 
number of agrammatic errors. However, the mean overall speech rate (words / minute) was 
substantially (though non-significantly) lower in the PSP-PNFA group than in the other PNFA 
cases, while speech production errors were significantly more frequent than healthy controls 
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only in the PNFA group. Relative to healthy controls, performance on comprehension, 
repetition and reading tasks was impaired in the PNFA group but not the PSP-PNFA group, 
however the performance of the two disease groups did not differ significantly. Spelling was 
significantly more impaired in the PNFA group than the PSP-PNFA group. 
 
Table 5.6.1  
Neuropsychological data in patients and healthy controls 
 
  PSP-PNFA PNFA without PSP Controls 
Number of subjects 4 10 14 
%Male 75% 70% 57% 
Age (years) 71.2 (5.8) 72.0 (7.4) 69.7 (4.7) 
Age at onset (years) 66.0 (6.8) 66.4 (7.9) N/A 
Duration from onset of language symptoms (years) 5.2 (2.5) 5.6 (2.1) N/A 
MMSE score (/30) 26.5 (2.4) 23.0 (6.2)a 29.6 (0.9) 
FAB score (/18) 8.3 (3.9)a 11.0 (4.2)a 17.8 (0.4) 
Ravens Advanced Matrices IQ 96.3 (23.2)a 94.5 (18.5)a 113.6 (9.9) 
Camden Pictorial Recognition Memory Test (/30)    27.5 (3.0)a,b 29.5 (0.8) 29.6 (0.9) 
Trail making test A (scaled score) 2.5 (1.6)a 4.0 (2.2)a 9.7 (2.8) 
Trail making test B (scaled score) 4.2 (2.1)a 3.7 (3.2)a 9.8 (2.8) 
VOSP Object Decision (/20) 16.5 (4.5) 16.4 (2.3) 17.1 (2.4) 
Limb apraxia (% of cases) 75% 40% 0% 
Digit span forwards 5.0 (1.2)a 4.7 (1.3)a 7.0 (0.6) 
 
ap<0.05 disease group worse than controls, bp<0.05 PSP-PNFA worse than PNFA without PSP 
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Table 5.6.2    
Neurolinguistic data in patients and healthy controls 
 
 PSP-PNFA* PNFA without PSP Controls 
Words/minute 21.0(12.6)a 40.3 (18.1)a 133.9 (22.9) 
Speech production errors/min 0.2 (0.3) 1.5 (1.7)a 0.0 (0.0) 
Agrammatic errors/min 0.8 (0.1)a 0.6 (0.5)a 0.0 (0.0) 
Apraxia of speech severity (/3) 1.8 (1.0)a 1.8 (0.9)a 0.0 (0.0) 
Naming (/20) 13.5 (9.1)a 11.3 (6.4)a 19.7 (0.7) 
Warrington synonyms test (/50) 40.0 (1.4)a 38.1 (6.9)a 48.6 (1.3) 
Modified PALPA 55 test  (/24) 20.0 (13.5)a 19.2 (4.3)a 23.4 (0.9) 
Single word repetition (/30) 22.5 (15.0) 22.0 (10.8)a 29.8 (0.4) 
Sentence repetition (/10) 6.8 (4.6) 5.3 (4.6)a 10.0 (0.0) 
Irregular word reading test (/30) 20.0 (13.5) 15.2 (8.1)a 28.0 (1.8) 
Graded difficulty nonword reading test (/20) 11.3 (8.4)a 8.1 (5.7)a 19.6 (0.7) 
Graded difficulty spelling test (/30) 24.7 (3.2) 7.6 (7.8)a,b 25.6 (2.8) 
 
ap<0.05 disease group worse than controls, bp<0.05 PNFA without PSP worse than PSP-PNFA  
*One PSP-PNFA case was mute at the time of assessment 
!
Brain imaging analysis (Table 5.6.3 and Figures 5.6.1 and 5.6.2) 
Mean total brain volume as a percentage of intracranial volume was significantly smaller than 
controls only in the PNFA group. Mean midbrain volume was smaller than controls in the PSP-
PNFA and PSP-RS groups. Mean midbrain volume in the PSP-PNFA group was significantly 
smaller than the PNFA group but significantly larger than the PSP-RS group (Table 5.6.3).  
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Table 5.6.3  
Brain volumetric data in patients, controls and a pathologically-confirmed group of patients with 
classical PSP (PSP-RS) 
 
  
PSP-PNFA 
(n=4) 
PNFA without PSP 
(n=10) 
PSP-RS 
(n=5) 
Controls 
(n=14) 
Brain volume (% of TIV) 65.2 (5.9) 62.1 (4.9)a 65.4 (4.1)
 
69.4 (4.2) 
Midbrain volume (% of TIV) 4.2 (0.5)a,b 5.2 (1.0) 3.1 (0.5)
a,c,d 
5.3 (0.6) 
 
ap<0.05 disease group smaller than controls, bp<0.05 PSP-PNFA smaller than PNFA without PSP, cp<0.05 PSP  (RS) 
smaller than PSP-PNFA v, dp<0.05 PSP (RS) smaller than PNFA without PSP !
Cortical thickness maps showed a characteristic pattern of predominantly left hemispheric 
atrophy in the PNFA group compared to the control group with most significant thinning of 
inferior frontal and superior temporal cortices (Figure 5.6.1A). The PSP-PNFA group had 
significant cortical thinning mainly in the left inferior and superior frontal lobe (Figure 5.6.1B). 
There were no significant areas of cortical thinning in the PSP-RS group compared to controls. 
There were no significant differences in cortical thickness between any of the disease groups 
when compared directly and corrected for multiple comparisons. Uncorrected significance 
maps and percentage thickness difference maps between groups are shown in Figure 5.6.2: 
cortical thickness was reduced in bilateral prefrontal areas in PSP-PNFA compared to PNFA 
(blue areas in Figure 5.6.2A); in a more extensive network of predominantly left-sided and 
mainly prefrontal areas in PSP-PNFA versus PSP-RS (blue areas in Figure 5.6.2B); and in 
superior and mid-temporal and posterior peri-Sylvian areas in PNFA versus PSP-PNFA 
(red/yellow areas in Figure 5.6.2A); there were no significant areas (at an uncorrected level of 
p=0.05) of cortical thinning in PSP-RS versus PSP-PNFA (Figure 5.6.2B).  
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Figure 5.6.1  
Cortical thickness maps showing patterns of cortical thinning in disease groups (yellow/red) compared 
to controls (blue): A) PNFA without PSP and B) PSP-PNFA. No significant areas of thinning were seen in 
a comparison of PSP-RS and controls. Left hemisphere is shown above, right hemisphere below; for 
each hemisphere, the top panels are lateral views, the bottom panels medial views. Coloured bar 
represents FDR corrected p-values.   
 
 
 
 
 
 
 
 
 
 
  200 
Figure 5.6.2  
Cortical thickness maps showing patterns of cortical thinning in disease comparisons: A) PNFA without 
PSP (yellow/red) versus PSP-PNFA (blue) and B) PSP-PNFA (blue) versus PSP-RS. Left hemisphere is 
shown above, right hemisphere below with lateral views shown. Left sided pictures represent 
significance maps with coloured bar representing uncorrected p-values; right-sided maps represent 
percentage thinning maps with coloured bar representing a percentage value. 
 
 
 !
Summary of published literature 
A total of 12 cases of PSP presenting with a speech production disorder from seven separate 
studies were identified (Table 5.6.4: Boeve et al, 2003; Josephs et al, 2005; Josephs et al, 2006; 
Karnik et al, 2006; Mochizuki et al, 2003; Wakabayashi et al, 2000; Perkin et al, 1978). The 
diagnosis during life in these cases was most commonly recorded as PNFA, nonfluent 
dysphasia, PPA or AOS. Ten of the 12 cases were examined at post mortem and five classified 
as having typical PSP pathology. Atypical PSP pathology, or combinations of pathological 
abnormalities with PSP as the predominant diagnosis were identified in the five remaining 
cases (Table 5.6.4). The age at onset, disease duration and age at death of these cases did not 
differ significantly from other phenotypes of pathologically-proven PSP (classical PSP or 
Richardson’s syndrome, PSP-RS, PSP-Parkinsonism or PSP-P and pure akinesia with gait 
freezing or PAGF: data from Williams et al, 2005; Williams et al, 2007) (Table 5.6.5). However 
disease duration was closer to the classical PSP phenotype (RS) than to PSP-P or PAGF.  
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Table 5.6.4  
Cases with PSP and speech production impairment (PSP = progressive supranuclear palsy, PPA = primary progressive aphasia, PNFA = progressive non-fluent aphasia, 
AOS = apraxia of speech, NA = not available, NK = not known, OCD = obsessive compulsive disorder. *cases not already described in previous publication by the same 
authors. * - not pathologically proven) 
 
Author 
Nomenclature 
N 
Age at 
onset 
(years) 
Symptoms/Signs at onset 
Gaze palsy  
(duration 
from onset - 
years) 
Falls 
(duration 
from onset 
- years)  
Duration 
to death 
(years) 
Other symptoms and signs during 
disease course 
Pathological 
diagnosis 
67 Articulatory difficulty: hesitant, effortful 
speech, confusion between yes and no 
+ (3) + (3) NK Mild limb bradykinesia and rigidity, limb 
apraxia 
NK 
73 Speech production impairment with word-
finding difficulty and hesitancy 
+ (3) + (1) NK Apathy, depression NK 
65 Articulatory difficulty with effortfulness and 
word-finding difficulty. Loss of ability to hum or 
whistle. 
+ (8.5) + (8) NK Mild parkinsonian syndrome, with right limb 
myoclonus and limb apraxia 
NK 
This series 
PNFA 
4 
57 Decreased speech amount with hesitancy and 
effortfulness in speech production 
+ (5) + (4) NK Limb apraxia NK 
Wakabayashi et al. 
PPA 1 
72 
 
“Aphemia”, decreased speech output - NA 6 No other early signs. Late right hemisphere 
(temporal/occipital) stroke. 
PSP 
Boeve et al. 
PNFA 1 
71 Anomia, AOS. - + (5-6) 6 Mild Parkinsonism, agitation. Atypical PSP 
Amyloid angiopathy 
77 
 
Naming difficulty and non-fluent speech. 
 
+ (2) 
 
+ (3) 
 
5 
 
Mild asymmetric spasticity, axial rigidity. 
 
Atypical PSP 
Hippocampal sclerosis 
Braak stage I 
53 
 
Articulatory difficulty, AOS, emotional lability. 
 
 
- 
 
 
- 
 
 
8 
 
Late obsessional behaviour, brisk reflexes. 
 
Atypical PSP 
Braak stage III 
 
69 
 
 
Difficulty with pronunciation, confusion 
between yes/no. 
 
+ (4) 
 
 
- 
 
 
8 
 
 
Head tremor, brisk reflexes. Family history of 
motor neuron disease and dementia. 
Atypical PSP 
Braak stage IV-V 
Transitional LB 
Josephs et al. 
AOS 
PNFA 
 
4 
70 
 
Anomia, hesitancy, paragrammatic errors, 
AOS. 
- - 7 
 
Mild hypomimia, late behavioural problems. Atypical PSP 
Amyloid angiopathy 
69 AOS. + (NA) - 9 Limb apraxia, rigidity and bradykinesia. PSP Josephs et al. 
Progressive 
aphasia/AOS* 
2 
74 AOS. - - 8 Limb apraxia, rigidity and bradykinesia. PSP 
Karnik et al. 
PNFA 
1 
62 Apathy, anhedonia, worsening depression, 
effortful non-fluent speech 
- + (2) 4 Severe OCD since aged 40yrs, falls in context 
of post surgical foot drop.  
PSP 
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Mochizuki et al. 
PPA 
1 
64 Difficulty with spontaneous speech on the 
telephone. 
- + (10) 10 Right upper limb clumsiness, brisk reflexes. 
Repetitive behaviour. 
PSP 
57 Speech production difficulties NA NA NK Right upper limb tremor and rigidity NK Perkin et al. 
PSP with 
dysphasia 
2 58 Non-fluent dysphasia NA NA NK Right upper limb rigidity NK 
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Table 5.6.5  
Comparison of age of onset, disease duration and age at death in the different PSP phenotypes (based 
on data from Table 2 and previous studies of classical PSP (PSP-RS) and PSP-P) 
 
 
Clinical presentation Age at onset 
Disease 
duration 
Age at death 
PSP-PNFA Difficulty with speech production 64.9 (7.2) 6.7 (2.0) 73.8 (7.0) 
PSP-RS Gaze palsy, axial rigidity and falls 66.5 (7.4) 6.3 (2.4) 72.8 (7.1) 
PSP-P 
Asymmetric tremor, late falls and 
gaze palsy 
63.2 (9.9) 11.7 (4.9) 74.9 (9.3) 
PAGF Gradual onset of freezing of gait 
61  
(age range 44-78) 
13  
(age range 5-21) 
Not available 
 
DISCUSSION 
This study characterises the syndrome of progressive nonfluent aphasia/apraxia of speech with 
clinical features of PSP. The neuropsychological and neurolinguistic profile of PSP-PNFA is 
similar to PNFA (Table 5.6.1 and 5.6.2), consistent with the extensively overlapping pattern of 
cortical atrophy in these two syndromes (Figure 5.6.1). However, the syndromes do differ in 
certain respects: compared with PNFA, PSP-PNFA is associated with more profound reduction 
in spontaneous speech, and more prominent deficits of praxis and episodic memory, but fewer 
speech errors and less marked impairment of literacy skills. This pattern of clinical and 
cognitive deficits in PSP-PNFA is consistent with the relatively greater involvement of prefrontal 
areas and less marked involvement of temporal and posterior perisylvian areas visualised in the 
cortical thickness analysis of the PSP-PNFA cases.  However, it is noteworthy that more severe 
midbrain atrophy was observed in the PSP-PNFA group than the PNFA-only group: midbrain 
atrophy here is likely to represent a marker for more extensive involvement of basal ganglia 
and other subcortical structures in PSP-PNFA. Lesions of subcortical nuclei can themselves give 
rise to a range of neuropsychological deficits (Warren et al, 2000). Furthermore, pathological 
examination in cases of PSP with progressive aphasia/apraxia of speech has demonstrated grey 
matter atrophy predominantly affecting the superior premotor cortex spreading to the bank of 
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the precentral gyrus and supplemental motor area and other frontal regions, as well as the 
caudate nuclei and the globus pallidus (Josephs et al, 2006).  Considering these lines of 
evidence together, it is therefore plausible that a conjunction of cortical and subcortical 
damage determines the neuropsychological profile in PSP-PNFA.  
 
Though subject to ascertainment bias, the present study suggests a prevalence of PSP-PNFA of 
the order of 29% of all cases of PNFA. Although our cases have not been pathologically 
confirmed, they share a number of clinical and neuroradiological similarities with 
pathologically proven cases in the PSP spectrum. A review of the presenting clinical features of 
the 170 cases of pathologically-confirmed PSP in the Queen Square Brain Bank database 
revealed four cases with speech or language problems at presentation although no detailed 
clinical assessments were available on these patients. These retrospective data suggest an 
approximate prevalence of PSP-PNFA of at least 2% of all pathologically-confirmed PSP: this is 
likely to be an underestimate, due to incomplete data recording and ascertainment bias (the 
majority of cases were recruited and assessed via a specialist movement disorders clinic). 
Previous work has demonstrated that diseases in the FTLD spectrum may show evolution of the 
clinical phenotype over the course of the illness: patients may present with a particular 
syndrome, and subsequently develop features of another syndrome. In one series of 60 patients 
with FTLD (Kertesz et al, 2005), 22 initially presented with PPA: of these 9 developed features 
suggestive of PSP/CBS during the course of the disease, however none had specific PSP 
pathology at post mortem. One case presenting as typical PSP clinically developed progressive 
aphasia as a late manifestation and was found to have histopathological features of PSP.  Taken 
together with the evidence of previous cases of speech-led presentations of pathologically 
proven PSP (Table 4.6.4), it is possible that progressive aphasia is more commonly 
underpinned by PSP pathology than is widely recognised. On the other hand, a proportion of 
these cases have ‘atypical’ features histopathologically, and the role of such anomalies in 
modifying the clinical phenotype has not been defined. There are several potential sources of 
bias in work of this kind. Patients presenting with progressive aphasia may not undergo 
comprehensive general neurological examination later in the illness, patients with PNFA in 
whom clinical features of PSP rapidly supervene may be less frequently included in 
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pathological series of FTLD cases, while patients with classical PSP who develop speech or 
language deficits later in the illness may not have detailed neuropsychological assessment. 
Conversely, it is unclear what proportion of ‘typical’ PNFA cases may have ‘subclinical’ 
features of the PSP syndrome: this would entail a detailed (longitudinal) analysis of oculomotor 
function in all patients presenting with PNFA, which was not undertaken here. These 
observations further underline the need for detailed longitudinal studies with pathological 
correlation in patients presenting with PNFA and PSP. 
 
Taking these caveats into account, the present study suggests the existence of a fourth clinico-
anatomical variant of PSP, in line with previous calls for greater recognition of this syndrome. 
The PSP-PNFA syndrome is of both clinical and neurobiological importance. Clinically, the 
patient with progressive speech apraxia and early marked impoverishment of propositional 
speech without prominent speech errors should be observed closely for development of the 
PSP syndrome. Neurobiologically, such cases suggest that PSP should no longer be regarded as 
a paradigmatic ‘subcortical’ dementia: rather (analogously with other neurodegenerative 
disorders, such as dementia with Lewy bodies and corticobasal degeneration) it represents a 
spectrum of overlapping syndromes that may have a cortical emphasis at presentation. 
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Chapter 5 summary 
This Chapter has looked at a prospective series of patients with progressive language 
impairment. The clinical and anatomical syndromes seen in patients with semantic dementia in 
this series are as previously described, all presenting with verbal semantic impairment and all 
in this study with left greater than right temporal lobe atrophy. The novel aspects of this 
Chapter rest upon the descriptions of the nonfluent aphasia variants – there is preliminary 
evidence from the neurological, neuropsychological, neuroanatomical, genetic and 
pathological evidence presented here that there are at least three nonfluent PPA syndromes:  
• The PNFA syndrome, where apraxia of speech is an early feature but patients develop 
agrammatism over time. This is associated clinically with atypical parkinsonian 
syndromes, either corticobasal syndrome or progressive supranuclear palsy. Previous 
studies and the work presented in Chapter 4 suggest that these clinical syndromes (CBS 
and PSP) are usually associated with tau-positive pathology.  
• The LPA syndrome, where word-finding pauses are prominent as is a short-term 
(phonological) memory deficit. However, this study suggests that this syndrome is far more 
complex cognitively than previously described: other cognitive domains involved, 
particularly as the disease develops, are likely to include phonological code retrieval, 
verbal memory impairment and semantic processing. The CSF data and the review of the 
pathological series suggest a strong association with Alzheimer’s disease pathology as with 
previous reports. The imaging in these cases, which is asymmetric, mainly affecting the left 
hemisphere, suggests that LPA is a focal variant of AD initially affecting the left hemisphere 
rather than symmetrically as seen in typical amnestic AD. As discussed in Chapter 1, it is 
important to be clear on the descriptive levels of classification when discussing this 
syndrome – it is not inconsistent to call this syndrome either logopenic/phonological 
aphasia (i.e. a clinical/neuropsychological classification) or an atypical language 
presentation of Alzheimer’s disease (i.e. a clinico-pathological classification).  
• A GRN-PPA syndrome, associated with progranulin mutations, where anomia is a 
prominent initial feature and there is nonfluency secondary to anomia with relatively mild 
agrammatism but with early semantic impairment. This study has only looked at a small 
  207 
number of these patients and whilst it is uncontroversial that this is a separate pathogenetic 
PPA syndrome, the prediction that this forms a separate clinical/neuropsychological 
phenotype that maps directly on to the pathogenetics remains to be answered with larger 
studies.  
 
It will be important to conduct further group and detailed single case studies in patients with 
nonfluent aphasias and particularly those with pathological confirmation to define the full 
clinico-pathological and clinico-genetic spectrum, to establish the extent to which GRN-PPA, 
LPA and other nonfluent cases can be distinguished on neuropsychological grounds (or 
whether they represent one instance of a broader continuum of non-fluent aphasia cases with 
different molecular substrates), and to address in detail the anatomical and pathophysiological 
basis of the different language disorders. 
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6. Further neuropsychological and behavioural studies 
As described in the previous Chapters, patients with PPA have a wide variety of speech and 
language deficits that differ between the subtypes: anomia and impaired single word 
comprehension secondary to a verbal semantic deficit in SD; agrammatism, motor speech 
impairment, anomia and impaired repetition in PNFA; and anomia and impaired sentence 
repetition and comprehension in LPA. Consistent with this, both structural and functional MRI 
studies have shown involvement of a distributed left hemisphere fronto-temporo-parietal 
language network in PPA (Sonty et al, 2003; Vandenbulcke et al, 2005; Sonty et al, 2007). 
Following on from the work in the prospective series of patients with PPA described in Chapter 
5, individual studies addressing particular neuropsychological and behavioural aspects of 
patients with progressive aphasias are presented in this Chapter: studies of single word 
processing (6.1), prosody (6.2), the production of neologistic jargon (6.3), apraxia (6.4) and 
abnormal behaviour (6.5) are presented, all areas which have been little studied in most cases 
in the progressive aphasias previously. 
 
The specific hypotheses of Chapter 6 are: 
1. Impairment of single word processing in the progressive aphasias will be associated with a 
network of areas in the left hemisphere. 
2. Prosodic processing will be impaired in patients with nonfluent aphasias. 
3. Orofacial and limb apraxia will be associated with nonfluent aphasia and limb apraxia will 
be particularly associated with the atypical parkinsonian disorders, corticobasal syndrome 
and progressive supranuclear palsty syndrome. 
4. Behavioural abnormalities will occur in progressive aphasias particularly with increased 
disease severity and the pattern of abnormalities will differ across the different clinical 
subtypes. 
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6.1 Single word processing in primary progressive aphasia 
Single word processing is thought to rely upon widespread neural networks within the 
dominant hemisphere (Price, 2000; Martin, 2003). Historically, study of these cognitive 
processes has relied upon discrete lesions in patients with neurological deficits such as stroke 
and tumours (Dronkers et al, 2004; Hillis, 2007) although in recent years this has been 
supplemented with an array of functional MRI experiments mostly in cognitively-normal 
individuals (Fiez et al, 1998; Price 2000; Bookheimer, 2002; Martin, 2003; Demonet et al, 
2005; Vigneau et al, 2006). More recently, diffusion tractography has been used as a method of 
identifying white matter tracts involved in language (Breier et al, 2008; Friederici, 2009). Fewer 
studies have looked at neurodegenerative disease as a model for investigating single word 
processes such as naming, comprehension and reading.  
 
During the early stages of the disease all of the progressive aphasias have naming deficits with 
anomia more marked in SD than LPA and relatively mild impairment in PNFA. VBM studies 
suggest that overlapping but distinct areas of the language network correlate with anomia 
(Galton et al, 2001; Grossman et al, 2004; McMillan et al, 2004; Amici et al, 2007): in SD 
anomia is associated mostly with anterior temporal lobe atrophy, whilst in PNFA a more 
widespread network of areas is associated with anomia, particularly inferior frontal, lateral 
temporal and anterior parietal lobes. Single word comprehension/semantic impairment in SD is 
associated with anterior temporal lobe atrophy (Davies et al, 2004; Nestor et al, 2006; Davies 
et al, 2008). The development of single word comprehension deficits in both LPA and PNFA 
has not been studied in detail and the underlying cognitive domains involved remain unclear. 
Reading deficits differ between the subtypes: surface dyslexia is seen in SD (i.e. inability to 
read irregular or exception words) and in an fMRI study a group of SD patients (unlike 
cognitively-normal controls) did not activate anterior temporal lobe areas thought to be 
required for exception word reading but instead activated a left inferior parietal area not seen 
in normal individuals (which may explain the regularization of exception words that SD 
patients commonly exhibit) (Wilson et al, 2009a). Phonological dyslexia is seen in PNFA and 
LPA i.e. particular difficulty reading nonsense or pseudowords, and is associated in PPA with 
left temporo-parietal atrophy (Brambati et al, 2009a).  
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In this study single word processing (naming, comprehension and reading) was investigated in 
the group of 32 patients with PPA and volumetric imaging described in Chapters 5.2 and 5.3 
using the unbiased whole brain technique of voxel-based morphometry in order to look at the 
neuroanatomical correlates. 
 
METHODS 
The 32 patients (14 PNFA, 9 SD, 7 LPA, 2 GRN-PPA) had been tested on a various measures of 
single word processing as described in Chapter 2.2 and 5.2: 1) a 20-item oral picture naming 
task, 2) two tests of single word comprehension; A) a purely verbal single word comprehension 
task, the Warrington synonyms task which consists of 25 concrete words and 25 abstract words 
(Warrington et al, 1998); and B) a verbal-visual single word comprehension task, a shortened 
version of the word-picture matching British Picture Vocabulary Scale; and 3) a single word 
reading task consisting of 30 irregular words (i.e. mainly sampling vocabulary-based reading). 
Results in each of the tests from the different groups are shown in Table 6.1.1. Naming and 
verbal comprehension were similarly impaired in the SD and LPA groups (and more impaired 
than PNFA) with the worst performance in the GRN-PPA group. The SD group were worse than 
both LPA and PNFA on the visual-verbal comprehension task with similar performance to the 
GRN-PPA group. Reading was most severely affected in GRN-PPA and least affected in PNFA. 
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Table 6.1.1  
Demographic and neuropsychological data 
 
 ALL PPA SD PNFA GRN-PPA LPA 
Age (years) 67.0 (8.6) 62.3 (9.0) 71.8 (6.8) 60.7 (12.7) 65.1 (6.4) 
Number of subjects 32 9 14 2 7 
Gender (M:F) 18:14 3:6 10:4 1:1 4:3 
Duration (years) 5.0 (1.7) 5.3 (1.2) 5.3 (2.1) 3.7 (0.0) 4.4 (1.0) 
Naming (/20) 7.9 (6.6) 4.4 (3.2) 12.7 (6.4) 0.0 (0.0) 5.1 (4.2) 
Verbal  
comprehension (/50) 
33.9 (7.5) 28.9 (5.3) 39.9 96.7) 26.0 (0.0) 30.7 (2.4) 
Visual-verbal 
comprehension (/30) 
21.0 (6.0) 15.1 (5.2) 25.4 (4.0) 15.5 (2.1) 21.1 (2.7) 
Reading (/20) 15.5 (8.3) 15.4 (8.3) 18.1 (8.6) 4.5 (0.7) 13.4 (6.6) !
The results from these four tests were used to investigate the neuroanatomical basis of single 
word processing by correlating score on the tests with grey matter intensity on T1 MRI brain 
scans using voxel-based morphometry (VBM). VBM was performed using SPM5 software with 
default settings for all parameters as described in Chapter 2. Linear regression models were 
used to examine correlations between psychological test score and grey matter intensity. Voxel 
intensity was modelled as a function of score in each of the four tests (within the same model) 
with group membership (i.e. SD, PNFA, LPA or GRN-PPA), subject age and total intracranial 
volume (TIV) included as nuisance covariates. Maps showing statistically significant 
correlations between score and voxel intensity were generated, correcting for multiple 
comparisons by thresholding the images of t-statistics to control the False Discovery Rate (FDR) 
at a 0.05 significance level (Figures 6.1.1 and 6.1.2). Statistical parametric maps were 
displayed as overlays on a study-specific template, created by warping all native space whole-
brain images to the final DARTEL template and calculating the average of the warped brain 
images. !
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RESULTS 
A similar network of mainly left-sided grey matter areas correlated with the naming, 
comprehension and reading scores: temporal lobe, insula, inferior frontal lobe, inferior parietal 
lobe and anterior cingulate (Figure 6.1.1). For naming the most significant areas were in the left 
anterior temporal lobe [-51, 5, -21; -33, 0, -17; -28, -6, -32] and more posterior middle 
temporal [-51, -22, -16] and superior temporal [-40, -9, -10] lobes within the same hemisphere 
with significant right anterior temporal  [24, -1, -33] involvement also. There was less 
significant involvement of the left anterior cingulate [-7, 39, -3], insula [-34, 1, 3], inferior 
frontal lobe [-36, 27, 1] and inferior parietal lobe [-45, -44, 22]. Verbal comprehension 
involved a similar network of areas with anterior temporal lobe [-36, 20, 18] being most 
significant. For the visual-verbal comprehension task there was also particularly significant 
correlation with the posterior inferior temporal lobe [-38, -43, -12] and there was more right 
temporal lobe [25, 3, -30; 40, -18, -15] involvement than the purely verbal comprehension 
task. Reading was associated with the same network of areas but in contrast to the naming and 
comprehension was most significantly associated with grey matter atrophy in the middle and 
superior temporal gyrus posteriorly [-50, -36, 1; -45, -24, -3; -45, -39, -5].  
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Figure 6.1.1  
VBM analysis correlating grey matter with scores on the naming, comprehension and reading tasks in 
the PPA cohort. Statistical parametric maps (SPMs) have been thresholded at p<0.05 (FDR corrected) 
and rendered on a study-specific average group T1-weighted MRI template image in DARTEL space. The 
colour bar (right) indicates the t score. The right hemisphere is shown on the right side of the image in 
the coronal sections. 
 
 
 
DISCUSSION 
This study describes an overlapping network of mainly left hemisphere areas associated with 
single word processing in primary progressive aphasia. In particular, common cortical areas 
affected were in the temporal lobe (particularly the pole and the posterior superior and middle 
temporal gyri), posterior inferior frontal gyrus, insula, inferior parietal and anterior cingulate 
lobes.  
 
Naming from a picture relies on a number of cognitive processes including semantic 
knowledge of the concept in the picture, linking the semantic concept to the word, retrieving 
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the word from the lexicon, and then expressing the word (Indefrey et al, 2004; Grossman et al, 
2004; Patterson et al, 2007). A widely spread network of cortical areas is therefore predicted to 
be associated with this process as is seen in this study: semantic areas such as anterior 
temporal lobe, posterior superior temporal lobe, areas involved in speech production such as 
the insula and association areas such as inferior parietal lobe. As with naming, single word 
comprehension requires knowledge of the semantic concepts involved in the task but also 
involves phonological decoding of syllables. In a purely verbal task, it is mainly the key 
semantic areas of the left hemisphere involved but with a visual component to the task there is 
also greater involvement of the right hemisphere consistent with this hemisphere’s involvement 
in visual semantic knowledge (Pobric et al, 2009). The ability to read an irregularly spelled 
word requires prior knowledge of the word and is therefore likely to rely on similar semantic 
and lexical areas as naming and comprehension tasks. In this study, similar grey matter regions 
to the other tasks correlated with reading score although more posterior temporal areas were 
most significant which may signify the major requirement of lexical access in this task.  
 
One of the difficulties of studying a heterogeneous group of patients where the underlying 
pathological causes may be different is the validity of combining such such patients. It may be 
that different pathologies have differential effects on grey matter volume e.g. some may cause 
impaired function without volume loss compared with others which cause substantial volume 
loss. Caution must therefore be taken in the results from any study with mixed pathological 
groups. 
 
The ability to study patterns of language impairment in degenerative disease and its 
neuroanatomical correlations has potential advantages over other methods. Degenerative 
disease tends to affect areas of the brain substantially different to strokes e.g. anterior temporal 
lobe. This area of the brain is also more susceptible to artefact in fMRI studies with semantic 
task studies often showing more superior and posterior temporal involvement and inferior 
frontal lobe rather than anterior temporal lobe involvement (Vigneau et al, 2006).  
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6.2 Receptive prosody in nonfluent aphasia 
Whereas the production and processing of verbal material in PPA has been extensively studied, 
less attention has been paid to nonverbal aspects of vocal communication. Expressive prosody, 
or the ‘melody’ of speech, is abnormal in many patients with PPA (Josephs et al, 2006): apraxia 
of speech or expressive agrammatism in PNFA, and word-finding pauses in LPA tend to disrupt 
the rhythm and intonational structure of utterances, rendering them dysprosodic. However, it is 
not clear whether such patients have an underlying deficit in the comprehension of prosody, 
‘receptive dysprosodia’ (Ross, 1981). This issue is of both neurobiological and clinical 
importance: neurobiologically, such a deficit would signify a pervasive derangement in the 
processing of vocal signals in PPA, while clinically, there would be important implications for 
everyday communication. Prosody is complex and conveys multidimensional information 
about the speaker’s intentions and emotional state, while allowing disambiguation of the 
meaning of an utterance (e.g. statement versus question). At the most fundamental acoustic 
level, prosody comprehension depends on an ability to process variations in vocal pitch, 
duration and intensity (loudness) that constitute the building blocks of prosodic contours. 
Higher-order processing of intonational patterns is required to determine lexical stress and 
declarative versus interrogative intention (linguistic prosody), and representation of affective 
information is required to decode the speaker’s emotional state (affective prosody).  
 
In this study a systematic investigation of different dimensions of prosody processing (acoustic, 
linguistic and affective) was conducted in a cohort of patients with PPA versus healthy older 
control subjects. Voxel based morphometry was used to identify neuroanatomical correlates of 
prosodic functions in the PPA group. 
!
"#$%&'(!
Nineteen consecutive patients with a diagnosis of PNFA (n = 11), LPA (n = 5), GRN-PPA (n=3) 
and 14 cognitively-normal control subjects were recruited. This study was performed 
subsequently to those in Chapter 5 and so whilst there is some overlap in the patients, they are 
not equivalent. One patient (with LPA) had known mild industrial hearing loss; peripheral 
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hearing was assessed in relation to age norms using pure tone audiometry in 17 patients, and 
subclinical peripheral hearing loss involving speech frequencies (below 4000 Hz) was detected 
in a further two cases (both with PNFA). All patients had an initial general neuropsychological 
assessment including tests of single word comprehension (the Warrington synonyms test, 
Warrington et al, 1998), executive function (Trail Making Test, Reitan, 1959) and a forwards 
digit span. Demographic and neuropsychological data are summarised in Table 6.2.1: the PPA 
group performed significantly worse than controls on all tests, while the only significant 
difference between the PNFA and LPA subgroups was more impaired single word 
comprehension in LPA. All patients underwent MR brain imaging as described in Chapter 2.  !
Table 6.2.1  
Demographic and neuropsychological data 
 
 ALL PPA PNFA LPA GRN-
PPA 
Controls 
Number of subjects  19 11 5 3 14 
Age (years) 68.6 (7.9) 72.8 (6.5) 63.1 (4.4) 62.0 (8.5) 68.2 (4.8) 
Gender (M:F) 12:7 7:4 3:2 2:1 7:7 
Duration (years) 4.9 (1.6) 5.3 (1.9) 4.5 (1.0) 4.3 (0.6) N/A 
Warrington synonyms test (/50) 36.2 (1.5) 39.6 (1.8) 31.4 (2.4) 31.7 (6.7) 48.0 (0.3) 
Trail making test A (scaled score) 3.8 (0.6) 2.9 (0.4) 5.7 (4.0) 4.2 (2.7) 10.1 (0.5) 
Trail making test B (scaled score) 3.0 (0.5) 3.1 (0.5) 2.0 (0.8) 4.5 (4.8) 10.7 (0.5) 
Digit span forwards 4.1 (0.3) 4.4 (0.4) 4.6 (1.5) 2.0 (1.0) 6.9 (0.1) !
All subjects were assessed using a battery of tests probing different aspects of receptive 
prosody. All stimuli were prepared or recorded as digital wavefiles from a notebook computer. 
AKG K141 Monitor headphones were used at comfortable listening level in a quiet room. 
Several practice trials were given for each test, to ensure subjects understood the task; no 
feedback was given about performance during the test.  !
Experiment 1 Acoustic processing of prosody components  
The structure of the experimental tasks is schematised in Figure 6.2.1. 
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A) Pair Discrimination (PD) task (12 trials) 
Subjects were presented with pairs of CV syllables (e.g., ‘ma’). On half the trials, syllables 
contained a single difference in pitch, intensity or duration; on the remaining trials the syllables 
were acoustically identical. Stimulus parameters were digitally manipulated using Matlab7.0© 
(www.mathworks.com); pitch was manipulated using a previously described algorithm (von 
Kriegstein et al, 2006). The prosody variations used were intended to be easily detectable by 
normal subjects (see Figure 1 legend for stimulus parameters). The task on each trial was to 
decide whether the two sounds were the same or different (i.e., a ‘match’ versus ‘non-match’ 
design). 
 
B) Contour Discrimination (CD) task (match/nonmatch, 12 trials) 
Subjects were presented with pairs of short (4-item) sequences of CV syllables as in (A), where 
each sequence in the pair contained a change in pitch, intensity or duration (parameters as in 
(A)), but this change could occur at either of two positions (position 2 or 3) with equal 
probability. The task was to decide whether the two prosodic (pitch, intensity or duration) 
contours in each pair were the same or different.  
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Figure 6.2.1  
Diagram showing the design of task 1, testing the acoustic processing of prosodic components: A) pair 
discrimination  subjects heard either a pair of syllables of same pitch, duration and intensity or two 
pairs of differing pitch, intensity (represented by thicker rectangle) or duration; and B) contour 
discrimination  subjects heard two 4-syllable sequences (1 and 2, in either order) for either pitch, 
intensity or duration and were asked to say whether same or different.  
 
!
 
Experiment 2 Linguistic prosody   
 
A) Stress Discrimination (SD) task (2 alternative forced choice, 14 trials) 
Subjects heard a spoken phrase of the type: ‘black and blue’ [stressed word in bold] and were 
asked to decide whether the first or second colour in the phrase was stressed. 
 
B) Intonation Discrimination (ID) task (2 alternative forced choice, 14 trials) 
Subjects heard a two-syllable word (name of a food) spoken either declaratively or 
interrogatively (e.g. ‘apple’ vs. ‘apple?’). The subject’s task was to decide whether what they 
heard was a statement (as if read from a list) or a question (as if they were being asked if they 
wanted the food).  
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Experiment 3 Emotional (affective) prosody (6 alternative forced choice, 24 trials) 
This experiment was adapted from Sauter (PhD thesis, 2006), based on a previously normed set 
of vocal emotional stimuli. Subjects heard a semantically neutral three digit number (e.g. ‘one 
hundred and forty-seven’) recorded by an actor and spoken to convey one of six basic 
emotions (happiness, surprise, fear, sadness, disgust, anger; the set of sounds representing 
‘happiness’ were spoken to convey either amusement or achievement). For each of the six 
emotions, four trials representing that emotion were administered; stimuli that were most 
consistently identified as representing that vocal emotion by the previous group of healthy 
control subjects (Sauter, PhD thesis, 2006) were selected. The task on each trial was to decide 
which of these emotions was represented.  
 
Behavioural analysis 
Behavioural data were analysed statistically using STATA 10.0 (Stata Corporation, College 
Station, TX). Linear regression models were used to compare performance on the tests between 
groups after adjusting for age. 95% bias-corrected bootstrap confidence intervals with 1000 
replicates were used. To look at within disease group comparisons Wilcoxon signed-rank tests 
were used to assess differences between patient scores as a percentage of the control mean.  
 
RESULTS 
 
Behavioural data 
On the acoustic processing and linguistic prosody tests, the LPA subgroup performed 
significantly worse than controls on all tests (Table 6.2.2). The PNFA and GRN-PPA subgroups 
were significantly worse than controls on all tests apart from stress discrimination (Table 6.2.2). 
The LPA group performed significantly worse than the PNFA group on the pair and intonation 
discrimination subtests, and worse than the GRN-PPA group on the pair and stress 
discrimination subtests. For the PPA group as a whole, performance was significantly worse on 
contour discrimination compared to pair discrimination (p=0.02) and on intonation 
discrimination compared to stress discrimination (p=0.002); there was a significant correlation 
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between the total acoustic processing score and linguistic prosody score (r=0.50, p=0.03). The 
three patients with peripheral hearing deficits performed within the range of performance of 
patients without hearing deficits, suggesting that prosodic deficits were not attributable simply 
to peripheral hearing loss. No prosody subtest score correlated with auditory short term 
memory capacity, as indexed by digit span, in any of the subgroups.  
 
On the emotional prosody test, the PNFA subgroup performed significantly worse than controls 
in total and on each of the individual emotions (Table 6.2.2). The LPA subgroup performed 
significantly worse than controls in total and on each of the individual emotions except 
surprise where there was a trend to worse performance. The small GRN-PPA did not perform 
significantly worse than controls on any of the emotions although there was a trend to worse 
performance on each of the emotions. There was no significant difference between the 
subgroups on any of the individual emotions. For the PPA cohort overall, sadness and surprise 
were best recognised and disgust and fear least well recognised; there were statistically 
significant differences in recognition performance for fear versus surprise (p=0.03) and sadness 
(p=0.02) and for disgust versus surprise (p=0.046). The qualitative pattern of recognition 
performance for individual emotions was similar in patients and healthy controls (Table 6.2.2).  
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Table 6.2.2  
Acoustic processing, linguistic prosody and emotional prosody data !
 ALL PPA PNFA LPA GRN-PPA Controls 
Acoustic processing      
Pair discrimination (/12) 9.3 (1.6)* 9.5 (1.8)* 8.2 (1.1)*,a,b 10.0 (1.0)* 11.4 (0.7) 
Contour discrimination (/12) 7.8 (2.5)* 7.5 (2.9)* 7.8 (2.6)* 9.0 (0.0)* 11.5 (0.5) 
TOTAL(/24) 17.1(3.4)* 17.0 (3.8)* 16.0 (3.5)* 19.0 (1.0)* 22.9 (1.0) 
Linguistic prosody      
Stress discrimination (/14) 12.1 (2.6)* 12.5 (1.8) 10.2 (3.8)*,b 14.0 (0.0) 13.9 (0.5) 
Intonation discrimination (/14) 9.1 (2.5)* 9.6 (2.9)* 8.0 (2.2)*,a 9.0 (1.0)* 13.4 (1.0) 
TOTAL(/28) 21.2 (4.0)* 22.1 (4.0)* 18.2 (3.8)*,a,b 23.0 (1.0)* 27.2 (1.4) 
Emotional prosody      
Sadness (%) 65.8 (32.5)* 75.0 (29.6)* 55.0 (27.4)* 50.0 (50.0) 98.2 (6.7) 
Surprise (%) 60.5 (29.2)* 61.4 (30.3)* 55.0 (37.1) 66.7 (14.4) 91.1 (15.8) 
Anger (%) 46.1 (35.6)* 50.0 (40.3)* 40.0 (28.5)* 41.7 (38.2) 85.7 (16.2) 
Happiness (%) 44.7 (24.4)* 40.9 (23.1)* 45.0 (32.6)* 58.3 (14.4) 80.4 (20.0) 
Disgust (%) 31.6 (23.3)* 38.6 (20.5)* 15.0 (13.7)* 33.3 (38.2) 64.3 (25.4) 
Fear (%) 30.3 (27.1)* 31.8 (22.6)* 20.0 (32.6)* 41.7 (38.2) 78.6 (29.2) 
TOTAL (/24) 11.1 (3.7)* 11.8 (2.9)* 9.2 (2.8)* 11.7 (7.1) 19.9 (2.6) 
 
*p<0.05 disease group worse than controls , ap<0.05 LPA worse than PNFA, bp<0.05 LPA worse than GRN-PPA !
DISCUSSION 
This study has demonstrated impairments of receptive prosody in nonfluent PPA syndromes. 
Deficits were exhibited for acoustic, linguistic and affective dimensions of prosodic analysis. 
The finding of impairment even at the level of the basic acoustic building blocks of prosodic 
contours and the correlation between acoustic and linguistic prosody performance argue for 
the involvement of early perceptual mechanisms that cascade to higher levels of prosodic 
processing in PPA. Whereas prosodic variation in syllables and words typically extends over 
tens to hundreds of milliseconds, prosodic contours typically extend over hundreds to 
thousands of milliseconds: the prosodic subtests used here (syllable pairs/word stress versus 
contour/intonation) might index the processing of prosodic structure over shorter versus longer 
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timescales, respectively. Contour discrimination was significantly more impaired than pair 
discrimination and intonation discrimination was significantly more impaired than stress 
discrimination at phrasal level: this pattern suggests that the representation of longer range 
prosodic structure is relatively more vulnerable. While this pattern might be at least partly 
attributable to an associated short term memory impairment, the lack of correlation between 
prosodic and short term memory performance argues for an additional specific deficit of 
receptive prosody.  
 
Within the domain of affective prosody, recognition of certain emotions (in particular, disgust 
and fear) was relatively more impaired. The pattern observed would be consistent with a 
primary defect of perceptual analysis: whereas emotions such as sadness and surprise can be 
conveyed vocally from relatively coarse perceptual cues (e.g., large shifts in intensity or pitch), 
the perception of vocal expressions of other negative emotions is likely to depend on accurate 
encoding of fine-grained perceptual features (Juslin et al, 2003; Hammerschmidt et al, 2007). 
Healthy subjects may be able to exploit additional acoustic features of affective prosodic 
utterances, or alternatively, there may be an additional specific deficit in processing particular 
vocal emotions in PPA: the present data do not resolve this issue. 
 
Perception of prosody has been little studied in degenerative disease. Impairments of affective 
prosody processing have been documented in Huntington’s disease (Speedie et al, 1990), 
Parkinson’s disease (Dara et al, 2008), Alzheimer’s disease (Taler et al, 2008a) and 
frontotemporal dementia (right temporal lobe atrophy: Perry et al, 2001). The brain basis for 
prosodic deficts in these disorders remains largely unexplored. Studies of prosody in patients 
with stroke or fMRI studies in cognitively-normal individuals have implicated a predominantly 
right-sided (though often bilateral) distributed fronto-temporo-parietal network in the 
processing of emotional prosody, with less consistent lateralisation for the processing of 
linguistic prosody (e.g. Tong et al, 2005; Ethofer et al, 2006; Pell, 2006a; Pell, 2006b; 
Wildgruber et al, 2006; Beaucousin et al, 2007; Arciuli et al, 2007; Wiethoff et al, 2008; Ross 
et al, 2008). Speech prosody serves a key ‘metalinguistic’ function in human communication, 
and deficits of prosody processing therefore have potentially important clinical consequences. 
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Indeed, as PPA typically affects the left hemisphere initially, receptive dysprosodia may 
become more clinically significant with increasing right hemisphere involvement as the disease 
evolves. This may also be the reason for worse performance in the LPA group which was 
shown to have greater right hemisphere involvement than the other groups in Chapter 5. 
Further longitudinal studies with larger PPA cohorts are needed to establish the natural history 
of prosody impairment in PPA in relation to linguistic deficits, to explore other aspects of 
complex sound processing across the PPA spectrum and to define the brain basis of prosodic 
deficits in detail. 
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6.3 Neologistic jargon in primary progressive aphasia 
The production of incomprehensible language containing frequent phonemic distortions, 
semantic errors or neologisms secondary to neurological disease has been termed jargon 
aphasia (or if writing is affected, jargon agraphia).  The production of inappropriate language 
can be considered in the context of either normal propositional speech or writing, or in the 
production of single words in the context of naming tasks performed during 
neuropsychological assessment. Three types of jargon aphasia have been described 
(Alajouanine, 1956; Perecman et al, 1985): the production of language which is devoid of 
content and consists of real words that are inappropriate given the context of the situation 
(semantic jargon); the production of language containing inappropriate words that are 
nonetheless phonemically-related to what the patient is attempting to convey, and may 
therefore be either real or non-existent words (phonemic or phonological jargon); and the 
production of language containing non-existent words or true neologisms, which are not 
phonemically-related to the target (neologistic jargon). Patients may have one or more of these 
types of jargon as part of the same disorder. The occurrence of true ‘abstruse’ neologisms is 
most common in acute neurological disorders and in particular Wernicke’s aphasia.  
 
Analogously, jargon agraphia can comprise semantic jargon, phonological jargon 
(phonologically-related misspelled words which can be either real words or nonwords) and 
neologistic jargon (Cappa et al, 1987; Schonauer et al, 1994; Marien et al, 2001; Marshall, 
2006). Jargon aphasia and agraphia can occur in the same individual but they can also occur 
in the presence of normal output in the other language channel (Schonaeur et al, 1994; Hillis 
et al, 1999). They are rarely described in the setting of neurodegenerative disease (Ostberg et 
al, 2001; Graham et al, 2001). Two cases of neologistic jargon in primary progressive aphasia 
(PPA) are described: jargon aphasia in a case of atypical semantic dementia (SD) and jargon 
agraphia in a case of progressive non-fluent aphasia (PNFA). !
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CASE REPORTS 
Case 1 
A 75 year-old right-handed woman presented with a three-year history of word-finding 
difficulties. Her husband had noticed she would frequently use ‘thing’ in place of a more 
specific word and would confuse words of related meaning (such as ‘door’ for ‘window’). For 
the previous two years she had also had increased difficulties with arithmetic, writing and 
spelling. Over the same time period her comprehension of speech had also deteriorated. There 
had been no significant difficulties with episodic memory and she had never become lost. 
There were no behavioural symptoms or changes in appetite. There was no family history of 
dementia. When first assessed she had a fluent aphasia with circumlocutory speech. Repetition 
for single words was preserved but sentence repetition was impaired. There was bilateral limb 
apraxia. The general neurological examination was normal. Detailed neuropsychological 
assessment revealed severe anomia (only able to produce ‘train’ on a simple naming task) and 
impaired comprehension (13/50 on the British Picture Vocabulary Scale, Dunn et al, 1982), 
poor reading skills (2/50 on the National Adult Reading Test, Nelson, 1991) with errors for both 
irregular and nonwords as well as evidence of parietal dysfunction consisting of dyscalculia 
(0/24 on the Graded Difficulty Calculation Test, Jackson et al, 1986), poor spelling and 
decreased digit span (four digits forwards, unable to repeat two digits backwards.). There was 
also evidence of executive dysfunction  
 
Over the next year the patient’s speech became more circumlocutory and with increased 
word-finding difficulties. In addition, abstruse neologisms emerged in her spontaneous speech 
and she produced neologistic jargon on a simple naming task and when reading (see Table 
6.3.1). She would produce words that were completely unrelated to the target word (e.g., 
‘adepgood’ for ‘spade’). At a further assessment seven months later she continued to produce 
multiple abstruse neologisms (Table 6.3.1).  She showed no awareness of the errors she made. !!!
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Table 6.3.1 
Simple picture naming task and spoken responses from Case 1 (International Phonetic Alphabet 
characters in parentheses; Response 1 at 4 years after onset)  
!!
It is difficult to characterise the syndromic diagnosis in this patient. Based on the leading 
features of fluent, empty speech with profound anomia, loss of word meaning, impaired single 
word comprehension and surface dyslexia, the case fulfilled modified consensus criteria for SD 
(Neary et al, 1998; Adlam et al, 2006). However, the early development of dominant parietal 
lobe deficits (dyscalculia, limb apraxia and decreased digit span) are clearly atypical for SD, 
and suggest that the syndrome here might be more appropriately characterised as LPA although 
the early single word comprehension abnormalities would be against this. 
!
Brain imaging 
The patient had volumetric brain MRI scans (Figure 6.3.1A) 3.5 and 5 years from symptom 
onset i.e. pre and post the onset of jargon. Visual inspection of the baseline scan revealed 
asymmetrical atrophy affecting predominantly the left cerebral hemisphere and, in particular, 
the temporal lobe and, to a lesser extent, the parietal lobe. There was no antero-posterior 
gradient of atrophy within the temporal lobe and the superior, middle and inferior temporal 
lobe gyri were all affected. There was no vascular disease. The pattern of regional atrophy 
progression between the two scans (i.e. over the period when jargon developed) was assessed 
using a fluid registration technique producing a voxel compression map as described in 
Chapter 2. This showed that progressive atrophy was maximal in the left temporal and inferior 
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parietal lobes (see figure 6.3.1A), with additional heavy involvement of dorsal prefrontal areas 
that are likely to be functionally connected with the inferior parietal lobe (Warren et al, 2005). 
 
Case 2 
A 70-year-old right-handed man presented with an eighteen month history of progressive 
speech production impairment. There were no other cognitive or behavioural symptoms. 
When first assessed he had a non-fluent aphasia with phonemic paraphasias, agrammatism and 
poor polysyllabic word and sentence repetition. He also had evidence of a mild motor speech 
disturbance with hesitancy and effortfulness in articulation. The Mini-Mental State Examination 
score (Folstein et al, 1975) was 25/30 with points lost on naming, writing and registration. The 
general neurological examination was normal. There was no family history of degenerative 
disease. EEG performed at this time showed excess slow wave activity in the left 
frontotemporal region but there was preserved alpha rhythm. 
 
Detailed neuropsychological assessment at presentation revealed a verbal IQ of 77 and a 
performance IQ of 148 on the WAIS-R (Wechsler, 1981). Despite the speech production 
impairment naming was relatively intact at this time scoring between the 75th and 90th 
percentile on the Graded Naming Test (McKenna et al, 1980). There was evidence of mild 
executive dysfunction (Modified Card Sorting Test, Nelson, 1976), mild to moderate 
impairment of calculation (Graded Difficulty Calculation Test) and decreased digit span (four 
digits forwards). However, single word comprehension was intact (50-75th percentile on the 
Synonyms test, Warrington et al, 1998) as was memory (25th percentile on the Warrington 
Recognition Memory Test for Words and 75th on the Faces subtest, Warrington, 1984). 
Visuoperceptual skills were also intact (18/20 on the Object Decision subtest of the VOSP, 
Warrington et al, 1991).   
 
Over the next two years the patient’s speech production continued to deteriorate and he 
developed difficulties with speech comprehension. In order to communicate he would write 
things down but there were frequent grammatical and spelling errors. There was also evidence 
of impaired calculation although no behavioural abnormalities. When assessed three and a half 
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years after the onset of symptoms there was little spontaneous speech output beyond ‘yes’ and 
‘no’. There was evidence of orofacial apraxia although no limb apraxia. Neuropsychological 
assessment at this time revealed a Raven’s matrices equivalent IQ score of 120, intact memory 
(50-75th percentile on the Camden Pictorial Memory Test, Warrington, 1996) and intact 
visuoperceptual skills (75-100th percentile on the Object Decision subtest of the VOSP). There 
was executive dysfunction as previously. In addition there was now evidence of deterioration 
in single word comprehension, scoring only at the 10th to 25th percentile on the Synonyms test. 
There was profound anomia: on the Graded Naming Test he was only able to provide written 
answers to the test (Table 6.3.2) with multiple phonological (e.g., ‘squeezers’ for ‘tweezers’) 
and semantic (e.g., ‘elephant’ for ‘anteater’) errors and evidence of perseveration. On a further 
writing task he was asked to construct sentences containing a target word: he produced grossly 
agrammatic and often nonsensical phrases containing semantic errors, though no neologisms.  
 
When assessed one year later he was almost mute. Speech comprehension had further 
deteriorated, now scoring below the 5th percentile on the Synonyms test. Written responses to 
the Graded Naming Test (Table 6.3.2) contained phonological (e.g., ‘rudii’ for ‘radius’), 
semantic (e.g., ‘hood’ for ‘cowl’) and perseverative errors as previously. However, these were 
now accompanied by multiple abstruse neologisms completely unrelated to the target word 
(e.g. ‘magiff’ for ‘sporran’, ‘gatyss’ for ‘centaur’). He appeared unaware of these errors. He was 
assessed once more when completely mute a further year later when he scored 8/20 on a 
subset of the British Picture Vocabulary Scale (Dunn et al, 1982): although this score is above 
chance it falls below the 5th percentile. Once again there were multiple abstruse neologisms on 
the Graded Naming Test with frequent perseverations and illegal letter combinations (e.g. in 
the neologism IN-KINJCK) (Table 6.3.2). 
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Table 6.3.2 
Written answers provided for the Graded Naming Test from Case 2 (Response 1 at 3.5 years after 
onset) !
  TARGET RESPONSE 1   RESPONSE 2 (+1 year) RESPONSE 3 (+2 years) 
1 Kangaroo KANGAROO KANGOROO GOWN 
2 Scarecrow SCARECROWS BREAKFAST NECKOR 
3 Buoy BOUYS BOUY ABOUT 
4 Thimble THIMBLE THUMB NEXT 
5 Handcuffs HANDCUFFS HANDCUFF NEWT-NOCKET 
6 Tweezers SQUEEZERS FISTCUFF NEWBOT 
7 Corkscrew CORKSCREWS SQUIDELL NEWBOT 
8 Sporran KILTS MAGIFF NEWBOLT 
9 Tassel TASSLE GNOME NEWBOLT 
10 Sundial TIMESCALE GNOME NEWBOLT-BRINE 
11 Chopsticks CROQUETS FORSTELL NEWBOLT 
12 Periscope PERISCOPE PERSPIME SINKS-TRINKET 
13 Boar BOARS BOAR BASIN-MISSKIKIET 
14 Blinkers BASKETS SQUID BINSTASS 
15 Monocle MONCLE BONECULE SINKS 
16 Turtle TORTOISE TORQUISE TRINS-MASSINESS 
17 Trampoline TAMPTOISE BONECULE MISSKITEN 
18 Bellows BELLOWS FIREBALL NISS-EN 
19 Shuttlecock TAMBLECOCKS COCKELL MISS-IN-TEKEN 
20 Anteater ELEPHANTS No written response MISS-IN-TAKIN 
21 Pagoda PELICANS No written response IN-TAKIN 
22 Radius RADIUS RUDII NO-NOKEN 
23 Leotard COSTUME CATUSS IN-TOKEN-NO 
24 Mitre MITRE MITRE IN TOKEN-MOTOKEN 
25 Yashmak MASKS SHIEL JUINK- 
26 Sextant SEXTENTS SEXTENT IN-JUNK 
27 Centaur M GATYSS IN-KINJCK 
28 Cowl HOODS HOOD IN JUINK-INJUINK 
29 Tutu FLUFFS BAYSONNE IN JUINK-BOSMENT 
30 Retort GLASS No written response JACKOO !
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As in Case 1, the syndromic diagnosis in this patient is not clear-cut. Based on the leading 
features of speech production impairment with agrammatism, sound errors and hesitancy, the 
clinical presentation here fulfilled consensus criteria for PNFA (Neary et al, 1998). However, 
other features, in particular the presence of parietal lobe deficits (dyscalculia, decreased digit 
span) at presentation would be relatively against this.   
 
Brain imaging 
The patient had volumetric brain MRI scans (Figure 6.3.1B) 3.5 and 4.5 years from symptom 
onset, i.e. pre and post the onset of jargon. Visual inspection revealed asymmetrical cerebral 
atrophy more marked on the left and particularly involving the inferior frontal gyrus and peri-
Sylvian region, with extension into the left parietal lobe. There was no vascular disease. As 
with case 1, the pattern of regional atrophy progression between the two scans (i.e. over the 
period when jargon developed) was assessed using a fluid registration technique (figure 
6.3.1B). This showed progressive atrophy extending posteriorly surrounding the Sylvian fissure 
with major involvement of the left inferior parietal lobe, in particular the angular gyrus (see 
figure 6.3.1B). !!!!!!!!!!!!!!!
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Figure 6.3.1 
Coronal T1-weighted MR images (with left hemisphere shown on the right of the images) through the 
frontal, mid-temporal, posterior temporo-parietal  and posterior parietal regions and a sagittal MR 
image through the left temporo-parietal region with a voxel-compression-mapping overlay to show the 
progression of regional atrophy (degree of volume loss and expansion coded in the colour scale: red 
represents 20% or greater expansion of voxels and blue represents 20% or greater contraction of 
voxels.): A) Case 1: coronal images 5 years after symptom onset; sagittal image shows change over time 
period 3.5 to 5 years from symptom onset B) Case 2: coronal images 4.5 years after symptom onset; 
sagittal image shows change over time period 3.5 to 4.5 years from symptom onset  !
!!
DISCUSSION 
Both patients described here developed neologistic jargon in the context of a 
neurodegenerative disease with a progressive aphasia phenotype. It is of interest to consider 
why jargon may have developed in these cases. While neologisms are common in aphasias 
resulting from acute focal brain damage (in particular strokes affecting the posterior superior 
temporal–inferior parietal region), neologistic jargon has rarely been reported in 
neurodegenerative disease (Ostberg et al, 2001; Graham et al, 2001). In particular, it is not 
mentioned in consensus criteria for frontotemporal lobar degeneration (FTLD) subtypes 
including PPA nor in recent reviews of PPA or FTLD (Grossman et al, 2004; Hodges et al, 
2007). The speech of patients with SD often consists of empty, circumlocutory phrases 
somewhat similar to those produced by patients with stroke aphasias such as transcortical 
sensory aphasia or Wernicke’s aphasia (Jefferies et al, 2006b), however neologisms are rarely 
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reported. One previously described case of SD studied late in the disease course exhibited 
nonword production on a verbal fluency task although spontaneous neologisms were not 
described (Jefferies et al, 2006b). Neologisms are rarely described as a feature of PNFA or LPA. 
Both cases here had a clinical syndrome of PPA with additional features that would be atypical 
for FTLD yet would not fulfil alternative diagnostic categorisations such as Alzheimer’s disease 
(AD). Although Case 1 had clear evidence of severe semantic memory impairment there were 
also early clinical features of dominant parietal lobe impairment which would not be typical of 
SD. Moreover, findings on brain imaging were not typical for SD (Chan et al, 2001b) in that 
there was no anteroposterior gradient of atrophy in the temporal lobes, the left superior 
temporal gyrus was severely involved, and atrophy extended posteriorly to involve the left 
parietal lobe. Case 2 had a diagnosis of PNFA, presenting with classical features of non-fluent 
speech, agrammatism, phonemic paraphasias and impaired polysyllabic word repetition. Of 
note, as well as asymmetrical left-sided predominant temporal lobe atrophy, he also had early 
involvement of the dominant inferior parietal lobe both clinically (dyscalculia) and 
radiologically with extension of atrophy along the Sylvian fissure. This pattern of atrophy is 
described in previous cases of PNFA although more often in the presence of a corticobasal 
degeneration syndrome which Case 2 did not have. The occurrence of neologistic errors in 
speech may be difficult to interpret in the setting of severe speech production impairment 
associated with speech apraxia and/or dysarthria. However, Case 2 exhibited clear neologistic 
errors in written output, demonstrating that such errors represent a true jargon language 
disturbance in the context of a non-fluent aphasia. 
 
One cannot argue that jargon was the only salient feature of the language disturbance in these 
cases (Case 2, for example, clearly made perseverative errors: see Table 6.3.2). Rather, it is 
proposed that the less typical finding of jargon in neurodegenerative disease (PPA) may have 
localising value as a clinical signature of the anatomical pattern of disease spread and may 
constitute a clinico-anatomical analogue of jargon in acute aphasia. While the 
histopathological diagnosis in these cases must remain moot, taken together, the clinical and 
radiological findings are consistent with the concept that involvement of the posterior superior 
temporal and parietal lobes may modify the phenotype of patients who present with 
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progressive language impairment due to a neurodegenerative disorder (PPA). The parieto-
temporal distribution of disease may lead to the appearance of neologistic jargon in a 
proportion of such cases. In SD and PNFA posterior temporal and parietal lobe involvement is 
usually a late feature, whereas in LPA these regions are implicated at presentation. It is 
noteworthy that detailed analysis of speech errors in patients with AD (in which parietal lobe 
involvement is typically prominent) reveals a number of similarities with ‘Wernicke’s aphasia’ 
(Nicholas et al, 1995), though aphasic disturbances including jargon may be relatively de-
emphasised in the face of the more widespread deficits that accompany evolving AD.  
 
Proposed explanations of the core defect in neologistic jargon aphasia include failure of lexical 
retrieval and impaired monitoring of own speech (Marshall et al, 1998). The former defect 
would account for failure to activate the correct item from the lexical store, while the latter 
defect could account for the frequent observation (as here) that patients with jargon language 
are frequently unaware of the errors they make. Self-monitoring is a complex neurolinguistic 
process with a number of elements which may break down in disease (Hartsuiker et al, 2005). 
It has been shown that failure of self-monitoring cannot be solely due to impaired speech 
comprehension and this would be consistent with the observation that most patients with 
primary progressive language disorders who have impaired comprehension do not produce 
jargon (Marshall et al, 1998).  
 
Jargon agraphia has been described in association with a number of anatomical lesions 
including both left and right-sided temporal lobe atrophy (Ostberg et al, 2001; Graham et al, 
2001; Shintani et al, 2001). It often occurs in conjunction with Wernicke’s aphasia, consistent 
with involvement of different language channels as part of the core syndrome. A number of 
deficits have been proposed to underpin jargon agraphia: these include impaired assembly of 
graphemes prior to production (the ‘graphemic buffer’), an impaired spelling system, and 
impaired access to orthographic information. While it is not possible to determine which if any 
of these deficits is responsible in Case 2, involvement of the dominant parietal lobe suggests 
that impaired access to stored orthographic representations is plausible, and might implicate a 
mechanism analogous to that governing spoken output. Due to the sparsity of spontaneous 
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speech in Case 2, it is not clear to what extent jargon agraphia signifies differential involvement 
of spoken and written language output pathways in this case. Unlike most reported cases of 
jargon aphasia and agraphia, neologistic production in Case 2 was at a single word level rather 
than a sentence level, arguing against a simple compensatory process (Marshall, 2006). 
 
Failure of lexical retrieval or self-monitoring in jargon aphasia would not in itself account for 
the production of novel, meaningless material (neologisms) (Marshall, 2006), and the lower 
frequency of this syndrome in chronic degenerative compared with acute disease states also 
remains to be explained. Functional disconnection between stored lexical representations and 
the language output pathways could lead to aberrant or random activation of phonemes in 
neologistic jargon, due to damage involving a key interface for linking stored lexical templates 
with verbal output in the posterior superior temporal – inferior parietal region (Warren et al, 
2005). This would be consistent with the emergence of neologisms in both Wernicke’s and 
conduction aphasia (Kertesz et al, 1970). One would predict that degenerative disease heavily 
involving this posterior region should also give rise to neologisms. The present cases illustrate 
the importance of longitudinal assessment of language in patients with PPA and other 
neurodegenerative diseases, and the need for clinicians to remain alert to the emergence of 
features that may signal particular patterns of disease in the brain and which may therefore 
ultimately have diagnostic value. A larger prospective study with post mortem correlation 
would be required to clarify fully the anatomical correlates of this phenomenon and its 
histopathological associations.  
 
It is likely that involvement of the posterior temporal – inferior parietal region is necessary but 
not of itself sufficient for the development of jargon in degenerative disease. In addition to the 
macroscopic distribution of disease, other factors such as the potential for partial functional 
compensation or reorganisation in progressive disease states and the microscopic distribution 
of tissue pathology within local cortical networks may influence the development of jargon. 
The study of patients with jargon may therefore provide insights into the broader and more 
fundamental issue of the brain mechanisms that underpin phenomenological similarities and 
divergences between the acute and progressive aphasias (Hillis, 2007). 
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6.4 Apraxia in progressive nonfluent aphasia 
Apraxia can be defined as a higher order motor disorder of skilled and/or learned motor 
movements (Leiguarda et al, 2000). The motor control deficit in apraxia may be specific for 
particular movements or body parts: amongst these, apraxia of limb movements is most often 
described, however apraxias of the cranial musculature (orofacial apraxia: Geschwind, 1965) 
and apraxia of the finely coordinated movements of articulation (apraxia of speech, AOS: Ogar 
et al, 2005) are also well recognised. The nature and brain basis for these specific disorders of 
voluntary action have not been fully defined, and apraxia remains an issue of considerable 
neurobiological as well as clinical interest.   
 
As discussed in previous Chapters recent studies (including that discussed in Chapter 5.2) have 
stressed the importance of apraxia of speech (AOS) as a defining feature of of patients with 
PNFA (Josephs et al, 2006; Josephs et al, 2008a): AOS is a motor speech disorder with the 
features of hesitancy, effortfulness with articulatory groping, phonetic errors and dysprosody 
(Croot, 2002; Ogar et al, 2005). As described above, PNFA may be associated clinically with 
parkinsonian syndromes, in particular either a corticobasal syndrome (CBS) or a progressive 
supranuclear palsy (PSP) syndrome. At post mortem, abnormal tau inclusions are often seen in 
PNFA, with the 4-repeat tauopathies of corticobasal degeneration or PSP common underlying 
pathologies (Josehs et al, 2006; Josephs et al, 2008a). Limb apraxia is a well-known feature of 
CBS (Graham et al, 2003) and can also occur with PSP syndromes (Pharr et al, 2001, Soliveri et 
al, 2005). Although less well studied, orofacial apraxia may also develop in CBS (Ozsancak et 
al, 2000; Ozsancak et al, 2004). The clinico-pathological overlap of CBS and PSP with PNFA, 
coupled with the central role of AOS in the PNFA syndrome, suggests that apraxia of different 
kinds may be clinically relevant in PNFA. Both orofacial (or buccofacial) apraxia (Tyrrell et al, 
1991; Fuh et al, 1994; Sakurai et al, 1996; Sakurai et al, 1998; Roth et al, 2006) and limb 
apraxia (Joshi et al, 2003) have been reported in PNFA, however these associations have not 
been studied systematically. Furthermore, although AOS has been associated with atrophy in 
the left frontal lobe and insula (Ogar et al, 2006: Ogar et al, 2007; Josephs et al, 2006), the 
neuroanatomical correlates of the apraxias accompanying focal dementia syndromes have not 
been established. In this study, speech, orofacial and limb praxis were assessed in a cohort of 
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patients with PNFA and assessed neuroanatomical correlates of the corresponding apraxis 
using the semi-automated and unbiased technique of voxel-based morphometry (VBM).  
 
METHODS 
Sixteen consecutively diagnosed patients with a diagnosis of PNFA were included in the study. 
This was performed subsequent to the study in Chapter 5 and so does not exactly coincide with 
the patients in that study. The PNFA cohort comprised twelve men and four women with a 
mean (standard deviation) age at assessment of 72.1 (6.9) years and disease duration from 
symptom onset of 5.8 (2.1) years. Five patients had parkinsonian features when assessed: three 
had CBS, and two PSP.   
 
Apraxia analysis 
The subscores from the Apraxia Battery for Adults 2 (ABA-2, Dabul, 2000) were used as 
measures of apraxia. Diadochokinetic (DDK) rate score (ABA-2 subtest 1) was measured by 
asking patients to repeat the phrases “puh-tuh”, “tuh-kuh”, “puh-tuh-kuh” and “pluh-kruh-tuh” 
as many times as possible in 3 seconds (for two syllable phrases) and 5 seconds (for three 
syllable phrases) for a maximum of three trials, and the sum of the best trials from each four 
phrases was used as the total score. DDK rate for alternating syllables is particularly sensitive to 
the presence of AOS (Ogar et al, 2006) and here is used as a surrogate measure of AOS 
severity. Orofacial apraxia score was based on ABA-2 subtest 3B in which patients were asked 
to perform the following actions: stick out your tongue, whistle, puff out your cheeks, pretend 
to kiss, clear your throat, bite your lower lip, show me your teeth, take a deep breath and hold 
it, lick your lips and open your mouth. Each action was scored out of 5 (i.e. maximum score 
was 50): a score of 5 was assigned when the subject made an accurate, prompt, complete and 
readable gesture; 4 when the subject made an ambiguous or incorrect gesture, but self 
corrected to an accurate response, 3 when the subject’s gesture was essentially correct, but 
crude and defective in amplitude, speed or accuracy. If the subject made no response after ten 
seconds, or attempted a response but was unsuccessful, the gesture was demonstrated by the 
examiner and scores were assigned as follows: 2 when the subject performed correctly after 
demonstration, 1 when the subject’s gesture, after demonstration was essentally correct, but 
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crude and defective in amplitude, speed or accuracy and 0 when, even after demonstration, 
the subject was unable to perform the correct gesture. Limb apraxia score was based on ABA-2 
subtest 3A in which patients were asked to perform the following gestures: make a fist, wave 
goodbye, snap your fingers, throw a ball, hide your eyes, make a hitch-hiking sign, make a 
pointing sign, salute, play the piano and scratch. Scoring was as for orofacial praxis with a 
maximum score of 50.  
 
VBM  analysis 
VBM analysis was performed as described in Chapter 2. Linear regression models were used to 
examine changes in GM volume as functions of apraxia of speech (as measured by 
diadochokinetic rate score, ABA-2 subtest 1), orofacial apraxia (ABA-2 subtest 3B score) and 
limb apraxia (ABA-2 subtest 3A score) across the PPA group. Voxel intensity, V, was modelled 
as a function of praxis score separately for each apraxia subtype, with subject age and total 
intracranial volume (TIV) included as nuisance covariates.  Maps showing statistically 
significant correlations were generated. No significant correlations were found following 
correction for multiple comparisons and maps are shown at an uncorrected p=0.001 
significance threshold. Statistical parametric maps were displayed as overlays on a study-
specific template, created by warping all native space whole-brain images to the final DARTEL 
template and calculating the average of the warped brain images. 
 
RESULTS 
All patients scored in the abnormal range for DDK rate (AOS): most (69%) scored in the mildly 
impaired range, 19% in the moderate range and 13% in the severe range (Figure 6.4.1A). For 
the orofacial apraxia measure 69% of patients scored within the abnormal range (50% mild, 
13% moderate and 6% severe) (Figure 6.4.1B). This included all of the patients with a 
parkinsonian syndrome. A substantial minority of PNFA patients had limb apraxia, 44% (7 
patients) scoring in the abnormal range (Figure 6.4.1C). These seven cases included the three 
patients with CBS and one of the patients with PSP. For orofacial apraxia score there was a 
correlation with estimated clinical disease duration (p=0.04); no such correlation was found for 
DDK rate score (p =0.23) or limb praxis (p=0.38). Although patients were not assessed formally 
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for the presence of swallowing apraxia, it is noteworthy that none of the patients included in 
this study reported clinical dysphagia. 
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Figure 6.4.1 
Diadochokinetic rate score (A), orofacial apraxia score (B) and limb apraxia score (C) as a function of disease duration in each of the patients. Mild, moderate and 
severe score cut-offs (based on ABA-2 norms) are denoted by dotted lines. !
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
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In the VBM analysis, reduced DDK rate (AOS) correlated with grey matter loss in the left 
posterior inferior frontal gyrus (frontal operculum) [-46, -1, 16] (Figure 6.4.2A), orofacial 
apraxia correlated with grey matter loss in the left inferior frontal [-32, 35, 13] and middle 
frontal [-30, 27, 27] gyri, and premotor and supplementary motor areas [-12, -7, 51] (Figure 
6.4.2B), and limb apraxia correlated with grey matter loss within the left parietal lobe [-51, -27, 
30] (Figure 6.4.2C).  !
Figure 6.4.2 
VBM analysis correlating grey matter loss with diadochokinetic rate (apraxia of speech) score (A), 
orofacial apraxia score (B) and limb apraxia score (C). Statistical parametric maps (SPMs) have been 
thresholded at p<0.001 (uncorrected) and rendered on coronal (left), axial (middle) and sagittal (right) 
sections of a study-specific average group T1-weighted MRI template image in DARTEL space. In 
coronal and axial sections, the left hemisphere (L) is shown on the left side of the image as indicated. 
All sagittal sections are through the left hemisphere. 
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DISCUSSION 
This study provides further confirmation that PNFA is associated with AOS, and reveals that 
orofacial apraxia occurs in the majority of cases while limb apraxia occurs in a substantial 
minority, particularly when there is an associated parkinsonian syndrome. Clinically, these 
findings suggest a need for some care in equating progressive apraxia with a particular entity 
such as CBS, and indicate the relevance of assessing patients presenting with PNFA for deficits 
in the programming of actions beyond speech articulation. The findings further demonstrate 
specific anatomical substrates for these different forms of apraxia in PNFA: AOS and orofacial 
apraxia are both associated with left inferior frontal gyrus atrophy, and orofacial apraxia is 
associated with additional atrophy of left middle frontal and premotor cortices, while limb 
apraxia is associated with more posterior atrophy in the left parietal lobe.  
 
The findings corroborate previous work mainly in aphasic stroke indicating that orofacial 
apraxia often though not invariably accompanies AOS (Ogar et al, 2006; Dronkers, 1996; 
Hillis et al, 2004b). Anatomically, AOS and orofacial apraxia in this neurodegenerative 
population showed common involvement of the left inferior frontal gyrus, indicating a critical 
substrate that is in proximity (though non-identical) in these disorders. The neuroanatomical 
correlates identified here are in keeping with previous evidence (Hillis et al, 2004b; Raade et 
al, 1991) and implicate shared mechanisms for the programming of different kinds of complex, 
learned motor sequences in the left inferior frontal lobe. Orofacial apraxia may have a more 
distributed anatomical basis, consistent with a more generic role in orofacial motor control. 
The finding that the development of orofacial apraxia but not AOS or limb apraxia correlates 
with disease duration may speak to the anatomical organisation of these functions: strategic 
damage involving relatively focal cortical modules may be sufficient to produce AOS or limb 
apraxia, while the more distributed control of relatively simple orofacial movements implies 
greater neural redundancy but may be correspondingly more vulnerable to cumulative cortical 
insults with the advancing neurodegenerative process.  
 
Consistent with a large body of clinical observation it was found that limb apraxia was 
associated with CBS (Okuda et al, 1999; Peigneux et al, 2001; Borroni et al, 2008), however 
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this association was not clinically specific: individual patients with PNFA and no associated 
parkinsonian features nevertheless exhibited limb apraxia. Anatomically, and in accord with 
previous anatomical evidence (Okuda et al, 1999; Peigneux et al, 2001; Borroni et al, 2008c) 
limb apraxia was associated with left parietal lobe atrophy, It may be that limb apraxia is 
indeed an early sign of the development of a parkinsonian syndrome, and longitudinal studies 
of PNFA cohorts will be required to resolve this. A further unsettled issue concerns the 
histopathological substrate for limb apraxia and for the other specific apraxias studied here, 
and in particular, any specificity for tau versus non-tau inclusions: it has been proposed that 
AOS (and indeed PNFA more generally) is closely associated with tau pathology, in particular 
corticobasal degeneration and PSP (Josephs et al, 2008a). This is a further important issue for 
future longitudinal studies with post mortem correlation. 
 !!!!!!!!!!!!!!!!!!!
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6.5 Behavioural symptoms in primary progressive aphasia 
In contrast to behavioural variant frontotemporal dementia (bvFTD) there have been relatively 
few studies of the phenomenology and brain basis of behavioural abnormalities in PPA 
(Marczinksi et al, 2004; Seeley et al, 2005; Snowden et al, 2001; Liu et al, 2004; Rosen et al, 
2006). Here clinical behavioural profiles are described in each of the subtypes of PPA and the 
neuroanatomical correlates of behavioural change in PPA are assessed using voxel-based 
morphometry. Accumulating neuroanatomical evidence suggests that complex behaviours in 
neurodegenerative disease are mediated by fronto-temporal networks, in particular, 
orbitofrontal cortex (OFC) and limbic structures with a right hemisphere emphasis. Informed by 
this previous work, the core neuroanatomical hypothesis here was that behavioural 
disturbances in PPA syndromes are associated with atrophy of OFC and its functional 
connections.  
 
METHODS  
All 33 patients described in Chapter 5.2 and 5.3 (9 with SD, 14 with PNFA, 7 with LPA and 3 
with GRN-PPA) were administered the Neuropsychiatric Inventory (NPI, Cummings et al, 
1994), a questionnaire examining the presence and severity of the following abnormal 
behaviours: delusions, hallucinations, agitation/aggression, depression/dysphoria, anxiety, 
elation/euphoria, apathy/indifference, disinhibition, irritability/lability, aberrant motor 
behaviour, abnormal sleep and abnormal appetite/eating behaviours. The NPI score is based 
on use of discrete scales: for each behaviour, the score (individual behaviours /12, total /144) is 
the mean product of individual scores on scales of severity [1, mild through to 3, severe] 
multiplied by frequency [1, occasionally through to 4, very frequently]; for severity of caregiver 
distress scores are given from 0, no distress, through to 5, extremely distressing. Apart from one 
patient with GRN-PPA who had a cardiac pacemaker all patients also had volumetric brain 
MRI. Demographic data in each of the subgroups are presented in Table 6.5.1.  !!!!
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Table 6.5.1  
Demographic data of patients !
Mean (standard deviation) SD PNFA LPA GRN-PPA 
Number of subjects 9 14 7 3 
%Male 33.3 71.4 57.1 66.6 
Age (years) 62.3 (9.0) 71.8 (6.8) 65.1 (6.4) 61.6 (9.1) 
Duration (years) 5.3 (1.2) 5.3 (2.1) 4.4 (1.0) 3.9 (0.3) 
 
Voxel-based morphometry (VBM) was performed on the patients’ brain MR images as 
described in Chapter 2. Linear regression models used to examine differences in grey matter 
intensity correlating with the presence of frequently abnormal behaviours (behaviour exhibited 
by >25% of the PPA cohort, as indexed by the NPI). For each behaviour, subjects were 
classified according to whether they did or did not exhibit that behaviour and the contrast of 
interest was the difference between these two groups. Voxel intensity, V, was modelled as a 
function of group, and subject age and total intracranial volume were included as nuisance 
covariates. No significant differences were found following correction for multiple 
comparisons. Maps showing statistically significant differences between the groups were 
generated uncorrected at p <0.001 significance level. Statistical parametric maps were 
displayed as overlays on a study-specific template, created by warping all native space whole-
brain images to the final DARTEL template and calculating the average of the warped brain 
images. 
 
RESULTS 
Abnormal behaviours exhibited by patients across the PPA cohort are summarised in Table 
6.5.2: the mean NPI score for patients exhibiting the behaviour (an index of behaviour 
salience, where each score is the mean product of individual scores [behaviour severity x 
behaviour frequency]) and the proportion of patients exhibiting each behaviour (an index of 
behaviour prevalence in that patient group) are shown. The most prevalent and salient 
behaviours across the PPA cohort were agitation/aggression, depression, anxiety, apathy, 
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disinhibition, irritability/lability, and abnormal appetite/eating disorders (Table 6.5.2). Total NPI 
score varied between 0 (in 5 patients) and 45 and there was no relationship between total 
score and duration of disease, either in the PPA cohort as a whole or in any of the subgroups. 
All patients with SD and a majority of patients in each of the PNFA, LPA and GRN-PPA 
subgroups exhibited at least one abnormal behaviour: the overall prevalence and salience of 
abnormal behaviours was similar between PPA subgroups as was the overall amount of 
caregiver distress created by the behaviours (Table 6.5.2). Most behaviours were exhibited by 
all PPA subgroups and none was wholly specific for a particular subgroup. However, different 
profiles of behavioural change were observed between subgroups. The most prevalent 
behaviours in each subgroup (defined arbitrarily as behaviours exhibited by at least half the 
patients in that subgroup), were: in SD (in rank order) depression, irritability/lability, 
disinhibition, abnormal appetite/eating disorders and anxiety; in PNFA, apathy, depression and 
agitation/aggression; in LPA, irritability/lability, anxiety, apathy and agitation/aggression; and in 
GRN-PPA, apathy and irritability/lability (Table 6.5.2).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  246 
Table 6.5.2  
NPI mean (standard deviation, StDev) scores and percentage of patients exhibiting abnormal behaviour 
in all PPA patients and in subgroups. Behaviours exhibited by at least 50% of patients in each subgroup 
are indicated in bold.  
 
 ALL SD PNFA LPA GRN-PPA 
 
Mean 
(StDev) 
% 
Mean 
(StDev) 
% 
Mean 
(StDev) 
% 
Mean 
(StDev) 
% 
Mean 
(StDev) 
% 
Delusions 0.4 (1.3) 9 0.4 (1.3) 11 0.4 (1.6) 7 0.4 (1.1) 14 0.0 (0.0) 0 
Hallucinations 0.1 (0.4) 6 0.2 (0.7) 11 0.0 (0.0) 0 0.1 (0.4) 14 0.0 (0.0) 0 
Agitation/ 
Aggression 
0.9 (1.4) 50 0.7 (1.0) 44 0.9 (1.2) 50 1.4 (2.1) 57 0.3 (0.6) 33 
Depression/ 
Dysphoria 
1.3 (1.8) 56 1.1 (0.9) 78 1.6 (2.2) 57 0.4 (0.8) 29 2.0 (3.5) 33 
Anxiety 1.2 (1.8) 50 0.8 (0.8) 56 0.8 (1.6) 36 2.6 (2.6) 71 0.7 (1.2) 33 
Elation/ 
Euphoria 
0.6 (1.6) 19 0.8 (2.0) 22 0.5 (1.6) 14 0.1 (0.4) 14 1.3 (2.3) 33 
Apathy/ 
Indifference 
1.7 (2.4) 56 0.7 (1.1) 33 2.1 (2.9) 64 2.0 (2.8) 57 1.7 (1.5) 67 
Disinhibition 1.3 (2.5) 38 2.0 (2.9) 67 0.7 (2.4) 14 1.7 (2.4) 43 0.7 (1.2) 33 
Irritability/ 
lability 
1.4 (1.9) 56 1.2 (1.4) 78 0.9 (2.1) 29 2.4 (2.3) 71 1.3 (1.2) 67 
Aberrant motor 
behaviour 
0.7 (1.6) 22 0.3 (0.7) 22 0.5 (1.2) 21 1.7 (2.9) 29 0.0 (0.0) 0 
Abnormal sleep 0.8 (1.6) 25 1.1 (1.5) 44 0.8 (1.6) 21 0.9 (2.3) 14 0.0 (0.0) 0 
Abnormal 
appetite/eating  
2.0 (3.1) 50 1.7 (1.6) 67 2.6 (4.3) 43 1.4 (2.3) 43 1.3 (2.3) 33 
Total 12.2 (12.4) 88 11.0 (7.4) 100 11.9 (14.8) 79 15.3 (15.3) 86 9.3 (8.1) 67 
Caregiver 
distress total 
9.2 (6.0) 88 9.4 (6.1) 100 7.4 (6.0) 79 9.6 (6.8) 86 5.3 (4.60 67 
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As the overall most prevalent abnormal behaviours were exhibited by all PPA subgroups, the 
subgroups were merged in the VBM analysis, in order to assess regional atrophy that correlated 
with the emergence of the behaviour for the PPA cohort as a whole. No VBM correlates were 
identified for the presence of depression or agitation/aggression (p<0.001 uncorrected). 
However partly overlapping VBM correlates were identified for other frequently abnormal 
behaviours (p<0.001 uncorrected) (Figure 6.5.1) in accord with the a priori anatomical 
hypotheses (Rosen et al, 2005; Peters et al, 2006; Whitwell et al, 2007b; Woolley et al, 2007; 
Zamboni et al, 2008; Massimo et al, 2009; Bruen et al, 2008). The presence of anxiety, apathy, 
irritability/lability, and abnormal appetite/eating disorders all correlated with reduced grey 
matter intensity in right lateral OFC (Figure 6.5.1 A-D), while the presence of disinhibition 
correlated with reduced grey matter in left lateral OFC [-34, 18, -21] (Figure 6.5.1 E). 
Additional areas of grey matter loss correlating specifically with the presence of particular 
behaviours were identified: the presence of apathy correlated with reduced grey matter 
intensity in right dorsolateral prefrontal cortex [30, 39, 37] (Figure 6.5.1 B); the presence of 
irritability/lability correlated with reduced grey matter intensity in right anterior cingulate [2, 2, 
37] (Figure 6.5.1 C); and the presence of disinhibition correlated with reduced grey matter 
intensity in left anterior superior temporal gyrus [-42, 3, -18] and entorhinal cortex [-26, -3, -
35] (Figure 6.5.1 E). !
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Figure 6.5.1  
VBM analyses on grey matter regions in contrasts based on presence versus absence of abnormal 
behaviours as shown. Statistical parametric maps (SPMs) have been thresholded at p<0.001 
(uncorrected) and rendered on a study-specific average group T1-weighted MRI template image in 
DARTEL space. In coronal and axial sections, the right hemisphere (R) is shown on the right side of the 
image. Left (L) and right (R) markers are shown for the sagittal sections. !
!!
DISCUSSION 
This study demonstrates that abnormal behaviour can develop in any of the canonical subtypes 
of PPA. While particular PPA subtypes did not show an overall predilection to develop 
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behavioural abnormalities, partly differentiable profiles of behavioural impairment were 
associated with different subtypes. In previous work, abnormal eating patterns and disinhibition 
have also been associated, as here, with SD (Snowden et al, 2001; Rosen et al, 2006). 
However, in contrast to one earlier study using the NPI (Rosen et al, 2006) this study did not 
find a substantial overall increase in behavioural dysfunction in SD compared with the other 
groups. This may be partly attributable to the variability in disease duration, but other factors 
including the fact that Rosen et al, 2006 may have included patients with ‘right temporal 
variant’ SD (who have more behavioural problems) may also have contributed. 
 
 Previous studies addressing the neuroanatomical correlates of behavioural impairment in 
dementia have implicated a predominantly right-sided network of frontal (particularly OFC), 
cingulate and striatal areas in the pathogenesis of apathy, disinhibition and abnormal appetite 
(Rosen et al, 2005; Peters et al, 2006; Whitwell et al, 2007b; Woolley et al, 2007; Zamboni et 
al, 2008; Massimo et al, 2009; Bruen et al, 2008). The present data corroborate these previous 
findings, and underline the critical role of right OFC damage in the production of a range of 
abnormal behaviours in PPA. It has been proposed that OFC is involved in processing stimulus-
reward associations: neuronal loss in this area leads to impaired ability to make such 
associations, with resulting abnormal behaviour (Viskontas et al, 2007). It has been further 
proposed that lateral OFC may be involved in organising behaviour toward a goal, while 
medial OFC evaluates the outcome (Wallis, 2007), suggesting that lateral OFC may play a 
generic role in the regulation of different kinds of behavioural output. Damage involving lateral 
OFC is therefore predicted to be associated (as here) with the emergence of a range of 
disorganised or context-inappropriate behaviours. The additional areas identified here may 
signify brain areas with more specific roles in the pathogenesis of particular abnormal 
behaviours, consistent with previous clinical studies and with emerging concepts of the 
cerebral organisation of these behaviours: dorsolateral prefrontal cortex damage has previously 
been linked with apathy (Zamboni et al, 2008), anterior cingulate dysfunction has been 
associated with emotional lability (Green et al, 2007), and entorhinal cortex participates in 
cerebral networks that mediate adaptive avoidance behaviours (Charney et al, 1996). 
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The issue of cerebral lateralisation is more problematic: neuroanatomical correlates of 
abnormal behaviour, in the present and in previous studies, are predominantly located in the 
right hemisphere, however disinhibition here correlated with damage in a left-sided 
frontotemporal network. Disinhibition might result from impaired ability to make affect-
incongruent responses, a role attributed to left OFC in normal subjects (Roelofs et al, 2009). 
Clinically, the present findings suggest that the primacy of right hemisphere damage in the 
pathogenesis of abnormal behaviour is relative rather than absolute. It is noteworthy that those 
abnormal behaviours correlating with right hemisphere atrophy in the present study (anxiety, 
apathy, irritability, appetite) might broadly result from deranged processing of internally 
generated (e.g. affective) cues, while the behaviour correlating with left hemisphere damage 
(disinhibition) results from deranged processing of external (environmental) cues. This suggests 
a possible pathophysiological basis for the differential lateralisation observed that is broadly 
consistent with other lines of evidence in affective neuroscience (Panksepp, 2003).   
 
The PPA syndromes are likely to overlap anatomically and histopathologically with bvFTD, in 
which behavioural disturbances are an early and defining feature. An anterior-cingulate fronto-
insular network with projection zones including OFC has been implicated as a critical 
substrate in bvFTD (Seeley et al, 2007). In light of the present findings in PPA, the relative 
preponderance of language versus behavioural phenomenology in the various syndromic 
variants of FTLD might reflect differential involvement of common cerebral networks. This 
issue should be explored in future longitudinal studies of behavioural impairment in PPA, 
including techniques such as diffusion tractography and functional MRI that can capture 
structure:function relations in the distributed neural networks that mediate complex 
behaviours. 
!
!
!
!
!
!
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Chapter 6 summary 
This Chapter builds upon the work in the previous Chapters to study in detail other behavioural 
and neuropsychological aspects of progressive language impairment. Single word processing 
problems seen in the groups were as predicted from previous studies and associated with a 
predominantly left-sided network of known language areas in the brain. There have been few 
studies of receptive prosody previously, and this preliminary study suggests that problems do 
occur in PPA and that this may partly account for some of the comprehension problems that 
occur as the disease progresses. Further studies are required in this area, particularly relating it 
to the underlying neuroanatomy. Neologistic jargon remains a relatively rare problem in the 
progressive language disorders and more studies are required in this area. This is difficult as it 
is likely to be a relatively late feature of the disease, and thus becomes much more difficult to 
study when patients are more globally impaired. However, identification of the LPA and GRN-
PPA phenotypes which affect more posterior temporo-parietal areas likely to give rise to jargon, 
may lead to more descriptions of this phenomenon. Apraxias are more commonly seen in the 
progressive aphasias with orofacial apraxia worsening with increased PNFA disease burden. 
Limb apraxia occurs in subset of nonfluent patients. Behavioural problems have been studied 
to a small extent before in progressive language impairment, most commonly in SD with this 
study providing added information about the nonfluent phenotypes which have been little 
studied. One of the major issues with the study presented in Chapter 6.5 is the relative 
insensitivity of the Neuropsychatric Inventory as a measure of behavioural symptoms – better 
measures are needed (of which some, e.g. the Cambridge Behavioural Inventory, are starting to 
be studied in the neurodegenerative disease population) and more longitudinal studies of 
behavioural change over time are also required.  
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7. General conclusions: the progressive aphasias 
This study provides a series of insights into the progressive aphasias from the clinical, 
neuropsychological, anatomical and molecular aspects of disease. As well as the canonical 
syndromes of PNFA and SD there is evidence of other key clinical syndromes namely LPA and 
the suggestion that the clinical syndrome associated with GRN mutations is also unique. The 
key features of the clinical/neuropsychological phenotypes of progressive language impairment 
and their anatomical, pathological and genetic associations are shown in Table 7.1.1 and 
Figure 7.1.1.  !!!!!!!!!!!!!!!!!!!!! !
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Table 7.1.1 
Clinical, neuropsychological, neuroanatomical and pathogenetic features of progressive language 
impairment !
 SD PNFA LPA GRN-PPA 
Spontaneous 
speech 
Normal rate but 
fluent, empty and 
circumlocutory 
 
Semantic errors 
Slow with hesitancy, 
effortfulness 
secondary to motor 
speech disorder 
and/or agrammatism 
 
Phonetic/apraxic 
errors 
Phonemic errors 
Slow spontaneous 
speech with word-
finding pauses 
Slow, sparse 
spontaneous speech 
with word-finding 
pauses 
Semantic 
knowledge/ 
single word 
comprehension 
Impaired secondary to 
verbal semantic 
impairment 
Initially intact but in 
late disease becomes 
affected 
Relatively intact 
Impaired relatively 
early on 
Word retrieval/ 
naming 
Anomia 
Initially can be normal 
but anomic as disease 
progresses 
Anomia Anomia 
Grammar/ 
sentence 
comprehension 
Normal initially but 
becomes impaired as 
single word 
comprehension 
deteriorates 
Impaired for complex 
sentences 
Impaired for simple 
and complex 
sentences 
Impaired 
Single word 
repetition 
Normal 
Impaired with 
phonetic/apraxic 
errors 
Relatively intact Impaired 
Sentence 
repetition 
Often normal initially 
but can make 
transposition errors 
Can be impaired Impaired Impaired 
Motor speech 
impairment/ 
apraxia of 
speech 
None Present None None 
Reading Surface dyslexia Phonological dyslexia Phonological dyslexia 
Deep/ 
phonological dyslexia 
 
  254 
Other cognitive 
domains involved 
Non-verbal semantic 
impairment, can 
develop object 
agnosia or 
prosopagnosia 
Can later develop 
dominant parietal 
impairment 
(dyscalculia, limb 
apraxia) particularly if 
associated with CBS 
Phonological memory 
deficit and therefore 
poor forwards digits 
span. Early dominant 
parietal impairment 
and verbal memory 
deficit 
Early dominant 
parietal impairment 
Behavioural 
symptoms 
Disinhibition, appetite 
change, depression 
Apathy, depression, 
agitation/aggression 
Anxiety, 
irritability/lability 
Apathy, 
irritability/lability 
Neurological 
examination 
Usually none 
Can be associated 
with a parkinsonian 
syndrome or rarely 
motor neurone 
disease 
Usually normal 
Usually normal but 
can be associated 
parkinsonian 
syndrome 
Neuroanatomy 
(predominant 
areas of atrophy) 
Asymmetrical 
anteroinferior 
temporal lobe 
involvement  
 
With spread to frontal 
and anterior cingulate 
areas (also parietal 
particularly when 
associated with Pick’s 
disease) 
Asymmetrical left 
inferior frontal and 
insula atrophy 
 
 
With spread to middle 
and superior frontal 
areas, temporal lobe, 
particularly superiorly 
and anterior parietal 
lobe 
Asymmetrical left 
greater than right 
temporo-parietal 
junction and 
hippocampal atrophy 
 
With spread more 
anteriorly in the 
temporal lobe and 
posterior cingulate 
involvement 
Asymmetrical left 
greater than right 
fronto-temporo-
parietal lobe atrophy 
 
 
With spread 
throughout the left 
hemisphere and then 
right hemisphere 
involvement. 
Pathogenetic 
associations 
FTLD-TDP type 1 >> 
Tau-positive Pick’s 
disease + few reports 
of AD pathology 
Tau-positive 
pathology i.e. CBD, 
PSP, Pick’s disease  
>> FTLD-TDP 
pathology + few 
reports of AD 
pathology 
AD >> FTLD-TDP 
pathology 
FTLD-TDP type 3 
pathology 
 
 GRN mutations 
!!!!!!!
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Figure 7.1.1  
Clinico-pathological and clinico-genetic associations in primary progressive aphasia. PPA as a syndrome 
has heterogeneous genetic and pathological associations. However, the importance of subtyping PPA is 
shown by the third row of boxes which show in a schematic manner the pathological associations with 
SD, PNFA, LPA and with the familial GRN-associated form of PPA, where one pathological subtype 
tends to dominate. Each of the pathological subtypes are indicated by a separate coloured box: FTLD-
TDP types 1 to 3 or type unclear if subtyping had not been performed, FTLD-tau (corticobasal 
degeneration, CBD; progressive supranuclear palsy, PSP; and Pick’s disease), and Alzheimer pathology.  
!
!
!
Importantly, this study also opens up two further important avenues of research in the 
progressive aphasias: firstly, a possible reclassification of the disorders in terms of the 
underlying proteinopathy which would allow patients with progressive language impairment to 
be entered into trials of disease-modifying treatment targeted at specific proteins and secondly, 
linking the underlying proteinopathy to the pathophysiological process occurring in these 
disorders which would allow insight into how neurodegenerative disorders occur and spread 
throughout the brain.  
 
The classification of the progressive aphasias by clinical/neuropsychological phenotype has 
been controversial amongst different research groups with some lumping all patients with 
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progressive language impairment together into one group called primary progressive aphasia. It 
is clear however from previous research reviewed here and the work in this study that PPA can 
be split into clinical/neuropsychological subtypes. This study suggests there are at least four 
subtypes but further work is required to support this work. Perhaps one way of overcoming 
such disagreements between PPA researchers is to primarily reclassify PPA at a different level, 
that of the underlying pathological and genetic basis. Such a classification is outlined in Table 
7.1.2. 
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Table 7.1.2 
Pathological/genetic classification of the progressive aphasias !
Pathological/genetic 
classification of 
progressive language 
impairment 
Definitive or probable diagnosis Likely diagnosis 
FTLD-TDP type 1 No diagnostic test available 
Asymmetrical pattern of atrophy or 
hypometabolism limited to 
anterior/inferior temporal lobe on 
MRI/PET/SPECT 
FTLD-TDP type 2 
(not studied here) 
No diagnostic test available 
Presence of motor neurone disease 
(type 2 or 3) 
FTLD-TDP type 3 (mostly 
due to progranulin 
mutations) 
Testing for progranulin mutations 
or progranulin ELISA 
No diagnostic test for non-GRN 
cases 
Presence of motor neurone disease 
(type 2 or 3) 
CBD No diagnostic test available 
Presence of a corticobasal 
syndrome 
PSP No diagnostic test available 
Presence of a progressive 
supranuclear palsy syndrome 
Pick’s disease No diagnostic test available None 
Alzheimer’s disease 
Positive PIB-PET scan or 
characteristic CSF biomarker 
profile (high tau/low A!42) 
- 
!
As can be seen from Table 7.1.2, the ability to classify patients pathogenetically is currently 
difficult. However, patients with AD pathology can be identified if a PIB-PET scan is available 
or diagnosed with good sensitivity and specificity if CSF biomarkers of tau and A!42 are 
available. This diagnosis will become easier when a ligand with a longer half-life than PIB 
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becomes available (and therefore obviate the need to be a centre with a cyclotron) or when 
more pathologically-based studies of CSF biomarkers show high sensitivity and sensitivity for a 
diagnosis of AD (and the availability of the biomarkers become more widespread). This leaves 
the patients with the FTLD pathologies of tau and TDP-43 pathology and the difficulty of 
separating these two groups either into just tau versus TDP-43 or into the six subtypes (3 FTLD-
TDP pathologies, type 1 to 3, and 3 tau-pathologies, CBD, PSP and Pick’s disease). There is 
currently no molecular PET imaging for tau or TDP-43 proteins nor any specific serum or CSF 
biomarkers (although there are small studies of serum TDP-43 levels which requires further 
investigation: (Foulds et al, 2008; Foulds et al, 2009). There are however some supportive 
features which will give a variable sensitivity and specificity for either tau or TDP-43 
pathology. The presence of a progressive supranuclear palsy syndrome is suggestive of tau 
pathology (although not 100% as some very rare cases have been described with ubiquitin-
positive inclusions (Paviour et al, 2004) and as shown in Chapter 5 it is often not present early 
on). The presence of an apraxia of speech is also likely to be suggestive of tau pathology 
(Josephs et al, 2006). A corticobasal syndrome is likely to be due to tau pathology but it is less 
specific than a PSP syndrome as there are a number of cases described with TDP pathology in 
association with progressive language impairment. With FTLD-TDP, a diagnosis of a 
progranulin mutation is definitive for such pathology but it may be easier (and cheaper) to 
initially perform a progranulin level by ELISA which has recently been shown to be highly 
predictive of progranulin mutations (Coppola et al, 2008; Finch et al, 2008). The presence of 
motor neurone disease is also predictive of TDP pathology (either type 2 or 3) but may occur 
later in the disease after the presentation with language impairment. The presence of the 
classical SD imaging pattern of asymmetrical anteroinferior temporal lobe atrophy also has 
relatively high specificity and sensitivity for FTLD-TDP type 1 pathology. In summary, a 
combination of neurological, neuropsychological, imaging and CSF (or PIB-PET) data currently 
can provide an imperfect pathogenetic classification of the progressive aphasias but it is likely 
that with improved molecular imaging and CSF techniques this will improve.  
 
One of the questions that arises from the classification of the progressive aphasias as 
proteinopathies is how such protein deposition in neurones actually causes progressive 
  259 
language impairment. This topic was briefly touched upon in Chapter 1 when discussing the 
differences between these disorders and the acute, particularly vascular, aphasias and also, 
more substantially, in Chapter 4.3 discussing the differences between patterns of atrophy in 
GRN and MAPT mutations. It is likely that the clinical/neuropsychological phenotype of 
progressive language disorders arises from dysfunction with a specific neural network: both 
pathological and neuroimaging research has suggested that this is the case for bvFTD, ascribed 
to selective vulnerability of von Economo neurons within a frontal-insula-anterior cingulate 
network (Seeley et al, 2006; Seeley et al, 2007; Seeley, 2008; Seeley et al, 2008). 
Pathophysiological networks are less clear for the progressive language disorders but there are 
suggestions arising from this work. As discussed in Chapter 4.3, the different mutations and 
pathologies can have variable clinical/neuropsychological presentations suggesting that 
molecular lesions do not specify a precise initial anatomical locus of brain damage. However, 
the evidence here suggests that, once initiated, the pattern of disease evolution that can occur 
in the different pathologies is constrained by the underlying molecular abnormality. TDP type 1 
and type 3 and also the tau-positive pathologies have been shown to be associated with 
asymmetrical atrophy. Although spread occurs to the other hemisphere it appears to spread 
more easily through the same hemisphere (the evidence in Chapter 3.4 and 4.4 suggestive of 
increasing asymmetry of atrophy as the disease progresses) and the extent and time from 
disease onset when the right hemisphere becomes involved differs between the different 
pathologies. The extent of symmetry (or asymmetry) is likely to depend on whether the disease 
spreads preferentially through long-range association tracts (which appears to be the case in 
most of these pathologies) rather than short-range interhemispheric connections (which seems 
to be the case in MAPT mutations). This suggests that the long-range association tracts in the 
left hemisphere which are well-known to be part of the language neural network (e.g. the 
superior and inferior longitudinal fasciculi) are vulnerable to the deposition of certain proteins 
within the cells in that network. Spread of disease through a particular vulnerable network 
predicts the likely clinical phenotypes associated with a particular pathology e.g. CBD 
pathology, when it affects the left hemisphere is likely to cause PNFA if it affects the anterior 
section of the fronto-parietal network or a corticobasal syndrome if it affects the posterior part. 
This also predicts that there is a right hemisphere mirror network which can also be affected 
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initially causing bvFTD if the anterior part of the network is affected and corticobasal syndrome 
if the posterior part is affected first. These predictions are easily testable and there is 
preliminary evidence from the different phenotypes seen with CBD pathology that this is the 
case. Further pathological and imaging studies (e.g. resting state functional MRI or 
tractography) are required to fully identify such networks and the vulnerable neuronal 
populations in the different pathologies. 
 
This thesis therefore provides neurological, neuropsychological and imaging data with related 
genetic and pathological information that can provide greater insights into the natural history 
and classification, and therefore pathophysiological basis of the neurodegenerative disorders 
that cause primary progressive language impairment. Ultimately, this information will 
hopefully be useful in moving the neuroscientific community further forwards in understanding 
these conditions, so that treatments can be discovered, trialled and finally used in clinical 
practice to treat, and eventually cure the progressive language disorders. 
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